Bacteroides caccae 3452A is an anaerobe, rod-shaped bacterium that was isolated from human faeces.
rod-shaped anaerobe genome sequence 16S sequence Bacteria| @ref 20215 |
|
|
| Domain Bacteria |
| Phylum Bacteroidota |
| Class Bacteroidia |
| Order Bacteroidales |
| Family Bacteroidaceae |
| Genus Bacteroides |
| Species Bacteroides caccae |
| Full scientific name Bacteroides caccae Johnson et al. 1986 |
| BacDive ID | Other strains from Bacteroides caccae (4) | Type strain |
|---|---|---|
| 142386 | B. caccae CCUG 12221 | |
| 143032 | B. caccae CCUG 16431 | |
| 159505 | B. caccae H6_7, DSM 108144 | |
| 159506 | B. caccae H1_3, DSM 108159 |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 7844 | COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) | Medium recipe at MediaDive | Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base | ||
| 7844 | CHOPPED MEAT MEDIUM (DSMZ Medium 78) | Medium recipe at MediaDive | Name: CHOPPED MEAT MEDIUM (DSMZ Medium 78; with strain-specific modifications) Composition: Ground beef 500.0 g/l Casitone 30.0 g/l Agar 15.0 g/l Ethanol 9.5 g/l (optional) K2HPO4 5.0 g/l Yeast extract 5.0 g/l L-Cysteine HCl 0.5 g/l Haemin 0.005 g/l Resazurin 0.001 g/l Vitamin K3 0.0005 g/l (optional) Vitamin K1 (optional) NaOH (optional) Distilled water | ||
| 34561 | MEDIUM 20 - for Anaerobic bacteria | Agar (15.000 g);Glucose (5.000 g);Yeast extract (20.000 g);Tryptone (30.000 g);Cysteine hydrochloride (0.500 g);distilled water (1000.000 ml);Hemin solution -M00149 (25.000 ml) | |||
| 7844 | FASTIDIOUS ANAEROBE BROTH (DSMZ Medium 1203a) | Medium recipe at MediaDive | Name: FASTIDIOUS ANAEROBE BROTH (DSMZ Medium 1203a) Composition: Fastidious Anaerobe Basal Broth 35.4 g/l Distilled water | ||
| 117087 | CIP Medium 20 | Medium recipe at CIP |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68380 | 29016 ChEBI | arginine | - | hydrolysis | from API rID32A |
| 68367 | 17057 ChEBI | cellobiose | - | builds acid from | from API 20A |
| 68367 | 17634 ChEBI | D-glucose | + | builds acid from | from API 20A |
| 68367 | 16899 ChEBI | D-mannitol | - | builds acid from | from API 20A |
| 68380 | 16024 ChEBI | D-mannose | + | fermentation | from API rID32A |
| 68367 | 16024 ChEBI | D-mannose | + | builds acid from | from API 20A |
| 68367 | 65327 ChEBI | D-xylose | + | builds acid from | from API 20A |
| 68367 | 4853 ChEBI | esculin | + | hydrolysis | from API 20A |
| 68367 | 5291 ChEBI | gelatin | - | hydrolysis | from API 20A |
| 68367 | 17754 ChEBI | glycerol | - | builds acid from | from API 20A |
| 68367 | 30849 ChEBI | L-arabinose | + | builds acid from | from API 20A |
| 68380 | 29985 ChEBI | L-glutamate | + | degradation | from API rID32A |
| 68367 | 62345 ChEBI | L-rhamnose | + | builds acid from | from API 20A |
| 68367 | 17716 ChEBI | lactose | + | builds acid from | from API 20A |
| 68367 | 17306 ChEBI | maltose | - | builds acid from | from API 20A |
| 68367 | 6731 ChEBI | melezitose | - | builds acid from | from API 20A |
| 68380 | 17632 ChEBI | nitrate | - | reduction | from API rID32A |
| 117087 | 17632 ChEBI | nitrate | - | reduction | |
| 117087 | 16301 ChEBI | nitrite | - | reduction | |
| 68380 | 16634 ChEBI | raffinose | + | fermentation | from API rID32A |
| 68367 | 16634 ChEBI | raffinose | + | builds acid from | from API 20A |
| 68367 | 17814 ChEBI | salicin | - | builds acid from | from API 20A |
| 68367 | 30911 ChEBI | sorbitol | - | builds acid from | from API 20A |
| 68367 | 17992 ChEBI | sucrose | + | builds acid from | from API 20A |
| 68367 | 27082 ChEBI | trehalose | + | builds acid from | from API 20A |
| 68380 | 27897 ChEBI | tryptophan | - | energy source | from API rID32A |
| 68367 | 27897 ChEBI | tryptophan | - | energy source | from API 20A |
| 68380 | 16199 ChEBI | urea | - | hydrolysis | from API rID32A |
| 68367 | 16199 ChEBI | urea | - | hydrolysis | from API 20A |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68382 | acid phosphatase | - | 3.1.3.2 | from API zym |
| 68380 | alanine arylamidase | + | 3.4.11.2 | from API rID32A |
| 68382 | alkaline phosphatase | + | 3.1.3.1 | from API zym |
| 68380 | alkaline phosphatase | + | 3.1.3.1 | from API rID32A |
| 68382 | alpha-chymotrypsin | - | 3.4.21.1 | from API zym |
| 68382 | alpha-fucosidase | - | 3.2.1.51 | from API zym |
| 68380 | alpha-fucosidase | + | 3.2.1.51 | from API rID32A |
| 68382 | alpha-galactosidase | - | 3.2.1.22 | from API zym |
| 68380 | alpha-galactosidase | + | 3.2.1.22 | from API rID32A |
| 68382 | alpha-glucosidase | - | 3.2.1.20 | from API zym |
| 68382 | alpha-mannosidase | - | 3.2.1.24 | from API zym |
| 68380 | arginine dihydrolase | - | 3.5.3.6 | from API rID32A |
| 68382 | beta-galactosidase | + | 3.2.1.23 | from API zym |
| 68380 | beta-galactosidase | + | 3.2.1.23 | from API rID32A |
| 68380 | beta-Galactosidase 6-phosphate | - | from API rID32A | |
| 68382 | beta-glucosidase | - | 3.2.1.21 | from API zym |
| 68367 | beta-glucosidase | + | 3.2.1.21 | from API 20A |
| 68382 | beta-glucuronidase | - | 3.2.1.31 | from API zym |
| 117087 | catalase | - | 1.11.1.6 | |
| 68367 | catalase | - | 1.11.1.6 | from API 20A |
| 68382 | cystine arylamidase | - | 3.4.11.3 | from API zym |
| 68382 | esterase (C 4) | - | from API zym | |
| 68382 | esterase lipase (C 8) | + | from API zym | |
| 68367 | gelatinase | - | from API 20A | |
| 68380 | glutamate decarboxylase | + | 4.1.1.15 | from API rID32A |
| 68380 | L-arginine arylamidase | + | from API rID32A | |
| 68382 | leucine arylamidase | - | 3.4.11.1 | from API zym |
| 68380 | leucine arylamidase | + | 3.4.11.1 | from API rID32A |
| 68380 | leucyl glycin arylamidase | + | 3.4.11.1 | from API rID32A |
| 68382 | lipase (C 14) | - | from API zym | |
| 68382 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 | from API zym |
| 68382 | naphthol-AS-BI-phosphohydrolase | - | from API zym | |
| 117087 | oxidase | - | ||
| 68380 | proline-arylamidase | - | 3.4.11.5 | from API rID32A |
| 68380 | pyrrolidonyl arylamidase | - | 3.4.19.3 | from API rID32A |
| 68382 | trypsin | - | 3.4.21.4 | from API zym |
| 68380 | tryptophan deaminase | - | 4.1.99.1 | from API rID32A |
| 117087 | urease | - | 3.5.1.5 | |
| 68380 | urease | - | 3.5.1.5 | from API rID32A |
| 68367 | urease | - | 3.5.1.5 | from API 20A |
| 68382 | valine arylamidase | - | from API zym |
| @ref | pathway | enzyme coverage | annotated reactions | external links | |
|---|---|---|---|---|---|
| 66794 | coenzyme A metabolism | 100 | 4 of 4 | ||
| 66794 | gluconeogenesis | 100 | 8 of 8 | ||
| 66794 | C4 and CAM-carbon fixation | 100 | 8 of 8 | ||
| 66794 | L-lactaldehyde degradation | 100 | 3 of 3 | ||
| 66794 | ppGpp biosynthesis | 100 | 4 of 4 | ||
| 66794 | O-antigen biosynthesis | 100 | 5 of 5 | ||
| 66794 | palmitate biosynthesis | 100 | 22 of 22 | ||
| 66794 | cis-vaccenate biosynthesis | 100 | 2 of 2 | ||
| 66794 | acetate fermentation | 100 | 4 of 4 | ||
| 66794 | glycogen metabolism | 100 | 5 of 5 | ||
| 66794 | formaldehyde oxidation | 100 | 3 of 3 | ||
| 66794 | biotin biosynthesis | 100 | 4 of 4 | ||
| 66794 | anapleurotic synthesis of oxalacetate | 100 | 1 of 1 | ||
| 66794 | folate polyglutamylation | 100 | 1 of 1 | ||
| 66794 | suberin monomers biosynthesis | 100 | 2 of 2 | ||
| 66794 | sulfopterin metabolism | 100 | 4 of 4 | ||
| 66794 | CDP-diacylglycerol biosynthesis | 100 | 2 of 2 | ||
| 66794 | teichoic acid biosynthesis | 100 | 1 of 1 | ||
| 66794 | tetrahydrofolate metabolism | 92.86 | 13 of 14 | ||
| 66794 | vitamin B6 metabolism | 90.91 | 10 of 11 | ||
| 66794 | chorismate metabolism | 88.89 | 8 of 9 | ||
| 66794 | lipid A biosynthesis | 88.89 | 8 of 9 | ||
| 66794 | aspartate and asparagine metabolism | 88.89 | 8 of 9 | ||
| 66794 | propanol degradation | 85.71 | 6 of 7 | ||
| 66794 | vitamin B1 metabolism | 84.62 | 11 of 13 | ||
| 66794 | pyrimidine metabolism | 84.44 | 38 of 45 | ||
| 66794 | pentose phosphate pathway | 81.82 | 9 of 11 | ||
| 66794 | metabolism of amino sugars and derivatives | 80 | 4 of 5 | ||
| 66794 | peptidoglycan biosynthesis | 80 | 12 of 15 | ||
| 66794 | glycine betaine biosynthesis | 80 | 4 of 5 | ||
| 66794 | starch degradation | 80 | 8 of 10 | ||
| 66794 | lipoate biosynthesis | 80 | 4 of 5 | ||
| 66794 | threonine metabolism | 80 | 8 of 10 | ||
| 66794 | vitamin K metabolism | 80 | 4 of 5 | ||
| 66794 | photosynthesis | 78.57 | 11 of 14 | ||
| 66794 | NAD metabolism | 77.78 | 14 of 18 | ||
| 66794 | valine metabolism | 77.78 | 7 of 9 | ||
| 66794 | d-mannose degradation | 77.78 | 7 of 9 | ||
| 66794 | serine metabolism | 77.78 | 7 of 9 | ||
| 66794 | phenylalanine metabolism | 76.92 | 10 of 13 | ||
| 66794 | alanine metabolism | 75.86 | 22 of 29 | ||
| 66794 | purine metabolism | 75.53 | 71 of 94 | ||
| 66794 | 6-hydroxymethyl-dihydropterin diphosphate biosynthesis | 75 | 6 of 8 | ||
| 66794 | glycogen biosynthesis | 75 | 3 of 4 | ||
| 66794 | CMP-KDO biosynthesis | 75 | 3 of 4 | ||
| 66794 | glutamate and glutamine metabolism | 75 | 21 of 28 | ||
| 66794 | isoleucine metabolism | 75 | 6 of 8 | ||
| 66794 | flavin biosynthesis | 73.33 | 11 of 15 | ||
| 66794 | degradation of hexoses | 72.22 | 13 of 18 | ||
| 66794 | cardiolipin biosynthesis | 71.43 | 5 of 7 | ||
| 66794 | citric acid cycle | 71.43 | 10 of 14 | ||
| 66794 | propionate fermentation | 70 | 7 of 10 | ||
| 66794 | myo-inositol biosynthesis | 70 | 7 of 10 | ||
| 66794 | Entner Doudoroff pathway | 70 | 7 of 10 | ||
| 66794 | acetoin degradation | 66.67 | 2 of 3 | ||
| 66794 | octane oxidation | 66.67 | 2 of 3 | ||
| 66794 | UDP-GlcNAc biosynthesis | 66.67 | 2 of 3 | ||
| 66794 | CO2 fixation in Crenarchaeota | 66.67 | 6 of 9 | ||
| 66794 | glycolysis | 64.71 | 11 of 17 | ||
| 66794 | proline metabolism | 63.64 | 7 of 11 | ||
| 66794 | d-xylose degradation | 63.64 | 7 of 11 | ||
| 66794 | degradation of sugar alcohols | 62.5 | 10 of 16 | ||
| 66794 | degradation of pentoses | 60.71 | 17 of 28 | ||
| 66794 | hydrogen production | 60 | 3 of 5 | ||
| 66794 | cellulose degradation | 60 | 3 of 5 | ||
| 66794 | non-pathway related | 57.89 | 22 of 38 | ||
| 66794 | isoprenoid biosynthesis | 57.69 | 15 of 26 | ||
| 66794 | ubiquinone biosynthesis | 57.14 | 4 of 7 | ||
| 66794 | lysine metabolism | 54.76 | 23 of 42 | ||
| 66794 | metabolism of disaccharids | 54.55 | 6 of 11 | ||
| 66794 | methionine metabolism | 53.85 | 14 of 26 | ||
| 66794 | leucine metabolism | 53.85 | 7 of 13 | ||
| 66794 | histidine metabolism | 51.72 | 15 of 29 | ||
| 66794 | lipid metabolism | 51.61 | 16 of 31 | ||
| 66794 | ketogluconate metabolism | 50 | 4 of 8 | ||
| 66794 | dTDPLrhamnose biosynthesis | 50 | 4 of 8 | ||
| 66794 | ethanol fermentation | 50 | 1 of 2 | ||
| 66794 | pantothenate biosynthesis | 50 | 3 of 6 | ||
| 66794 | adipate degradation | 50 | 1 of 2 | ||
| 66794 | phenylmercury acetate degradation | 50 | 1 of 2 | ||
| 66794 | butanoate fermentation | 50 | 2 of 4 | ||
| 66794 | degradation of sugar acids | 48 | 12 of 25 | ||
| 66794 | tryptophan metabolism | 47.37 | 18 of 38 | ||
| 66794 | oxidative phosphorylation | 46.15 | 42 of 91 | ||
| 66794 | arginine metabolism | 45.83 | 11 of 24 | ||
| 66794 | cysteine metabolism | 44.44 | 8 of 18 | ||
| 66794 | polyamine pathway | 43.48 | 10 of 23 | ||
| 66794 | reductive acetyl coenzyme A pathway | 42.86 | 3 of 7 | ||
| 66794 | degradation of aromatic, nitrogen containing compounds | 41.67 | 5 of 12 | ||
| 66794 | bacilysin biosynthesis | 40 | 2 of 5 | ||
| 66794 | methylglyoxal degradation | 40 | 2 of 5 | ||
| 66794 | glycine metabolism | 40 | 4 of 10 | ||
| 66794 | factor 420 biosynthesis | 40 | 2 of 5 | ||
| 66794 | arachidonate biosynthesis | 40 | 2 of 5 | ||
| 66794 | coenzyme M biosynthesis | 40 | 4 of 10 | ||
| 66794 | sulfate reduction | 38.46 | 5 of 13 | ||
| 66794 | phenylpropanoid biosynthesis | 38.46 | 5 of 13 | ||
| 66794 | ascorbate metabolism | 36.36 | 8 of 22 | ||
| 66794 | tyrosine metabolism | 35.71 | 5 of 14 | ||
| 66794 | selenocysteine biosynthesis | 33.33 | 2 of 6 | ||
| 66794 | nitrate assimilation | 33.33 | 3 of 9 | ||
| 66794 | acetyl CoA biosynthesis | 33.33 | 1 of 3 | ||
| 66794 | cyanate degradation | 33.33 | 1 of 3 | ||
| 66794 | molybdenum cofactor biosynthesis | 33.33 | 3 of 9 | ||
| 66794 | (5R)-carbapenem carboxylate biosynthesis | 33.33 | 1 of 3 | ||
| 66794 | IAA biosynthesis | 33.33 | 1 of 3 | ||
| 66794 | glycolate and glyoxylate degradation | 33.33 | 2 of 6 | ||
| 66794 | androgen and estrogen metabolism | 31.25 | 5 of 16 | ||
| 66794 | urea cycle | 30.77 | 4 of 13 | ||
| 66794 | glutathione metabolism | 28.57 | 4 of 14 | ||
| 66794 | dolichyl-diphosphooligosaccharide biosynthesis | 27.27 | 3 of 11 | ||
| 66794 | vitamin E metabolism | 25 | 1 of 4 | ||
| 66794 | alginate biosynthesis | 25 | 1 of 4 | ||
| 66794 | lactate fermentation | 25 | 1 of 4 | ||
| 66794 | cyclohexanol degradation | 25 | 1 of 4 | ||
| 66794 | toluene degradation | 25 | 1 of 4 | ||
| 66794 | phosphatidylethanolamine bioynthesis | 23.08 | 3 of 13 | ||
| 66794 | arachidonic acid metabolism | 22.22 | 4 of 18 |
| @ref | IND | URE | GLU | MAN | LAC | SAC | MAL | SAL | XYL | ARA | GEL | ESC | GLY | CEL | MNE | MLZ | RAF | SOR | RHA | TRE | CAT | Spores presentSPOR | GramGRAM | Morphology coccus="+" rod="-"COCC | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7844 | - | - | + | - | + | + | - | - | + | + | - | + | - | - | + | - | + | - | + | + | - | - | - | - | |
| 7844 | not determinedn.d. | - | + | - | + | + | - | - | + | + | - | + | - | - | + | - | + | - | + | + | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. |
| @ref | URE | ADH (Arg) | alpha GAL | beta GAL | beta-Galactosidase 6-phosphatebeta GP | alpha GLU | beta GLU | alpha ARA | beta GUR | beta-N-Acetyl-beta-glucosaminidasebeta NAG | MNE | RAF | GDC | alpha FUC | Reduction of nitrateNIT | IND | PAL | L-arginine arylamidaseArgA | ProA | LGA | Phenylalanine arylamidasePheA | Leucine arylamidaseLeuA | PyrA | Tyrosine arylamidaseTyrA | Alanine arylamidaseAlaA | Glycin arylamidaseGlyA | Histidine arylamidaseHisA | Glutamyl-glutamate arylamidaseGGA | Serine arylamidaseSerA | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7844 | - | - | + | + | - | + | + | + | +/- | + | + | + | + | + | - | - | + | + | - | + | + | + | - | + | + | + | + | + | + | |
| 7844 | - | - | + | + | - | + | + | + | - | + | + | + | + | + | - | - | + | + | - | + | + | + | - | + | + | +/- | + | + | + | |
| 7844 | - | - | + | + | - | + | + | + | - | + | + | + | + | + | - | - | + | + | - | + | +/- | + | - | +/- | + | - | +/- | + | - | |
| 7844 | - | - | + | + | - | + | + | + | + | + | + | + | + | + | - | - | + | + | - | + | - | + | - | - | + | - | + | + | - | |
| 7844 | - | - | + | + | - | +/- | +/- | +/- | - | +/- | + | + | + | + | - | - | + | + | - | + | +/- | + | - | +/- | + | - | +/- | +/- | - |
| Cat1 | Cat2 | Cat3 | |
|---|---|---|---|
| #Host | #Human | - | |
| #Host Body Product | #Gastrointestinal tract | #Feces (Stool) |
| @ref | Sample type | Host species | Geographic location | Country | Country ISO 3 Code | Continent | Isolation date | |
|---|---|---|---|---|---|---|---|---|
| 7844 | human faeces | Homo sapiens | Texas | USA | USA | North America | ||
| 54426 | Human feces | Homo sapiens | Texas | USA | USA | North America | ||
| 67770 | Human feces | Homo sapiens | ||||||
| 117087 | Human, Feces | Homo sapiens | Texas | United States of America | USA | North America | 1968 |
Global distribution of 16S sequence AB510697 (>99% sequence identity) for Bacteroides from Microbeatlas ![]()
| @ref | Description | Assembly level | INSDC accession | BV-BRC accession | IMG accession | NCBI tax ID | Score | |
|---|---|---|---|---|---|---|---|---|
| 66792 | ASM222261v2 assembly for Bacteroides caccae ATCC 43185 | complete | 47678 | 98.11 | ||||
| 124043 | ASM1672630v1 assembly for Bacteroides caccae FDAARGOS_1097 | complete | 47678 | 97.49 | ||||
| 66792 | ASM2514631v1 assembly for Bacteroides caccae ATCC 43185 | complete | 47678 | 97.31 | ||||
| 67770 | ASM295971v1 assembly for Bacteroides caccae ATCC 43185 | contig | 47678 | 77.71 | ||||
| 67770 | ASM16901v1 assembly for Bacteroides caccae ATCC 43185 | contig | 411901 | 73.78 | ||||
| 66792 | ASM2853953v1 assembly for Bacteroides caccae DSM 19024 | contig | 47678 | 67.55 |
| @ref | Description | Accession | Length | Database | NCBI tax ID | |
|---|---|---|---|---|---|---|
| 20218 | Bacteroides caccae 16S ribosomal RNA gene, partial sequence; 16S-23S ribosomal RNA intergenic spacer region, complete sequence; and 23S ribosomal RNA gene, partial sequence | AY153428 | 676 | 47678 | ||
| 20218 | Bacteroides caccae strain JCM9498 16S ribosomal RNA gene, partial sequence | EU136686 | 1972 | 47678 | ||
| 7844 | Bacteroides caccae gene for 16S ribosomal RNA, partial sequence, strain: JCM 9498 | AB510697 | 1478 | 47678 | ||
| 124043 | Bacteroides caccae strain ATCC 43185 16S ribosomal RNA gene, partial sequence. | MN326670 | 1336 | 47678 |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Microbially-produced folate forms support the growth of Roseburia intestinalis but not its competitive fitness in fecal batch fermentations. | Kundra P, Geirnaert A, Pugin B, Pluss S, Kariluoto S, Lacroix C, Greppi A. | BMC Microbiol | 10.1186/s12866-024-03528-6 | 2024 | ||
| Design of a proteolytic module for improved metabolic modeling of Bacteroides caccae. | Paulay A, Grimaud GM, Caballero R, Laroche B, Leclerc M, Labarthe S, Maguin E. | mSystems | 10.1128/msystems.00153-24 | 2024 | ||
| Environmental factors drive bacterial degradation of gastrointestinal mucus. | Arias SL, van Wijngaarden EW, Balint D, Jones J, Crawford CC, Shukla PJ, Silberstein M, Brito IL. | NPJ Biofilms Microbiomes | 10.1038/s41522-025-00741-7 | 2025 | ||
| Diet-driven differential response of Akkermansia muciniphila modulates pathogen susceptibility. | Wolter M, Grant ET, Boudaud M, Pudlo NA, Pereira GV, Eaton KA, Martens EC, Desai MS. | Mol Syst Biol | 10.1038/s44320-024-00036-7 | 2024 | ||
| Distinct in vitro utilization and degradation of porcine gastric mucin glycans by human intestinal bacteria. | de Ram C, Berkhout MD, O Pandeirada C, Vincken JP, Hooiveld GJEJ, Belzer C, Schols HA. | FEMS Microbiol Ecol | 10.1093/femsec/fiaf066 | 2025 | ||
| Opposing diet, microbiome, and metabolite mechanisms regulate inflammatory bowel disease in a genetically susceptible host. | Pereira GV, Boudaud M, Wolter M, Alexander C, De Sciscio A, Grant ET, Trindade BC, Pudlo NA, Singh S, Campbell A, Shan M, Zhang L, Yang Q, Willieme S, Kim K, Denike-Duval T, Fuentes J, Bleich A, Schmidt TM, Kennedy L, Lyssiotis CA, Chen GY, Eaton KA, Desai MS, Martens EC. | Cell Host Microbe | 10.1016/j.chom.2024.03.001 | 2024 | ||
| Phylogenetic diversity of core rumen microbiota as described by cryo-ET. | Wimmer BH, Morais S, Zalk R, Mizrahi I, Medalia O. | Microlife | 10.1093/femsml/uqad010 | 2023 | ||
| GABA Production by Human Intestinal Bacteroides spp.: Prevalence, Regulation, and Role in Acid Stress Tolerance. | Otaru N, Ye K, Mujezinovic D, Berchtold L, Constancias F, Cornejo FA, Krzystek A, de Wouters T, Braegger C, Lacroix C, Pugin B. | Front Microbiol | 10.3389/fmicb.2021.656895 | 2021 | ||
| Pathogenicity | Constructing a gnotobiotic mouse model with a synthetic human gut microbiome to study host-microbe cross talk. | Steimle A, De Sciscio A, Neumann M, Grant ET, Pereira GV, Ohno H, Martens EC, Desai MS. | STAR Protoc | 10.1016/j.xpro.2021.100607 | 2021 | |
| Maternal diet and gut microbiome composition modulate early-life immune development. | Grant ET, Boudaud M, Muller A, Muller A, Macpherson AJ, Desai MS. | EMBO Mol Med | 10.15252/emmm.202217241 | 2023 | ||
| Metabolism | Sulfonolipids as novel metabolite markers of Alistipes and Odoribacter affected by high-fat diets. | Walker A, Pfitzner B, Harir M, Schaubeck M, Calasan J, Heinzmann SS, Turaev D, Rattei T, Endesfelder D, Castell WZ, Haller D, Schmid M, Hartmann A, Schmitt-Kopplin P. | Sci Rep | 10.1038/s41598-017-10369-z | 2017 | |
| Metabolism | SIMMER employs similarity algorithms to accurately identify human gut microbiome species and enzymes capable of known chemical transformations. | Bustion AE, Nayak RR, Agrawal A, Turnbaugh PJ, Pollard KS. | Elife | 10.7554/elife.82401 | 2023 | |
| Development of an in vitro Model of Human Gut Microbiota for Screening the Reciprocal Interactions With Antibiotics, Drugs, and Xenobiotics. | El Houari A, Ecale F, Mercier A, Crapart S, Laparre J, Soulard B, Ramnath M, Berjeaud JM, Rodier MH, Crepin A. | Front Microbiol | 10.3389/fmicb.2022.828359 | 2022 | ||
| Preliminary safety evaluation of a new Bacteroides xylanisolvens isolate. | Ulsemer P, Toutounian K, Schmidt J, Karsten U, Goletz S. | Appl Environ Microbiol | 10.1128/aem.06641-11 | 2012 | ||
| Pathogenicity | The Use of Defined Microbial Communities To Model Host-Microbe Interactions in the Human Gut. | Elzinga J, van der Oost J, de Vos WM, Smidt H. | Microbiol Mol Biol Rev | 10.1128/mmbr.00054-18 | 2019 | |
| Metabolism | Diastereomer-specific quantification of bioactive hexosylceramides from bacteria and mammals. | von Gerichten J, Schlosser K, Lamprecht D, Morace I, Eckhardt M, Wachten D, Jennemann R, Grone HJ, Mack M, Sandhoff R. | J Lipid Res | 10.1194/jlr.d076190 | 2017 | |
| A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility. | Desai MS, Seekatz AM, Koropatkin NM, Kamada N, Hickey CA, Wolter M, Pudlo NA, Kitamoto S, Terrapon N, Muller A, Young VB, Henrissat B, Wilmes P, Stappenbeck TS, Nunez G, Martens EC. | Cell | 10.1016/j.cell.2016.10.043 | 2016 | ||
| Analysis of chondroitin degradation by components of a Bacteroides caccae polysaccharide utilization locus. | Alvarez B, Canil OF, Low KE, Hettle AG, Abbott DW, Boraston AB. | J Biol Chem | 10.1016/j.jbc.2025.110354 | 2025 | ||
| A Globally Distributed Bacteroides caccae Strain Is the Most Prevalent Mother-Child Shared Bacteroidaceae Strain in a Large Scandinavian Cohort. | Nilsen M, Rehbinder EM, Lodrup Carlsen KC, Haugen G, Hedlin G, Jonassen CM, Killingstad ME, Nordlund B, Ormaasen I, Skjerven HO, Snipen L, Staff AC, Soderhall C, Sorensen R, Vettukattil R, Wilborn LM, Rudi K. | Appl Environ Microbiol | 10.1128/aem.00789-23 | 2023 | ||
| Synthetic beta-d-Glucuronides: Substrates for Exploring Glucuronide Degradation by Human Gut Bacteria. | Gorecka A, Schacht H, Fraser MK, Teriosina A, London JA, Barsukov IL, Powell AK, Cartmell A, Stachulski AV, Yates EA. | ACS Omega | 10.1021/acsomega.4c09036 | 2025 | ||
| Production of deoxycholic acid by low-abundant microbial species is associated with impaired glucose metabolism. | Wahlstrom A, Brumbaugh A, Sjoland W, Olsson L, Wu H, Henricsson M, Lundqvist A, Makki K, Hazen SL, Bergstrom G, Marschall HU, Fischbach MA, Backhed F. | Nat Commun | 10.1038/s41467-024-48543-3 | 2024 | ||
| Differences in gut microbiota between Dutch and South-Asian Surinamese: potential implications for type 2 diabetes mellitus. | Nayman EI, Schwartz BA, Polmann M, Gumabong AC, Nieuwdorp M, Cickovski T, Mathee K. | Sci Rep | 10.1038/s41598-024-54769-4 | 2024 | ||
| Comprehensive profiling of genomic invertons in defined gut microbial community reveals associations with intestinal colonization and surface adhesion. | Jin X, Cheng AG, Chanin RB, Yu FB, Dimas A, Jasper M, Weakley A, Yan J, Bhatt AS, Pollard KS. | Microbiome | 10.1186/s40168-025-02052-7 | 2025 | ||
| Protection against fibrosis by a bacterial consortium in metabolic dysfunction-associated steatohepatitis and the role of amino acid metabolism. | Kwan SY, Gonzales KA, Jamal MA, Stevenson HL, Tan L, Lorenzi PL, Futreal PA, Hawk ET, McCormick JB, Fisher-Hoch SP, Jenq RR, Beretta L. | Gut Microbes | 10.1080/19490976.2024.2399260 | 2024 | ||
| A Gnotobiotic Mouse Model with Divergent Equol-Producing Phenotypes: Potential for Determining Microbial-Driven Health Impacts of Soy Isoflavone Daidzein. | Leonard LM, Simpson AMR, Li S, Reddivari L, Cross TL. | Nutrients | 10.3390/nu16071079 | 2024 | ||
| Hadza Prevotella require diet-derived microbiota-accessible carbohydrates to persist in mice. | Gellman RH, Olm MR, Terrapon N, Enam F, Higginbottom SK, Sonnenburg JL, Sonnenburg ED. | Cell Rep | 10.1016/j.celrep.2023.113233 | 2023 | ||
| Cross-feeding of bifidobacteria promotes intestinal homeostasis: a lifelong perspective on the host health. | Xiao M, Zhang C, Duan H, Narbad A, Zhao J, Chen W, Zhai Q, Yu L, Tian F. | NPJ Biofilms Microbiomes | 10.1038/s41522-024-00524-6 | 2024 | ||
| Culturing of a complex gut microbial community in mucin-hydrogel carriers reveals strain- and gene-associated spatial organization. | Jin X, Yu FB, Yan J, Weakley AM, Dubinkina V, Meng X, Pollard KS. | Nat Commun | 10.1038/s41467-023-39121-0 | 2023 | ||
| A Bacteroides thetaiotaomicron genetic locus encodes activities consistent with mucin O-glycoprotein processing and N-acetylgalactosamine metabolism. | Ndeh DA, Nakjang S, Kwiatkowski KJ, Sawyers C, Koropatkin NM, Hirt RP, Bolam DN. | Nat Commun | 10.1038/s41467-025-58660-2 | 2025 | ||
| GH20 and GH84 beta-N-acetylglucosaminidases with different linkage specificities underpin mucin O-glycan breakdown capability of Bifidobacterium bifidum. | Takada H, Katoh T, Sakanaka M, Odamaki T, Katayama T. | J Biol Chem | 10.1016/j.jbc.2023.104781 | 2023 | ||
| Pathogenicity | Common Oral Medications Lead to Prophage Induction in Bacterial Isolates from the Human Gut. | Sutcliffe SG, Shamash M, Hynes AP, Maurice CF. | Viruses | 10.3390/v13030455 | 2021 | |
| Phylogeny | Multiple classes and isoforms of the RNA polymerase recycling motor protein HelD. | Larsen JS, Miller M, Oakley AJ, Dixon NE, Lewis PJ. | Microbiologyopen | 10.1002/mbo3.1251 | 2021 | |
| Genetics | O-Mucin-degrading carbohydrate-active enzymes and their possible implication in inflammatory bowel diseases. | Labourel A, Parrou JL, Deraison C, Mercier-Bonin M, Lajus S, Potocki-Veronese G. | Essays Biochem | 10.1042/ebc20220153 | 2023 | |
| Genetics | Microbial characterization based on multifractal analysis of metagenomes. | Xie XH, Huang YJ, Han GS, Yu ZG, Ma YL. | Front Cell Infect Microbiol | 10.3389/fcimb.2023.1117421 | 2023 | |
| Actively replicating gut bacteria identified by 5-ethynyl-2'-deoxyuridine (EdU) click chemistry and cell sorting. | Beauchemin ET, Hunter C, Maurice CF. | Gut Microbes | 10.1080/19490976.2023.2180317 | 2023 | ||
| Proteomic insight into arabinogalactan utilization by particle-associated Maribacter sp. MAR_2009_72. | Kalenborn S, Zuhlke D, Riedel K, Amann RI, Harder J. | FEMS Microbiol Ecol | 10.1093/femsec/fiae045 | 2024 | ||
| Phylogeny | Identifying Group-Specific Sequences for Microbial Communities Using Long k-mer Sequence Signatures. | Wang Y, Fu L, Ren J, Yu Z, Chen T, Sun F. | Front Microbiol | 10.3389/fmicb.2018.00872 | 2018 | |
| Toward FAIR Representations of Microbial Interactions. | Pacheco AR, Pauvert C, Kishore D, Segre D. | mSystems | 10.1128/msystems.00659-22 | 2022 | ||
| How microbial glycosyl hydrolase activity in the gut mucosa initiates microbial cross-feeding. | Berkhout MD, Plugge CM, Belzer C. | Glycobiology | 10.1093/glycob/cwab105 | 2022 | ||
| Enzymology | Two distinct gut microbial pathways contribute to meta-organismal production of phenylacetylglutamine with links to cardiovascular disease. | Zhu Y, Dwidar M, Nemet I, Buffa JA, Sangwan N, Li XS, Anderson JT, Romano KA, Fu X, Funabashi M, Wang Z, Keranahalli P, Battle S, Tittle AN, Hajjar AM, Gogonea V, Fischbach MA, DiDonato JA, Hazen SL. | Cell Host Microbe | 10.1016/j.chom.2022.11.015 | 2023 | |
| Gut Bacteroides act in a microbial consortium to cause susceptibility to severe malaria. | Mandal RK, Mandal A, Denny JE, Namazii R, John CC, Schmidt NW. | Nat Commun | 10.1038/s41467-023-42235-0 | 2023 | ||
| Microbiome-encoded bile acid metabolism modulates colonic transit times. | Li N, Koester ST, Lachance DM, Dutta M, Cui JY, Dey N. | iScience | 10.1016/j.isci.2021.102508 | 2021 | ||
| Metabolism | Genetic Variation of the SusC/SusD Homologs from a Polysaccharide Utilization Locus Underlies Divergent Fructan Specificities and Functional Adaptation in Bacteroides thetaiotaomicron Strains. | Joglekar P, Sonnenburg ED, Higginbottom SK, Earle KA, Morland C, Shapiro-Ward S, Bolam DN, Sonnenburg JL. | mSphere | 10.1128/mspheredirect.00185-18 | 2018 | |
| Pathogenicity | Recovery of the Gut Microbiota after Antibiotics Depends on Host Diet, Community Context, and Environmental Reservoirs. | Ng KM, Aranda-Diaz A, Tropini C, Frankel MR, Van Treuren W, O'Loughlin CT, Merrill BD, Yu FB, Pruss KM, Oliveira RA, Higginbottom SK, Neff NF, Fischbach MA, Xavier KB, Sonnenburg JL, Huang KC. | Cell Host Microbe | 10.1016/j.chom.2019.10.011 | 2019 | |
| Metabolism | Strain-level fitness in the gut microbiome is an emergent property of glycans and a single metabolite. | Park SY, Rao C, Coyte KZ, Kuziel GA, Zhang Y, Huang W, Franzosa EA, Weng JK, Huttenhower C, Rakoff-Nahoum S. | Cell | 10.1016/j.cell.2022.01.002 | 2022 | |
| Immunoglobulin A antibody composition is sculpted to bind the self gut microbiome. | Yang C, Chen-Liaw A, Spindler MP, Tortorella D, Moran TM, Cerutti A, Faith JJ. | Sci Immunol | 10.1126/sciimmunol.abg3208 | 2022 | ||
| Gut Microbiota Contributes to Spontaneous Colitis in E3 Ligase Itch-Deficient Mice. | Kathania M, Tsakem EL, Theiss AL, Venuprasad K. | J Immunol | 10.4049/jimmunol.1701478 | 2020 | ||
| Pathogenicity | In Vitro and In Vivo Activities of DS-2969b, a Novel GyrB Inhibitor, against Clostridium difficile. | Mathur T, Barman TK, Kumar M, Singh D, Kumar R, Khera MK, Yamada M, Inoue SI, Upadhyay DJ, Masuda N. | Antimicrob Agents Chemother | 10.1128/aac.02157-17 | 2018 | |
| Genetics | Strain/species identification in metagenomes using genome-specific markers. | Tu Q, He Z, Zhou J. | Nucleic Acids Res | 10.1093/nar/gku138 | 2014 | |
| Metabolism | Prospecting for microbial alpha-N-acetylgalactosaminidases yields a new class of GH31 O-glycanase. | Rahfeld P, Wardman JF, Mehr K, Huff D, Morgan-Lang C, Chen HM, Hallam SJ, Withers SG. | J Biol Chem | 10.1074/jbc.ra119.010628 | 2019 | |
| Design, construction, and in vivo augmentation of a complex gut microbiome. | Cheng AG, Ho PY, Aranda-Diaz A, Jain S, Yu FB, Meng X, Wang M, Iakiviak M, Nagashima K, Zhao A, Murugkar P, Patil A, Atabakhsh K, Weakley A, Yan J, Brumbaugh AR, Higginbottom S, Dimas A, Shiver AL, Deutschbauer A, Neff N, Sonnenburg JL, Huang KC, Fischbach MA. | Cell | 10.1016/j.cell.2022.08.003 | 2022 | ||
| Identification of D-arabinan-degrading enzymes in mycobacteria. | Al-Jourani O, Benedict ST, Ross J, Layton AJ, van der Peet P, Marando VM, Bailey NP, Heunis T, Manion J, Mensitieri F, Franklin A, Abellon-Ruiz J, Oram SL, Parsons L, Cartmell A, Wright GSA, Basle A, Trost M, Henrissat B, Munoz-Munoz J, Hirt RP, Kiessling LL, Lovering AL, Williams SJ, Lowe EC, Moynihan PJ. | Nat Commun | 10.1038/s41467-023-37839-5 | 2023 | ||
| Metabolism | Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide. | Romano KA, Vivas EI, Amador-Noguez D, Rey FE. | mBio | 10.1128/mbio.02481-14 | 2015 | |
| Metabolism | Strain dropouts reveal interactions that govern the metabolic output of the gut microbiome. | Wang M, Osborn LJ, Jain S, Meng X, Weakley A, Yan J, Massey WJ, Varadharajan V, Horak A, Banerjee R, Allende DS, Chan ER, Hajjar AM, Wang Z, Dimas A, Zhao A, Nagashima K, Cheng AG, Higginbottom S, Hazen SL, Brown JM, Fischbach MA. | Cell | 10.1016/j.cell.2023.05.037 | 2023 | |
| Metabolism | A bacterial bile acid metabolite modulates Treg activity through the nuclear hormone receptor NR4A1. | Li W, Hang S, Fang Y, Bae S, Zhang Y, Zhang M, Wang G, McCurry MD, Bae M, Paik D, Franzosa EA, Rastinejad F, Huttenhower C, Yao L, Devlin AS, Huh JR. | Cell Host Microbe | 10.1016/j.chom.2021.07.013 | 2021 | |
| Eukaryote to gut bacteria transfer of a glycoside hydrolase gene essential for starch breakdown in plants. | Arias MC, Danchin EG, Coutinho P, Henrissat B, Ball S. | Mob Genet Elements | 10.4161/mge.20375 | 2012 | ||
| Metabolism | Dps and DpsL Mediate Survival In Vitro and In Vivo during the Prolonged Oxidative Stress Response in Bacteroides fragilis. | Betteken MI, Rocha ER, Smith CJ. | J Bacteriol | 10.1128/jb.00342-15 | 2015 | |
| Metabolism | Mobilization of vitamin B12 transporters alters competitive dynamics in a human gut microbe. | Frye KA, Piamthai V, Hsiao A, Degnan PH. | Cell Rep | 10.1016/j.celrep.2021.110164 | 2021 | |
| Metabolism | Slimy partners: the mucus barrier and gut microbiome in ulcerative colitis. | Fang J, Wang H, Zhou Y, Zhang H, Zhou H, Zhang X. | Exp Mol Med | 10.1038/s12276-021-00617-8 | 2021 | |
| The prevalence of species and strains in the human microbiome: a resource for experimental efforts. | Kraal L, Abubucker S, Kota K, Fischbach MA, Mitreva M. | PLoS One | 10.1371/journal.pone.0097279 | 2014 | ||
| Metabolism | The microbial gbu gene cluster links cardiovascular disease risk associated with red meat consumption to microbiota L-carnitine catabolism. | Buffa JA, Romano KA, Copeland MF, Cody DB, Zhu W, Galvez R, Fu X, Ward K, Ferrell M, Dai HJ, Skye S, Hu P, Li L, Parlov M, McMillan A, Wei X, Nemet I, Koeth RA, Li XS, Wang Z, Sangwan N, Hajjar AM, Dwidar M, Weeks TL, Bergeron N, Krauss RM, Tang WHW, Rey FE, DiDonato JA, Gogonea V, Gerberick GF, Garcia-Garcia JC, Hazen SL. | Nat Microbiol | 10.1038/s41564-021-01010-x | 2022 | |
| Metabolism | Metabolic, Epigenetic, and Transgenerational Effects of Gut Bacterial Choline Consumption. | Romano KA, Martinez-Del Campo A, Kasahara K, Chittim CL, Vivas EI, Amador-Noguez D, Balskus EP, Rey FE. | Cell Host Microbe | 10.1016/j.chom.2017.07.021 | 2017 | |
| Metabolism | Two new families of the FtsZ-tubulin protein superfamily implicated in membrane remodeling in diverse bacteria and archaea. | Makarova KS, Koonin EV. | Biol Direct | 10.1186/1745-6150-5-33 | 2010 | |
| Metabolism | An ecological network of polysaccharide utilization among human intestinal symbionts. | Rakoff-Nahoum S, Coyne MJ, Comstock LE. | Curr Biol | 10.1016/j.cub.2013.10.077 | 2014 | |
| Metabolism | The Glycolytic Versatility of Bacteroides uniformis CECT 7771 and Its Genome Response to Oligo and Polysaccharides. | Benitez-Paez A, Gomez Del Pulgar EM, Sanz Y. | Front Cell Infect Microbiol | 10.3389/fcimb.2017.00383 | 2017 | |
| Phylogeny | Combining 16S rRNA gene variable regions enables high-resolution microbial community profiling. | Fuks G, Elgart M, Amir A, Zeisel A, Turnbaugh PJ, Soen Y, Shental N. | Microbiome | 10.1186/s40168-017-0396-x | 2018 | |
| Phylogeny | PCR assay for species-specific identification of Bacteroides thetaiotaomicron. | Teng LJ, Hsueh PR, Tsai JC, Chiang FL, Chen CY, Ho SW, Luh KT. | J Clin Microbiol | 10.1128/jcm.38.4.1672-1675.2000 | 2000 | |
| Genetics | Metagenomic binning and association of plasmids with bacterial host genomes using DNA methylation. | Beaulaurier J, Zhu S, Deikus G, Mogno I, Zhang XS, Davis-Richardson A, Canepa R, Triplett EW, Faith JJ, Sebra R, Schadt EE, Fang G. | Nat Biotechnol | 10.1038/nbt.4037 | 2018 | |
| A nested leucine rich repeat (LRR) domain: the precursor of LRRs is a ten or eleven residue motif. | Matsushima N, Miyashita H, Mikami T, Kuroki Y. | BMC Microbiol | 10.1186/1471-2180-10-235 | 2010 | ||
| Genetics | Assessment of k-mer spectrum applicability for metagenomic dissimilarity analysis. | Dubinkina VB, Ischenko DS, Ulyantsev VI, Tyakht AV, Alexeev DG. | BMC Bioinformatics | 10.1186/s12859-015-0875-7 | 2016 | |
| Pathogenicity | In vitro activities of gatifloxacin, two other quinolones, and five nonquinolone antimicrobials against obligately anaerobic bacteria. | Schaumann R, Ackermann G, Pless B, Claros MC, Rodloff AC. | Antimicrob Agents Chemother | 10.1128/aac.43.11.2783 | 1999 | |
| Defined microbiota transplant restores Th17/RORgammat+ regulatory T cell balance in mice colonized with inflammatory bowel disease microbiotas. | Britton GJ, Contijoch EJ, Spindler MP, Aggarwala V, Dogan B, Bongers G, San Mateo L, Baltus A, Das A, Gevers D, Borody TJ, Kaakoush NO, Kamm MA, Mitchell H, Paramsothy S, Clemente JC, Colombel JF, Simpson KW, Dubinsky MC, Grinspan A, Faith JJ. | Proc Natl Acad Sci U S A | 10.1073/pnas.1922189117 | 2020 | ||
| Metabolism | Recurrent neural networks enable design of multifunctional synthetic human gut microbiome dynamics. | Baranwal M, Clark RL, Thompson J, Sun Z, Hero AO, Venturelli OS. | Elife | 10.7554/elife.73870 | 2022 | |
| Longitudinal analysis of the prevalence, maintenance, and IgA response to species of the order Bacteroidales in the human gut. | Zitomersky NL, Coyne MJ, Comstock LE. | Infect Immun | 10.1128/iai.01348-10 | 2011 | ||
| Type VI secretion systems of human gut Bacteroidales segregate into three genetic architectures, two of which are contained on mobile genetic elements. | Coyne MJ, Roelofs KG, Comstock LE. | BMC Genomics | 10.1186/s12864-016-2377-z | 2016 | ||
| Metabolism | A selective gut bacterial bile salt hydrolase alters host metabolism. | Yao L, Seaton SC, Ndousse-Fetter S, Adhikari AA, DiBenedetto N, Mina AI, Banks AS, Bry L, Devlin AS. | Elife | 10.7554/elife.37182 | 2018 | |
| Metabolism | Biological systems discovery in silico: radical S-adenosylmethionine protein families and their target peptides for posttranslational modification. | Haft DH, Basu MK. | J Bacteriol | 10.1128/jb.00040-11 | 2011 | |
| Spatial organization of a model 15-member human gut microbiota established in gnotobiotic mice. | Mark Welch JL, Hasegawa Y, McNulty NP, Gordon JI, Borisy GG. | Proc Natl Acad Sci U S A | 10.1073/pnas.1711596114 | 2017 | ||
| Metabolism | The Stringent Response Determines the Ability of a Commensal Bacterium to Survive Starvation and to Persist in the Gut. | Schofield WB, Zimmermann-Kogadeeva M, Zimmermann M, Barry NA, Goodman AL. | Cell Host Microbe | 10.1016/j.chom.2018.06.002 | 2018 | |
| Top-down proteomic identification of furin-cleaved alpha-subunit of Shiga toxin 2 from Escherichia coli O157:H7 using MALDI-TOF-TOF-MS/MS. | Fagerquist CK, Sultan O. | J Biomed Biotechnol | 10.1155/2010/123460 | 2010 | ||
| Deciphering interactions between the gut microbiota and the immune system via microbial cultivation and minimal microbiomes. | Clavel T, Gomes-Neto JC, Lagkouvardos I, Ramer-Tait AE. | Immunol Rev | 10.1111/imr.12578 | 2017 | ||
| Genetics | Analysis of the genome sequence of Lactobacillus gasseri ATCC 33323 reveals the molecular basis of an autochthonous intestinal organism. | Azcarate-Peril MA, Altermann E, Goh YJ, Tallon R, Sanozky-Dawes RB, Pfeiler EA, O'Flaherty S, Buck BL, Dobson A, Duong T, Miller MJ, Barrangou R, Klaenhammer TR. | Appl Environ Microbiol | 10.1128/aem.00054-08 | 2008 | |
| Metabolism | Polysaccharides utilization in human gut bacterium Bacteroides thetaiotaomicron: comparative genomics reconstruction of metabolic and regulatory networks. | Ravcheev DA, Godzik A, Osterman AL, Rodionov DA. | BMC Genomics | 10.1186/1471-2164-14-873 | 2013 | |
| A novel extracellular metallopeptidase domain shared by animal host-associated mutualistic and pathogenic microbes. | Nakjang S, Ndeh DA, Wipat A, Bolam DN, Hirt RP. | PLoS One | 10.1371/journal.pone.0030287 | 2012 | ||
| Phylogeny | Diet-induced metabolic improvements in a hamster model of hypercholesterolemia are strongly linked to alterations of the gut microbiota. | Martinez I, Wallace G, Zhang C, Legge R, Benson AK, Carr TP, Moriyama EN, Walter J. | Appl Environ Microbiol | 10.1128/aem.00380-09 | 2009 | |
| Metabolism | Role of glycoside phosphorylases in mannose foraging by human gut bacteria. | Ladeveze S, Tarquis L, Cecchini DA, Bercovici J, Andre I, Topham CM, Morel S, Laville E, Monsan P, Lombard V, Henrissat B, Potocki-Veronese G. | J Biol Chem | 10.1074/jbc.m113.483628 | 2013 | |
| Analysis of rRNA restriction fragment length polymorphisms from Bacteroides spp. and Bacteroides fragilis isolates associated with diarrhea in humans and animals. | Smith CJ, Callihan DR. | J Clin Microbiol | 10.1128/jcm.30.4.806-812.1992 | 1992 | ||
| Metabolism | Evolutionary primacy of sodium bioenergetics. | Mulkidjanian AY, Galperin MY, Makarova KS, Wolf YI, Koonin EV. | Biol Direct | 10.1186/1745-6150-3-13 | 2008 | |
| Phylogeny | High-resolution microbial community reconstruction by integrating short reads from multiple 16S rRNA regions. | Amir A, Zeisel A, Zuk O, Elgart M, Stern S, Shamir O, Turnbaugh PJ, Soen Y, Shental N. | Nucleic Acids Res | 10.1093/nar/gkt1070 | 2013 | |
| A score of the ability of a three-dimensional protein model to retrieve its own sequence as a quantitative measure of its quality and appropriateness. | Martinez-Castilla LP, Rodriguez-Sotres R. | PLoS One | 10.1371/journal.pone.0012483 | 2010 | ||
| Phylogeny | Web-based software for rapid top-down proteomic identification of protein biomarkers, with implications for bacterial identification. | Fagerquist CK, Garbus BR, Williams KE, Bates AH, Boyle S, Harden LA. | Appl Environ Microbiol | 10.1128/aem.00079-09 | 2009 | |
| Noncellulosomal cohesin- and dockerin-like modules in the three domains of life. | Peer A, Smith SP, Bayer EA, Lamed R, Borovok I. | FEMS Microbiol Lett | 10.1111/j.1574-6968.2008.01420.x | 2009 | ||
| Phylogeny | Rapid and correct identification of intestinal Bacteroides spp. with chromosomal DNA probes by whole-cell dot blot hybridization. | Morotomi M, Ohno T, Mutai M. | Appl Environ Microbiol | 10.1128/aem.54.5.1158-1162.1988 | 1988 | |
| Phylogeny | Systematic analysis of compositional order of proteins reveals new characteristics of biological functions and a universal correlate of macroevolution. | Persi E, Horn D. | PLoS Comput Biol | 10.1371/journal.pcbi.1003346 | 2013 | |
| Metabolism | Effects of diet on resource utilization by a model human gut microbiota containing Bacteroides cellulosilyticus WH2, a symbiont with an extensive glycobiome. | McNulty NP, Wu M, Erickson AR, Pan C, Erickson BK, Martens EC, Pudlo NA, Muegge BD, Henrissat B, Hettich RL, Gordon JI. | PLoS Biol | 10.1371/journal.pbio.1001637 | 2013 | |
| Heterologous Expression and Characterization of Cellouronate (beta-1,4-Glucuronan) Lyase from a Human Intestinal Bacterium Bacteroides luhongzhouii. | Tanaka Y, Matsumura K, Ariga M, Konno N, Ogata M, Habu N. | J Appl Glycosci (1999) | 10.5458/jag.7203102 | 2025 | ||
| Development of culture methods capable of culturing a wide range of predominant species of intestinal bacteria. | Hirano R, Nishita I, Nakai R, Bito A, Sasabe R, Kurihara S. | Front Cell Infect Microbiol | 10.3389/fcimb.2023.1056866 | 2023 | ||
| Carotenoid productivity in human intestinal bacteria Eubacterium limosum and Leuconostoc mesenteroides with functional analysis of their carotenoid biosynthesis genes. | Matsumoto W, Takemura M, Nanaura H, Ami Y, Maoka T, Shindo K, Kurihara S, Misawa N. | Eng Microbiol | 10.1016/j.engmic.2024.100147 | 2024 | ||
| Gut butyrate-producers confer post-infarction cardiac protection. | Chen HC, Liu YW, Chang KC, Wu YW, Chen YM, Chao YK, You MY, Lundy DJ, Lin CJ, Hsieh ML, Cheng YC, Prajnamitra RP, Lin PJ, Ruan SC, Chen DH, Shih ESC, Chen KW, Chang SS, Chang CMC, Puntney R, Moy AW, Cheng YY, Chien HY, Lee JJ, Wu DC, Hwang MJ, Coonen J, Hacker TA, Yen CE, Rey FE, Kamp TJ, Hsieh PCH. | Nat Commun | 10.1038/s41467-023-43167-5 | 2023 | ||
| Metabolism | Gut microbial carbohydrate metabolism contributes to insulin resistance. | Takeuchi T, Kubota T, Nakanishi Y, Tsugawa H, Suda W, Kwon AT, Yazaki J, Ikeda K, Nemoto S, Mochizuki Y, Kitami T, Yugi K, Mizuno Y, Yamamichi N, Yamazaki T, Takamoto I, Kubota N, Kadowaki T, Arner E, Carninci P, Ohara O, Arita M, Hattori M, Koyasu S, Ohno H. | Nature | 10.1038/s41586-023-06466-x | 2023 | |
| Analysis of a new anti-depression mechanism of Chaigui granules based on multi-omics integration: In-depth mining of intestinal microbiota-metabolite interaction network. | Wu ZN, Zhao HL, Wang Q, Chen JL, Ren Y, Qin XM, Tian JS. | J Affect Disord | 10.1016/j.jad.2025.120319 | 2026 | ||
| Association between the gut microbiotic composition and dietary patterns in hypertensive elderly patients: a cross-sectional study. | Hung HC, Lin YY, Tien WJ, Chen YY, Yang SC. | Nutr Metab (Lond) | 10.1186/s12986-025-00963-8 | 2025 | ||
| Association between sphingomyelin levels and gut microbiota abundance in Alzheimer's disease: a two-sample Mendelian randomization study. | Wang L, Ding Y, Tang Y, Yang M, Yang Z, Yang X, Xia J. | BMC Neurol | 10.1186/s12883-025-04207-3 | 2025 | ||
| Intestinal Energy Harvest Mediates Gut Microbiota-Associated Weight Loss Following Bariatric Surgery. | Qian Y, Sorgen AA, Steffen KJ, Heinberg LJ, Reed K, Carroll IM. | Obes Surg | 10.1007/s11695-024-07467-z | 2024 | ||
| The role of monoammonium glycyrrhizinate as a methane inhibitor to limit the rumen methane emissions of Karakul sheep. | Bai T, Jiang C, Wang J, E G, Guo X, Liu J, Le VH, Cheng L. | Animal | 10.1016/j.animal.2024.101293 | 2024 | ||
| Genetics | Metagenome-informed metaproteomics methodology: a new breakthrough in revealing the mechanisms of host-microbiota-diet interactions in inflammatory bowel disease. | Zhang S, Xu Q. | Front Cell Dev Biol | 10.3389/fcell.2025.1634974 | 2025 | |
| Maternal dietary intervention during lactation impacts the maternal faecal and human milk microbiota. | Sindi AS, Stinson LF, Gridneva Z, Leghi GE, Netting MJ, Wlodek ME, Muhlhausler BS, Rea A, Trevenen ML, Geddes DT, Payne MS. | J Appl Microbiol | 10.1093/jambio/lxae024 | 2024 | ||
| Clinical and Gut Microbiome Characteristics of Medically Complex Patients Receiving Blenderized Tube Feeds vs. Standard Enteral Feeds. | Ferrer MF, Retuerto M, Thavamani A, San Valentin EM, Sferra TJ, Ghannoum M, Sankararaman S. | Nutrients | 10.3390/nu17122018 | 2025 | ||
| Pathogenicity | Gut microbiota alterations and their association with tumorigenic pathways in colorectal cancer: insights from a pooled analysis of 109 microbiome datasets. | Haque S, Bantun F, Jalal NA, Faidah H, Babalghith AO, Alobaidy MA, Aldairi AF, Ahmad F. | Gut Pathog | 10.1186/s13099-025-00712-5 | 2025 | |
| Probiotic Engraftment of Akkermansia muciniphila in an In Vitro Synthetic Microbial Community. | Berkhout MD, de Ram C, Boeren S, Plugge CM, Belzer C. | Microb Ecol | 10.1007/s00248-025-02605-1 | 2025 | ||
| Gut Colonization With Vancomycin-Resistant Enterococcus Shapes the Gut Microbiome in the Intensive Care Unit. | Park H, Abrams JA, Uhlemann AC, Freedberg DE. | J Infect Dis | 10.1093/infdis/jiaf194 | 2025 | ||
| Associations between the gut microbiota, immune cells, and different subtypes of epilepsy: A Mendelian randomization study. | Zhang X, Yang Z, Guo J, Wei Y, Li J. | Epilepsia Open | 10.1002/epi4.70072 | 2025 | ||
| Associations Between the Gut Microbiota and Its Related Metabolic Pathways and Uveitis: A Bidirectional Two-Sample Mendelian Randomization Study. | Luo M, Xing Z, Gou Y, Yang X, Zhang X, Yu W, Lv H. | Transl Vis Sci Technol | 10.1167/tvst.14.5.15 | 2025 | ||
| Interaction between Bacteroidetes species in the fermentation of Lycium barbarum arabinogalactan. | Cao C, Wang L, Zhang X, Ai C, Wang Z, Huang L, Song S, Zhu B. | Food Chem | 10.1016/j.foodchem.2022.135288 | 2023 | ||
| Analysis of Gut Microbiota and Their Metabolites in CADASIL Patients. | Watanabe-Hosomi A, Inoue R, Mizuta I, Matsuura J, Matsuura H, Fukunaga D, Ohara T, Naito Y, Mizuno T. | J Clin Neurol | 10.3988/jcn.2025.0231 | 2025 | ||
| Parity influences postpartum adaptations in the maternal gut microbiota. | Jarmukhanov Z, Vinogradova E, Mukhanbetzhanov N, Kozhakhmetov S, Khassenbekova D, Kushugulova A. | Sci Rep | 10.1038/s41598-025-02013-y | 2025 | ||
| Phylogeny | Alterations in the gut microbiome and metabolism with doxorubicin-induced heart failure severity. | Wang Q, Liu M, Liu T, Li L, Wang C, Wang X, Rong S, Zhou X. | Front Microbiol | 10.3389/fmicb.2024.1348403 | 2024 | |
| Genetics | Intestinal Microbial Profiles of Wild Zobaidy (Pampus argenteus) Fish Characterized by 16S rRNA Next Generation Sequencing. | Albaijan D, Albaijan D, Akbar A. | Curr Issues Mol Biol | 10.3390/cimb47110890 | 2025 | |
| Red meat consumption in higher healthy eating index diets is associated with brain health critical nutritional adequacy, and fecal microbial diversity. | Dhakal S, Hossain M, Parajuli S. | Sci Rep | 10.1038/s41598-025-18907-w | 2025 | ||
| Distinctions Between Fecal and Intestinal Mucosal Microbiota in Subgroups of Irritable Bowel Syndrome. | Hou Y, Dong L, Lu X, Shi H, Xu B, Zhong W, Ma L, Wang S, Yang C, He X, Zhao Y, Wang S. | Dig Dis Sci | 10.1007/s10620-022-07588-4 | 2022 | ||
| The Influence of Seasonal Variations in Clinical Trials Based on Gut Microbiota Studies. | Cocomazzi G, Panebianco C, Vallelunga A, De Ruvo D, Del Pup L, Smeazzetto S, Antinori M, Chimienti V, Maggio G, Finocchiaro C, Contu V, Pazienza V. | Microorganisms | 10.3390/microorganisms13102386 | 2025 | ||
| Genetics | The gut microbiome and HLA-B27-associated anterior uveitis: a case-control study. | Morandi SC, Herzog EL, Munk M, Kreuzer M, Largiader CR, Wolf S, Zinkernagel M, Zysset-Burri DC. | J Neuroinflammation | 10.1186/s12974-024-03109-4 | 2024 | |
| Gut microbiota profile in adults with abdominal obesity and non-abdominal obesity: links to body composition and macronutrient intake in Semarang, Indonesia-a brief research report. | Fadhillah FS, Arafat FB, Maharani N, Fadhilah J, Zariyah H, Sobirin MA, Tsutsui H, Wibowo A, Juniarto AZ, Pramono A. | Front Nutr | 10.3389/fnut.2025.1648575 | 2025 | ||
| Genetics | Alterations of Gut Microbiome in Patients with Colorectal Advanced Adenoma by Metagenomic Analyses. | Xiang J, Chai N, Li L, Hao X, Linghu E. | Turk J Gastroenterol | 10.5152/tjg.2024.24294 | 2024 | |
| Immune cells appraising the causal effect of gut microbiota on endometrial cancer: A Mendelian randomization analysis. | Liu L, Wu S, Lai X, Jin Q. | Medicine (Baltimore) | 10.1097/md.0000000000045088 | 2025 | ||
| Phylogeny | BN-BacArena: Bayesian network extension of BacArena for the dynamic simulation of microbial communities. | Blasco T, Balzerani F, Valcarcel LV, Larranaga P, Bielza C, Francino MP, Rufian-Henares JA, Planes FJ, Perez-Burillo S. | Bioinformatics | 10.1093/bioinformatics/btae266 | 2024 | |
| Enzymology | Novel Endo-beta-N-Acetylglucosaminidases Derived from Human Fecal Samples Selectively Release N-Glycans from Model Glycoproteins. | Bolino M, Haththotuwe Gamage N, Duman H, Abiodun O, De Mello AS, Karav S, Frese SA. | Foods | 10.3390/foods14081288 | 2025 | |
| Comparative Analysis of Bacteriome in Hair Follicle Layers of Patients with Female Pattern Androgenic Alopecia. | Park Y, Kyung S, Mun S, Yu BS, Yun K, Baek C, Lee DG, Kang S, Kim SR, Kim JH, Lee Y, Park BC, Han K. | Microorganisms | 10.3390/microorganisms13061365 | 2025 | ||
| Pathogenicity | Eurotium cristatum, a Probiotic Fungus from Fuzhuan Brick Tea, and Its Polysaccharides Ameliorated DSS-Induced Ulcerative Colitis in Mice by Modulating the Gut Microbiota. | Lu X, Jing Y, Zhang N, Cao Y. | J Agric Food Chem | 10.1021/acs.jafc.1c08301 | 2022 | |
| Genetics | Machine learning-based investigation of the relationship between gut microbiome and obesity status. | Liu W, Fang X, Zhou Y, Dou L, Dou T. | Microbes Infect | 10.1016/j.micinf.2021.104892 | 2022 | |
| Impact of Gut Dysbiosis on the Risk of Non-Small-Cell Lung Cancer. | Wei YF, Huang MS, Huang CH, Yeh YT, Hung CH. | Int J Environ Res Public Health | 10.3390/ijerph192315991 | 2022 | ||
| Phylogeny | Evaluation of the gastric microbiota based on body mass index using 16S rRNA gene sequencing. | Lee SH, Kim EB, Park SC, Nam SJ, Cho H, Jeon HJ, Lee SP. | Front Cell Infect Microbiol | 10.3389/fcimb.2025.1651316 | 2025 | |
| Fecal microbiota transplantation treatment for type 1 diabetes mellitus with malnutrition: a case report. | Xie YC, Jing XB, Chen X, Chen LZ, Zhang SH, Cai XB. | Ther Adv Chronic Dis | 10.1177/20406223221117449 | 2022 | ||
| Prebiotic, probiotic, and postbiotic properties of fermented corn starch and their application in type 2 diabetes management. | Gumenku L, Erukainure OL, Islam MS, Olaniran AO. | World J Diabetes | 10.4239/wjd.v16.i8.107775 | 2025 | ||
| Genetics | Integrating metagenomics and metabolomics to study the gut microbiome and host relationships in sports across different energy systems. | Aya V, Pardo-Rodriguez D, Vega LC, Cala MP, Ramirez JD. | Sci Rep | 10.1038/s41598-025-98973-2 | 2025 | |
| Gut microbiota predicts the diagnosis of ulcerative colitis in Saudi children. | El Mouzan M, Al Sarkhy A, Assiri A. | World J Clin Pediatr | 10.5409/wjcp.v13.i1.90755 | 2024 | ||
| Oral, not gut microbiota diversity, reflects the inflammation and neoplasia in patients with uveitis and vitreoretinal lymphoma. | Brichova M, Dlouha L, Tenglerova M, Rehakova J, Kostovcik M, Benesova K, Coufal S, Pivrncova E, Jiraskova Zakostelska Z, Kverka M, Skrlova E, Svozilkova P, Klimova A, Kostovcikova K, Trneny M, Heissigerova J. | J Ophthalmic Inflamm Infect | 10.1186/s12348-025-00517-2 | 2025 | ||
| Altered gut microbiota and metabolite profiles in community-acquired pneumonia: a metagenomic and metabolomic study. | Zhang F, Luan J, Suo L, Wang H, Zhao Y, Sun T, Ni Y, Cao H, Zou X, Liu B. | Microbiol Spectr | 10.1128/spectrum.02639-24 | 2025 | ||
| Bacteroides species differentially modulate depression-like behavior via gut-brain metabolic signaling. | Zhang Y, Fan Q, Hou Y, Zhang X, Yin Z, Cai X, Wei W, Wang J, He D, Wang G, Yuan Y, Hao H, Zheng X. | Brain Behav Immun | 10.1016/j.bbi.2022.02.007 | 2022 | ||
| Major heavy metals and human gut microbiota composition: a systematic review with nutritional approach. | Rezazadegan M, Forootani B, Hoveyda Y, Rezazadegan N, Amani R. | J Health Popul Nutr | 10.1186/s41043-025-00750-4 | 2025 | ||
| Pathogenicity | Association Between the Inflammatory Potential of Diet and Constipation Among Adults in the United States: A Cross-sectional Study. | Lu WF, Liu L, Zhang YH, Liu H. | J Clin Gastroenterol | 10.1097/mcg.0000000000002060 | 2025 | |
| Coleus forskohlii and Garcinia indica extracts attenuated lipid accumulation by regulating energy metabolism and modulating gut microbiota in obese mice. | Tung YC, Shih YA, Nagabhushanam K, Ho CT, Cheng AC, Pan MH. | Food Res Int | 10.1016/j.foodres.2021.110143 | 2021 | ||
| Pathogenicity | Fecal microbiota signatures of insulin resistance, inflammation, and metabolic syndrome in youth with obesity: a pilot study. | Del Chierico F, Manco M, Gardini S, Guarrasi V, Russo A, Bianchi M, Tortosa V, Quagliariello A, Shashaj B, Fintini D, Putignani L. | Acta Diabetol | 10.1007/s00592-020-01669-4 | 2021 | |
| Bloodstream Infection Caused by Bacteroides caccae in a Diabetic Patient: a Case Report and Review of the Literature. | Cheng Z, Huang Y, Wie W, Wang Y, Wang Z. | Clin Lab | 10.7754/clin.lab.2019.190534 | 2019 | ||
| Gut microbiota profiles associated with persistent anal HPV infection in men who have sex with men. | Yang H, Bian J, Yu W, Asilibieke S, Tian T, Zhang W, Lynn HS, He J, Dai J, Zhang G. | BMC Infect Dis | 10.1186/s12879-025-11624-9 | 2025 | ||
| Genetics | Metagenomic profiling of gut microbiome in early chronic kidney disease. | Sato N, Kakuta M, Hasegawa T, Yamaguchi R, Uchino E, Murashita K, Nakaji S, Imoto S, Yanagita M, Okuno Y. | Nephrol Dial Transplant | 10.1093/ndt/gfaa122 | 2021 | |
| Eggerthella lenta down regulated flavone and flavonol biosynthesis promoted Kawasaki disease. | Yeh YT, Chen KD, Huang CH, Tsai JR, Kuo HC. | Virulence | 10.1080/21505594.2025.2512401 | 2025 | ||
| Comparative analysis of dietary fiber impact on bile acid metabolism and gut microbiota composition in mice. | Zochling A, Seneca J, Pjevac P, Aunon-Lopez A, Zebeli Q, Pignitter M, Duszka K. | NPJ Gut Liver | 10.1038/s44355-025-00041-z | 2025 | ||
| Bloodstream infection caused by Bacteroides caccae in a patient with renal hypertension: a case report. | Yang Y, Zhang Q, Hu H, Zhang W, Lu T. | J Int Med Res | 10.1177/03000605211047277 | 2021 | ||
| Dietary inflammatory index and its relationship with gut microbiota in individuals with intestinal constipation: a cross-sectional study. | Costa LM, Mendes MM, Oliveira AC, Magalhaes KG, Shivappa N, Hebert JR, da Costa THM, Botelho PB. | Eur J Nutr | 10.1007/s00394-021-02649-2 | 2022 | ||
| CO2 Is Beneficial to Gut Microbiota Homeostasis during Colonoscopy: Randomized Controlled Trial. | Yang X, Xiu WB, Wang JX, Li LP, He C, Gao CP. | J Clin Med | 10.3390/jcm11185281 | 2022 | ||
| Exploring the Interplay Between Gut Microbiota and the Melatonergic Pathway in Hormone Receptor-Positive Breast Cancer. | Laborda-Illanes A, Boutriq S, Aranega-Martin L, Castellano-Castillo D, Sanchez-Alcoholado L, Plaza-Andrades I, Peralta-Linero J, Alba E, Fernandez-Garcia JC, Gonzalez-Gonzalez A, Queipo-Ortuno MI. | Int J Mol Sci | 10.3390/ijms26146801 | 2025 | ||
| The Accumulation of Gut Microbiome-derived Indoxyl Sulfate and P-Cresyl Sulfate in Patients With End-stage Renal Disease. | Lin X, Liang W, Li L, Xiong Q, He S, Zhao J, Guo X, Xiang S, Zhang P, Wang H, Ying C, Yao Y, Zuo X. | J Ren Nutr | 10.1053/j.jrn.2021.09.007 | 2022 | ||
| Deciphering oxidative stress responses in human gut microbes and fecal microbiota: a cultivation-based approach. | Zund JN, Caflisch M, Mujezinovic D, Pluss S, Lacroix C, Pugin B. | FEMS Microbiol Ecol | 10.1093/femsec/fiaf054 | 2025 | ||
| Two-Decade Retrospective Analysis of Endogenous Endophthalmitis in Spain and Mexico: A Comprehensive Study. | de Esteban Macineira E, Bande MF, Soberanes-Perez JI, Paniagua L, Golzarri MF, Fromow-Guerra J, Blanco Teijeiro MJ, Tourino Peralba R. | J Clin Med | 10.3390/jcm13174990 | 2024 | ||
| Genetics | Investigating gut microbiota-blood and urine metabolite correlations in early sepsis-induced acute kidney injury: insights from targeted KEGG analyses. | Xu Y, Xu J, Zhu Y, Mao H, Li J, Kong X, Zhu X, Zhang J. | Front Cell Infect Microbiol | 10.3389/fcimb.2024.1375874 | 2024 | |
| Functional Muffins Exert Bifidogenic Effects along with Highly Product-Specific Effects on the Human Gut Microbiota Ex Vivo. | Deyaert S, Poppe J, Dai Vu L, Baudot A, Bubeck S, Bayne T, Krishnan K, Giusto M, Moltz S, Van den Abbeele P. | Metabolites | 10.3390/metabo14090497 | 2024 | ||
| Metabolism | Methanogenesis associated with altered microbial production of short-chain fatty acids and human-host metabolizable energy. | Dirks B, Davis TL, Carnero EA, Corbin KD, Smith SR, Rittmann BE, Krajmalnik-Brown R. | ISME J | 10.1093/ismejo/wraf103 | 2025 | |
| Combining Bifidobacterium longum subsp. infantis and human milk oligosaccharides synergistically increases short chain fatty acid production ex vivo. | De Bruyn F, James K, Cottenet G, Dominick M, Katja J. | Commun Biol | 10.1038/s42003-024-06628-1 | 2024 | ||
| Prognostic value of 24-hour cultivation of peritoneal fluid to distinguish complicated from uncomplicated acute appendicitis: a prospective cohort study. | Mark-Christensen A, Bro Sorensen D, Qvist N, Justesen US, Moller S, Ellebaek MB. | Langenbecks Arch Surg | 10.1007/s00423-024-03428-3 | 2024 | ||
| Phylogeny | Full-length 16S rRNA Sequencing Reveals Gut Microbiome Signatures Predictive of MASLD in children with obesity. | Lin YC, Wu CC, Li YE, Chen CL, Lin CR, Ni YH. | BMC Microbiol | 10.1186/s12866-025-03849-0 | 2025 | |
| Disruption and adaptation: infant gut microbiota's dynamic response to SARS-CoV-2 infection. | Zhu LT, Zhao L, Zhu Y, Xu XL, Lin JJ, Duan YF, Long L, Wu YY, Xu WJ, Chen JY, Yin YH, Obeten AU, Huang Q. | Microbiome | 10.1186/s40168-025-02029-6 | 2025 | ||
| Modulation of the gut microbiome and Firmicutes phylum reduction by a nutraceutical blend in the obesity mouse model and overweight humans: A double-blind clinical trial. | Nehmi-Filho V, de Freitas JA, Franco LA, Martins RC, Turri JAO, Santamarina AB, Fonseca JVDS, Sabino EC, Moraes BC, Souza E, Murata GM, Costa SF, Alcantara PS, Otoch JP, Pessoa AFM. | Food Sci Nutr | 10.1002/fsn3.3927 | 2024 | ||
| Assessment of ecological fidelity of human microbiome-associated mice in observational studies and an interventional trial. | Wong MK, Armstrong E, Heirali AA, Schneeberger PHH, Chen H, Cochrane K, Sherriff K, Allen-Vercoe E, Siu LL, Spreafico A, Coburn B. | mBio | 10.1128/mbio.01904-25 | 2025 | ||
| Genetics | Infant Gut Microbial Metagenome Mining of alpha-l-Fucosidases with Activity on Fucosylated Human Milk Oligosaccharides and Glycoconjugates. | Moya-Gonzalvez EM, Pena-Gil N, Rubio-Del-Campo A, Coll-Marques JM, Gozalbo-Rovira R, Monedero V, Rodriguez-Diaz J, Yebra MJ. | Microbiol Spectr | 10.1128/spectrum.01775-22 | 2022 | |
| B.uniformis IM01-derived IAA alleviates asthma via AhR/NLRP3 pathways in mice. | He Y, Yang T, Mi J, He S, Yang Z, Lu S, Yue K, Huang Y, Song L, Xiao Y, Ren Z. | Cell Mol Life Sci | 10.1007/s00018-025-05910-7 | 2025 | ||
| Investigating the causal relationship of gut microbiota with GERD and BE: a bidirectional mendelian randomization. | Liu Y, Yu J, Yang Y, Han B, Wang Q, Du S. | BMC Genomics | 10.1186/s12864-024-10377-0 | 2024 | ||
| Consumption of Limosilactobacillus fermentum Inhibits Corneal Damage and Inflammation in Dry Eye Disease Mouse Model through Regulating the Gut Microbiome. | Lee K, Gwon H, Shim JJ, Kim JY, Lee JH. | Int J Mol Sci | 10.3390/ijms25063528 | 2024 | ||
| Genetics | Metagenomic analysis reveals distinct changes in the gut microbiome of obese Chinese children. | Li P, Jiang J, Li Y, Lan Y, Yang F, Wang J, Xie Y, Xiong F, Wu J, Liu H, Fan Z. | BMC Genomics | 10.1186/s12864-023-09805-4 | 2023 | |
| Assessing the gut microbiota composition in older adults: connections to physical activity and healthy ageing. | Ramos C, Magistro D, Walton GE, Whitham A, Camp N, Poveda C, Gibson GR, Hough J, Kinnear W, Hunter K. | Geroscience | 10.1007/s11357-025-01605-w | 2025 | ||
| Genetics | Structural and functional characterization of gut microbiota in dyslipidemic patients from high-altitude Tibetan pastoral areas. | Chen J, Luo Y, Hao Y, Wang Q, Wang Q. | Front Nutr | 10.3389/fnut.2025.1676238 | 2025 | |
| Comprehensive microbial and clinical profiling of functional constipation: A stratified comparative study of age and constipation subtype. | Zhu HT, Wang HF, Zhang Q, Bai JF, Wang M, Du SY, Zhang YL. | World J Gastroenterol | 10.3748/wjg.v31.i40.112637 | 2025 | ||
| Fecal Microbiota Transplant in Immunotherapy-Resistant Melanoma: What Can We Expect in the Near Future? | Ferreira A, Neves MT, Baleiras A, Malheiro M, Martins A. | Cureus | 10.7759/cureus.32586 | 2022 | ||
| Genetics | Exploring fecal microbiota signatures associated with immune response and antibiotic impact in NSCLC: insights from metagenomic and machine learning approaches | Han W, Zhou Y, Wang Y, Liu X, Sun T, Xu J. | Front Cell Infect Microbiol | 2025 | ||
| Co-variation of Host Gene Expression and Gut Microbiome in Intestine-Specific Spp1 Conditional Knockout Mice. | Li N, Gao G, Zhang T, Zhao C, Zhao Y, Zhang Y, Sun Z. | Curr Microbiol | 10.1007/s00284-025-04246-6 | 2025 | ||
| Bacterial dysbiosis in newly diagnosed treatment naïve pediatric ulcerative colitis in Saudi Arabia. | El Mouzan M, Al Mofarreh M, Alsaleem B, Al Sarkhy A, Alanazi A, Khormi M, Almasoud A, Assiri A. | Saudi J Gastroenterol | 10.4103/sjg.sjg_66_24 | 2025 | ||
| Pathogenicity | Effect of Sodium Butyrate Supplementation on Type 2 Diabetes-Literature Review. | Krauze W, Busz N, Pikula W, Maternowska M, Prowans P, Maciejewska-Markiewicz D. | Nutrients | 10.3390/nu17111753 | 2025 | |
| Pathogenicity | Spatial host-microbiome profiling demonstrates bacterial-associated host transcriptional alterations in pediatric ileal Crohn's disease. | Jang S, Lee EJ, Park S, Lim H, Ahn B, Huh Y, Koh H, Park YR. | Microbiome | 10.1186/s40168-025-02178-8 | 2025 | |
| Phylogeny | Microbiome metabolic capacity is buffered against phylotype losses by functional redundancy. | Cross K, Beckman N, Jahnes B, Sabree ZL. | Appl Environ Microbiol | 10.1128/aem.02368-24 | 2025 | |
| Benefits, side effects, and uses of Hericium erinaceus as a supplement: a systematic review. | Menon A, Jalal A, Arshad Z, Nawaz FA, Kashyap R. | Front Nutr | 10.3389/fnut.2025.1641246 | 2025 | ||
| Gut microbial structural variation associates with immune checkpoint inhibitor response. | Liu R, Zou Y, Wang WQ, Chen JH, Zhang L, Feng J, Yin JY, Mao XY, Li Q, Luo ZY, Zhang W, Wang DM. | Nat Commun | 10.1038/s41467-023-42997-7 | 2023 | ||
| Transcriptome | The fecal microbiota of patients with primary biliary cholangitis (PBC) causes PBC-like liver lesions in mice and exacerbates liver damage in a mouse model of PBC. | Jiang H, Yu Y, Hu X, Du B, Shao Y, Wang F, Chen L, Yan R, Li L, Lv L. | Gut Microbes | 10.1080/19490976.2024.2383353 | 2024 | |
| Detrimental effect of an early exposure to antibiotics on the outcomes of immunotherapy in a multi-tumor cohort of patients. | Guerrero P, Albarran V, Gonzalez-Merino C, Garcia de Quevedo C, Sotoca P, Chamorro J, Rosero DI, Barrill A, Alia V, Calvo JC, Moreno J, Perez de Aguado P, Alvarez-Ballesteros P, San Roman M, Serrano JJ, Soria A, Olmedo ME, Saavedra C, Cortes A, Gomez A, Lage Y, Ruiz A, Ferreiro MR, Longo F, Guerra E, Martinez-Delfrade I, Garrido P, Gajate P. | Oncologist | 10.1093/oncolo/oyae284 | 2025 | ||
| Metagenomic analysis of fecal samples in colorectal cancer Egyptians patients post colectomy: A pilot study. | Abo-Hammam RH, Salah M, Shabayek S, Hanora A, Zakeer S, Khattab RH. | AIMS Microbiol | 10.3934/microbiol.2024008 | 2024 | ||
| Metabolism | Effects of modified corn straw supplementation on laying performance, egg quality, immune response, antioxidant capacity, lipid metabolism and intestinal microbiota of post-peak laying hens. | Wang P, Chu Y, Fan X, Qin Y, Wang H, Chang J, Wang L, Jin S, Li X, Yuan L, Yin Q, Zuo R, Dang X, Lu F, Liu C, Chen J. | Poult Sci | 10.1016/j.psj.2025.105579 | 2025 | |
| Prenatal lead exposure is negatively associated with the gut microbiome in childhood. | Eggers S, Midya V, Bixby M, Gennings C, Torres-Olascoaga LA, Walker RW, Wright RO, Arora M, Tellez-Rojo MM. | Front Microbiol | 10.3389/fmicb.2023.1193919 | 2023 | ||
| Assessing Gut Microbiome Alterations in Children With Allergic Rhinitis: Associations With Allergen-Specific IgE Levels and Sensitization Patterns. | Li J, Shi Y, Hu L, He W, Li Y. | J Asthma Allergy | 10.2147/jaa.s496477 | 2025 | ||
| Mucin-driven ecological interactions in an in vitro synthetic community of human gut microbes. | Berkhout MD, Ioannou A, de Ram C, Boeren S, Plugge CM, Belzer C. | Glycobiology | 10.1093/glycob/cwae085 | 2024 | ||
| A taxon-specific measurement of disruption in a multi-modal study of microbiomes and metabolomes reveals system-wide dysbiosis preceding HIV-1 infection. | Fouladi F, Chen Y, Bera S, Jarmusch AK, Van Tyne D, Palella FJ, Margolick JB, Chew KW, Sun J, Martinson J, Rinaldo CR, Peddada SD. | Nat Commun | 10.1038/s41467-025-64822-z | 2025 | ||
| Metabolism | Gut microbiome alterations and hepatic encephalopathy post-TIPS in liver cirrhosis patients. | Li S, Xu Z, Diao H, Zhou A, Tu D, Wang S, Feng Y, Feng X, Lai Y, Yang S, Tang B. | J Transl Med | 10.1186/s12967-025-06774-y | 2025 | |
| Optimizing microbiome reference databases with PacBio full-length 16S rRNA sequencing for enhanced taxonomic classification and biomarker discovery. | Han H, Choi YH, Kim SY, Park JH, Chung J, Na HS. | Front Microbiol | 10.3389/fmicb.2024.1485073 | 2024 | ||
| Baseline intestinal microbiota composition influences response to a real-world dietary fiber intervention. | Hoffmann Sarda FA, Giuntini EB, Oliveira A, Souza GS, Prado SBR, Taddei CR, Tadini CC, Bittinger K, Bushman FD, Menezes EW, Hoffmann C. | NPJ Biofilms Microbiomes | 10.1038/s41522-025-00817-4 | 2025 | ||
| Checkpoint inhibitor responses can be regulated by the gut microbiota - A systematic review. | Zeriouh M, Raskov H, Kvich L, Gogenur I, Bennedsen ALB. | Neoplasia | 10.1016/j.neo.2023.100923 | 2023 | ||
| Pathogenicity | Nutraceutical Capsules LL1 and Silymarin Supplementation Act on Mood and Sleep Quality Perception by Microbiota-Gut-Brain Axis: A Pilot Clinical Study. | Santamarina AB, Nehmi Filho V, Freitas JA, Franco LAM, Fonseca JV, Martins RC, Turri JAO, Silva BFRBD, Gusmao AF, Olivieri EHR, Otoch JP, Pessoa AFM. | Nutrients | 10.3390/nu16183049 | 2024 | |
| The Association Between Maternal Diet and the Human Milk Microbiome: A Review of Evidence and Methodological Challenges. | Sindi AS. | Microorganisms | 10.3390/microorganisms13102347 | 2025 | ||
| Beneficial Effects of In Vitro Reconstructed Human Gut Microbiota by Ginseng Extract Fermentation on Intestinal Cell Lines. | Finazzi M, Bovio F, Forcella M, Lasagni M, Fusi P, Di Gennaro P. | Microorganisms | 10.3390/microorganisms13010192 | 2025 | ||
| Gut microbiome links obesity to type 2 diabetes: insights from Mendelian randomization. | Fu L, Baranova A, Cao H, Zhang F. | BMC Microbiol | 10.1186/s12866-025-03968-8 | 2025 | ||
| Christensenella minuta interacts with multiple gut bacteria. | Xu C, Jiang H, Feng LJ, Jiang MZ, Wang YL, Liu SJ. | Front Microbiol | 10.3389/fmicb.2024.1301073 | 2024 | ||
| Multimodal approach in a patient with Fournier's gangrene during the coronavirus pandemic. | Trama F, Illiano E, Bertuzzi G, Chiummariello S, Costantini E. | Urol Case Rep | 10.1016/j.eucr.2021.101825 | 2021 | ||
| Intermittent fasting and metabolic dysfunction-associated steatotic liver disease: the potential role of the gut-liver axis. | Zhang Z, Kong AP, Wong VW, Hui HX. | Cell Biosci | 10.1186/s13578-025-01406-w | 2025 | ||
| Pathogenicity | Comparative study of adenosine 3'-pyrophosphokinase domains of MuF polymorphic toxins. | Paulet EM, Bartoli J, Kabtan A, Piras CM, Tempier AC, Cascales E, Viala JP. | FEBS Open Bio | 10.1002/2211-5463.70038 | 2025 | |
| Gut Microbiota Patterns Predicting Long-Term Weight Loss Success in Individuals with Obesity Undergoing Nonsurgical Therapy. | Bischoff SC, Nguyen NK, Seethaler B, Beisner J, Kugler P, Stefan T. | Nutrients | 10.3390/nu14153182 | 2022 | ||
| The Role of Gut Microbiota in Pediatric Obesity and Metabolic Disorders: Insights from a Comprehensive Review. | Koller AM, Sasaran MO, Marginean CO. | Nutrients | 10.3390/nu17111883 | 2025 | ||
| Gut Microbiota and Bile Acids Mediate the Clinical Benefits of YH1 in Male Patients with Type 2 Diabetes Mellitus: A Pilot Observational Study. | Huang YH, Wu YH, Tang HY, Chen ST, Wang CC, Ho WJ, Lin YH, Liu GH, Lin PY, Lo CJ, Yeh YM, Cheng ML. | Pharmaceutics | 10.3390/pharmaceutics14091857 | 2022 | ||
| Pathogenicity | Development of the Gut Microbial Immune and Epithelial Cellular System (GutMICS) to Investigate the Immunological Role of Gut Anaerobes. | Kwon SY, Jo SH, Park J, Park JH, Kim YR, Baek JH, Kim MG, Choi BG, Hong NY, Jung HK, Ryu HW, Jeon JS, Kim YG. | Biotechnol Bioeng | 10.1002/bit.29031 | 2025 | |
| Systematic review: The gut microbiota as a link between colorectal cancer and obesity. | Ruiz-Malagon AJ, Rodriguez-Sojo MJ, Redondo E, Rodriguez-Cabezas ME, Galvez J, Rodriguez-Nogales A. | Obes Rev | 10.1111/obr.13872 | 2025 | ||
| Impact of the gut microbiome on response and toxicity to chemotherapy in advanced esophageal cancer. | Li N, Gao L, Ge Y, Zhao L, Wang Y, Bai C. | Heliyon | 10.1016/j.heliyon.2024.e32770 | 2024 | ||
| Microbial Biomarkers in Patients with Nonresponsive Celiac Disease. | Viitasalo L, Kurppa K, Ashorn M, Saavalainen P, Huhtala H, Ashorn S, Maki M, Ilus T, Kaukinen K, Iltanen S. | Dig Dis Sci | 10.1007/s10620-018-5285-z | 2018 | ||
| Genetics | Association between gut microbiota and central retinal artery occlusion: A two-sample Mendelian randomization study. | Chen J, Wang X, Yang J, Huang J, Xie M, Su Z, Jiang F. | Indian J Ophthalmol | 10.4103/ijo.ijo_3304_23 | 2024 | |
| Genetics | Metabolic response of intestinal microbiota to guar gum consumption. | Barber C, Sabater C, Guarner F, Margolles A, Azpiroz F. | Front Nutr | 10.3389/fnut.2023.1160694 | 2023 | |
| Discitis due to late-onset mesh infection 14 years after inguinal hernia repair: a case report. | Maeda C, Kato K, Yamada S, Tanaka M, Sujishi K, Sato R, Takanashi S, Waseda M, Suzuki T, Ishida Y, Kasahara F. | Surg Case Rep | 10.1186/s40792-022-01449-y | 2022 | ||
| Associations between gut microbiota and sarcopenia or its defining parameters in older adults: A systematic review. | Lapauw L, Rutten A, Dupont J, Amini N, Vercauteren L, Derrien M, Raes J, Raes J, Gielen E. | J Cachexia Sarcopenia Muscle | 10.1002/jcsm.13569 | 2024 | ||
| Does seasonality of the microbiota contribute to the seasonality of acute gout flare? | Schlesinger N, Brunetti L, Androulakis IP. | Clin Exp Rheumatol | 10.55563/clinexprheumatol/hdtge7 | 2022 | ||
| Enterotype-stratified gut microbial signatures in MASLD and cirrhosis based on integrated microbiome data. | Yuan H, Zhou J, Wu X, Wang S, Park S. | Front Microbiol | 10.3389/fmicb.2025.1568672 | 2025 | ||
| Mediation effect of gut microbiota on the relationship between physical activity and carotid plaque. | Ouyang W, Tang B, He Y, Wu H, Yang P, Yin L, Li X, Li Y, Huang X. | Front Microbiol | 10.3389/fmicb.2024.1432008 | 2024 | ||
| Gut microbiota differences in five-year-old children that were born preterm with a history of necrotizing enterocolitis: A pilot trial. | Magnusson A, Jabbari Shiadeh SM, Ardalan M, Swolin-Eide D, Elfvin A. | iScience | 10.1016/j.isci.2024.110325 | 2024 | ||
| Transcriptome | The altered TBI fecal microbiome is stable and functionally distinct. | Pyles RB, Miller AL, Urban RJ, Sheffield-Moore M, Wright TJ, Maxwell CA, Randolph KM, Danesi CP, McGovern KA, Vargas J, Armstrong P, Kreber L, Cumpa G, Randall K, Morrison M, Masel BE. | Front Mol Neurosci | 10.3389/fnmol.2024.1341808 | 2024 | |
| Nutraceutical blends predict enhanced health via microbiota reshaping improving cytokines and life quality: a Brazilian double-blind randomized trial. | Santamarina AB, de Freitas JA, Franco LAM, Nehmi-Filho V, Fonseca JV, Martins RC, Turri JA, da Silva BFRB, Fugi BEI, da Fonseca SS, Gusmao AF, Olivieri EHR, de Souza E, Costa S, Sabino EC, Otoch JP, Pessoa AFM. | Sci Rep | 10.1038/s41598-024-61909-3 | 2024 | ||
| Dissecting the molecular interactions between botanical extracts and the human gut microbiota. | Mancabelli L, Tarracchini C, Longhi G, Alessandri G, Ventura M, Turroni F. | Front Microbiol | 10.3389/fmicb.2025.1610170 | 2025 | ||
| Investigating volatile compounds in the Bacteroides secretome. | Shagaleeva OY, Kashatnikova DA, Kardonsky DA, Konanov DN, Efimov BA, Bagrov DV, Evtushenko EG, Chaplin AV, Silantiev AS, Filatova JV, Kolesnikova IV, Vanyushkina AA, Stimpson J, Zakharzhevskaya NB. | Front Microbiol | 10.3389/fmicb.2023.1164877 | 2023 | ||
| Phylogeny | Alterations of ileal mucosa-associated microbiota in hypercholesterolemia patients. | Li J, Ma J, Wang W, Du H, Tang S, Li Y, Zhu W, Zhang R, Wan J. | Heliyon | 10.1016/j.heliyon.2023.e22116 | 2023 | |
| Pathogenicity | Could dysbiosis of inflammatory and anti-inflammatory gut bacteria have an implications in the development of type 2 diabetes? A pilot investigation. | Kulkarni P, Devkumar P, Chattopadhyay I. | BMC Res Notes | 10.1186/s13104-021-05466-2 | 2021 | |
| The release patterns and potential prebiotic characteristics of soluble and insoluble dietary fiber-bound polyphenols from pinot noir grape pomace in vitro digestion and fermentation. | Li Y, Chen X, Wang G, Xu L, Liu Y, Yuan C, Li J. | Food Chem X | 10.1016/j.fochx.2025.102694 | 2025 | ||
| Metabolic disorder and intestinal microflora dysbiosis in chronic inflammatory demyelinating polyradiculoneuropathy. | Fu J, Shan J, Cui Y, Yan C, Wang Q, Han J, Cao G. | Cell Biosci | 10.1186/s13578-023-00956-1 | 2023 | ||
| Immunogenic peptides putatively from intratumor microbes: Opportunities for colorectal cancer treatment. | Guan X, Bu F, Fu Y, Zhang H, Xiang H, Chen X, Chen T, Wu X, Wu K, Liu L, Dong X. | iScience | 10.1016/j.isci.2024.111338 | 2024 | ||
| Prioritizing gut microbial SNPs linked to immunotherapy outcomes in NSCLC patients by integrative bioinformatics analysis. | Raziq MF, Khan N, Manzoor H, Tariq HMA, Rafiq M, Rasool S, Kayani MUR, Huang L. | J Transl Med | 10.1186/s12967-025-06370-0 | 2025 | ||
| The gut microbiota and diabetic nephropathy: an observational study review and bidirectional Mendelian randomization study. | Han YZ, Wang YZY, Zhu XY, Du BX, Wang YX, Zhang XQ, Jia JM, Liu WJ, Zheng HJ. | Trials | 10.1186/s13063-025-08755-4 | 2025 | ||
| Both viable Bifidobacterium longum subsp. infantis B8762 and heat-killed cells alleviate the intestinal inflammation of DSS-induced IBD rats. | Li Z, Peng C, Sun Y, Zhang T, Feng C, Zhang W, Huang T, Yao G, Zhang H, He Q. | Microbiol Spectr | 10.1128/spectrum.03509-23 | 2024 | ||
| Genetics | Using gut microbiome metagenomic hypervariable features for diabetes screening and typing through supervised machine learning. | Chavarria X, Park HS, Oh S, Kang D, Choi JH, Kim M, Cho YH, Yi MH, Kim JY. | Microb Genom | 10.1099/mgen.0.001365 | 2025 | |
| Fiber Intervention Study in Prader-Willi Syndrome: Insights into Metabolic and Microbiota Shifts. | Tan Q, Peng Y, Deehan EC, Vieira FT, Ho BWP, Afhami S, Wine E, Madsen KL, Field CJ, Pakseresht M, Ilkayeva O, Newgard CB, Walter J, Tun HM, Haqq AM. | J Clin Endocrinol Metab | 10.1210/clinem/dgaf142 | 2025 | ||
| Gestational exposure to HIV drugs alters intestinal mucosa-associated microbial diversity in adult rat offspring | Yanamadala Y, Muthumula C, Gokulan K, Karn K, Sutherland V, Cunny H, Santos J, Khare S. | Exp Biol Med (Maywood) | 2025 | |||
| Oral administration of pioglitazone inhibits pulmonary hypertension by regulating the gut microbiome and plasma metabolome in male rats. | Zhang Z, Liang Y, Mo S, Zhao M, Li Y, Zhang C, Shan X, Liu S, Liao J, Luo X, Zhu J, Wang C, Jiang Q, Hou C, Hong W, Lai N, Chen Y, Xu L, Lu W, Wang J, Wang Z, Yang K. | Physiol Rep | 10.14814/phy2.70174 | 2025 | ||
| Gut Microbiota Changes by an SGLT2 Inhibitor, Luseogliflozin, Alters Metabolites Compared with Those in a Low Carbohydrate Diet in db/db Mice. | Hata S, Okamura T, Kobayashi A, Bamba R, Miyoshi T, Nakajima H, Kitagawa N, Hashimoto Y, Majima S, Senmaru T, Okada H, Ushigome E, Nakanishi N, Takakuwa H, Sasano R, Hamaguchi M, Fukui M. | Nutrients | 10.3390/nu14173531 | 2022 | ||
| Genetics | Next-generation sequencing of the athletic gut microbiota: a systematic review. | Sabater C, Iglesias-Gutierrez E, Ruiz L, Margolles A. | Microbiome Res Rep | 10.20517/mrr.2022.16 | 2023 | |
| Observational study protocol: the faecal microbiome in the acute stage of new-onset paediatric type 1 diabetes in an Irish cohort. | Kennedy EC, Ross FC, O'Shea CA, Lavelle A, Ross P, Dempsey E, Stanton C, Hawkes CP. | BMJ Open | 10.1136/bmjopen-2024-089206 | 2025 | ||
| Phylogeny | PhyloFunc: phylogeny-informed functional distance as a new ecological metric for metaproteomic data analysis. | Wang L, Simopoulos CMA, Serrana JM, Ning Z, Li Y, Sun B, Yuan J, Figeys D, Li L. | Microbiome | 10.1186/s40168-024-02015-4 | 2025 | |
| Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition. | Sardaro MLS, Grote V, Baik J, Atallah M, Amato KR, Ring M. | Nutrients | 10.3390/nu17030458 | 2025 | ||
| Genetics | Impact of Baizhu, Daqingye, and Hehuanhua extracts on the human gut microbiome. | Lemons JMS, Narrowe AB, Liu L, Firrman J, Mahalak KK, Van den Abbeele P, Baudot A, Deyaert S, Li Y, Yu LL. | Front Cell Infect Microbiol | 10.3389/fcimb.2023.1298392 | 2023 | |
| Pathogenicity | Association of gut microbiota and inflammatory markers in obese patients with type 2 diabetes mellitus: post hoc analysis of a synbiotic interventional study. | Sugawara Y, Kanazawa A, Aida M, Yoshida Y, Yamashiro Y, Watada H. | Biosci Microbiota Food Health | 10.12938/bmfh.2021-081 | 2022 | |
| The gut microbiota modulates responses to anti-PD-1 and chemotherapy combination therapy and related adverse events in patients with advanced solid tumors. | Wu Z, Zhang S, Li L, Huang Z, Huang D, Hu Y. | Front Oncol | 10.3389/fonc.2022.887383 | 2022 | ||
| Integrated analysis of microbiota with bile acids for the phototherapy treatment of neonatal jaundice. | Zhang K, Fan S, Lv A, Ma Y, Fang X, Zhang J. | Arch Med Sci | 10.5114/aoms/134023 | 2023 | ||
| Effects of GLP-1 Analogues and Agonists on the Gut Microbiota: A Systematic Review. | Gofron KK, Wasilewski A, Malgorzewicz S. | Nutrients | 10.3390/nu17081303 | 2025 | ||
| Metabolism | Association of Subjective and Objective Measures of Sleep With Gut Microbiota Composition and Diversity in Older Men: The Osteoporotic Fractures in Men Study. | Estaki M, Langsetmo L, Shardell M, Mischel A, Jiang L, Zhong Y, Kaufmann C, Knight R, Stone K, Kado D. | J Gerontol A Biol Sci Med Sci | 10.1093/gerona/glad011 | 2023 | |
| Early infancy dysbiosis in food protein-induced enterocolitis syndrome: A prospective cohort study. | Su KW, Cetinbas M, Martin VM, Virkud YV, Seay H, Ndahayo R, Rosow R, Elkort M, Gupta B, Kramer E, Pronchick T, Reuter S, Sadreyev RI, Huang JL, Shreffler WG, Yuan Q. | Allergy | 10.1111/all.15644 | 2023 | ||
| Genetics | Impact of dietary fructooligosaccharides (FOS) on murine gut microbiota and intestinal IgA secretion. | Jangid A, Fukuda S, Kato T, Seki M, Suzuki Y, Taylor TD, Ohno H, Prakash T. | 3 Biotech | 10.1007/s13205-022-03116-3 | 2022 | |
| Bariatric Surgery Is Associated with Lower Concentrations of Fecal Secondary Bile Acids and Their Metabolizing Microbial Enzymes: A Pilot Study. | Hussan H, Ali MR, Lyo V, Webb A, Pietrzak M, Zhu J, Choueiry F, Li H, Cummings BP, Marco ML, Medici V, Clinton SK. | Obes Surg | 10.1007/s11695-024-07420-0 | 2024 | ||
| Pathogenicity | Gut Microbiome dysbiosis and immune activation correlate with somatic and neuropsychiatric symptoms in COVID-19 patients. | Scalzo PL, Marshall AG, Soriano S, Curry K, Dulay M, Hodics T, Quigley EMM, Treangen TJ, Piskorz MM, Villapol S. | J Transl Med | 10.1186/s12967-025-06348-y | 2025 | |
| Phylogeny | Probiotic administration correlated with reduced diarrheal incidence and improved gut microbiota diversity in young goats | Essa M, Cheng C, Li J, Han X, Wei Z, Abdelhadi L, Hassan H, Adam S, Husien H, Saleh A, Cheng D. | Front Vet Sci | 2025 | ||
| Hyperuricemia and the gut microbiota: current research hotspots and future trends. | Yang J, Chen J, Li D, Wu Q, Zhang Y, Li Y, Deng Y. | Front Microbiol | 10.3389/fmicb.2025.1620561 | 2025 | ||
| Butyricimonas is a key gut microbiome component for predicting postoperative recurrence of esophageal cancer. | Otsuka K, Isobe J, Asai Y, Nakano T, Hattori K, Ariyoshi T, Yamashita T, Motegi K, Saito A, Kohmoto M, Hosonuma M, Kuramasu A, Baba Y, Murayama M, Narikawa Y, Toyoda H, Funayama E, Tajima K, Shida M, Hirasawa Y, Tsurui T, Ariizumi H, Ishiguro T, Suzuki R, Ohkuma R, Kubota Y, Sambe T, Tsuji M, Wada S, Kiuchi Y, Kobayashi S, Horiike A, Goto S, Murakami M, Kim YG, Tsunoda T, Yoshimura K. | Cancer Immunol Immunother | 10.1007/s00262-023-03608-y | 2024 | ||
| Comprehensive analysis of vaginal microbiota, metabolites, and inflammatory factors in preterm and term pregnancies. | Shen LP, Cai BJ, Guan JX, Peng T, Jin L. | Front Microbiol | 10.3389/fmicb.2025.1689494 | 2025 | ||
| Apigenin protects ischemic stroke by regulating intestinal microbiota homeostasis, regulates brain metabolic profile. | Li J, Xu Q, Xu X, He W, Zhang H, Ren H, Wang Y, Wang X, Zhao D. | Front Pharmacol | 10.3389/fphar.2025.1553081 | 2025 | ||
| First-degree Relatives of Celiac Disease Patients Have Increased Seroreactivity to Serum Microbial Markers. | Viitasalo L, Iltanen S, Huhtala H, Saavalainen P, Kaukinen K, Lindfors K, Kurppa K. | Nutrients | 10.3390/nu12041073 | 2020 | ||
| Safety evaluation of Balanced Health Care Dan-A medicinal formulation containing traditional edible ingredients in lung tumor-loaded mice. | Dong F, Zhao C, He X, Dong Y, Liu H, Yao P, Xu W. | Food Sci Nutr | 10.1002/fsn3.3195 | 2023 | ||
| Pathogenicity | Influence of Short-Term Consumption of Hericium erinaceus on Serum Biochemical Markers and the Changes of the Gut Microbiota: A Pilot Study. | Xie XQ, Geng Y, Guan Q, Ren Y, Guo L, Lv Q, Lu ZM, Shi JS, Xu ZH. | Nutrients | 10.3390/nu13031008 | 2021 | |
| Compliance with Nutritional Recommendations and Gut Microbiota Profile in Galician Overweight/Obese and Normal-Weight Individuals. | Sinisterra-Loaiza L, Alonso-Lovera P, Cardelle-Cobas A, Miranda JM, Vazquez BI, Cepeda A. | Nutrients | 10.3390/nu15153418 | 2023 | ||
| Pathogenicity | Complex Probiotics Ameliorate Fecal Microbiota Transplantation-Induced IBS in Mice via Gut Microbiota and Metabolite Modulation. | Gao Y, Borjihan Q, Zhang W, Li L, Wang D, Bai L, Zhu S, Chen Y. | Nutrients | 10.3390/nu17050801 | 2025 | |
| Generation of genome-scale metabolic reconstructions for 773 members of the human gut microbiota. | Magnusdottir S, Heinken A, Kutt L, Ravcheev DA, Bauer E, Noronha A, Greenhalgh K, Jager C, Baginska J, Wilmes P, Fleming RM, Thiele I. | Nat Biotechnol | 10.1038/nbt.3703 | 2017 | ||
| Diagnostic, Prognostic, and Therapeutic Roles of Gut Microbiota in COVID-19: A Comprehensive Systematic Review. | Farsi Y, Tahvildari A, Arbabi M, Vazife F, Sechi LA, Shahidi Bonjar AH, Jamshidi P, Nasiri MJ, Mirsaeidi M. | Front Cell Infect Microbiol | 10.3389/fcimb.2022.804644 | 2022 | ||
| Proteome | Proteogenomic annotation of T6SS components identified in Bacteroides fragilis secretome. | Zakharzhevskaya NB, Shagaleeva OY, Kashatnikova DA, Goncharov AO, Evsyutina DV, Kardonsky DA, Vorobeva EA, Silantiev AS, Kazakova VD, Kolesnikova IV, Butenko IO, Vanyushkina AA, Smirnova SV, Chaplin AV, Efimov BA. | Front Microbiol | 10.3389/fmicb.2025.1495971 | 2025 | |
| Phylogeny | Unveiling the negative association of Faecalibacterium prausnitzii with ischemic stroke severity, impaired prognosis and pro-inflammatory markers. | Luo Y, Chang G, Yu G, Lin Y, Zhang Q, Wang Z, Han J. | Heliyon | 10.1016/j.heliyon.2024.e26651 | 2024 | |
| Randomized trial assessing impact of probiotic supplementation on gut microbiome and clinical outcome from targeted therapy in metastatic renal cell carcinoma. | Dizman N, Hsu J, Bergerot PG, Gillece JD, Folkerts M, Reining L, Trent J, Highlander SK, Pal SK. | Cancer Med | 10.1002/cam4.3569 | 2021 | ||
| A framework for predictive modeling of microbiome multi-omics data: latent interacting variable-effects (LIVE) modeling. | Munoz Briones J, Brubaker DK. | BMC Bioinformatics | 10.1186/s12859-025-06134-z | 2025 | ||
| Using whole-genome sequencing (WGS) to plot colorectal cancer-related gut microbiota in a population with varied geography. | Shuwen H, Yinhang W, Xingming Z, Jing Z, Jinxin L, Wei W, Kefeng D. | Gut Pathog | 10.1186/s13099-022-00524-x | 2022 | ||
| Pathogenicity | Altered Gut Microbial Profile Accompanied by Abnormal Fatty Acid Metabolism Activity Exacerbates Endometrial Cancer Progression. | Zhao SS, Chen L, Yang J, Wu ZH, Wang XY, Zhang Q, Liu WJ, Liu HX. | Microbiol Spectr | 10.1128/spectrum.02612-22 | 2022 | |
| Does gut microbiota dysbiosis impact the metabolic alterations of hydrogen sulfide and lanthionine in patients with chronic kidney disease? | Garcia-Martinez Y, Alexandrova E, Iebba V, Ferravante C, Spinelli M, Franci G, Amoresano A, Weisz A, Trepiccione F, Borriello M, Ingrosso D, Perna AF. | BMC Microbiol | 10.1186/s12866-024-03590-0 | 2024 | ||
| Metabolism | Taxonomic variations in the gut microbiome of gout patients with and without tophi might have a functional impact on urate metabolism. | Mendez-Salazar EO, Vazquez-Mellado J, Casimiro-Soriguer CS, Dopazo J, Cubuk C, Zamudio-Cuevas Y, Francisco-Balderas A, Martinez-Flores K, Fernandez-Torres J, Lozada-Perez C, Pineda C, Sanchez-Gonzalez A, Silveira LH, Burguete-Garcia AI, Orbe-Orihuela C, Lagunas-Martinez A, Vazquez-Gomez A, Lopez-Reyes A, Palacios-Gonzalez B, Martinez-Nava GA. | Mol Med | 10.1186/s10020-021-00311-5 | 2021 | |
| Effects of exercise and physical activity on gut microbiota composition and function in older adults: a systematic review. | Aya V, Jimenez P, Munoz E, Ramirez JD. | BMC Geriatr | 10.1186/s12877-023-04066-y | 2023 | ||
| Development of an infant colon simulating in vitro model, I-TIM-2, to study the effects of modulation strategies on the infant gut microbiome composition and function. | Colberg O, Hermes GDA, Licht TR, Wichmann A, Baker A, Laursen MF, Wellejus A. | Microbiol Spectr | 10.1128/spectrum.00724-24 | 2024 | ||
| Association Between Adult Antibiotic Use, Microbial Dysbiosis and Atopic Conditions - A Systematic Review. | Ng WZJ, van Hasselt J, Aggarwal B, Manoharan A. | J Asthma Allergy | 10.2147/jaa.s401755 | 2023 | ||
| Astragalus Polysaccharide Modulates the Gut Microbiota and Metabolites of Patients with Type 2 Diabetes in an In Vitro Fermentation Model. | Zhang X, Jia L, Ma Q, Zhang X, Chen M, Liu F, Zhang T, Jia W, Zhu L, Qi W, Wang N. | Nutrients | 10.3390/nu16111698 | 2024 | ||
| Phylogeny | Development of a Novel Metagenomic Biomarker for Prediction of Upper Gastrointestinal Tract Involvement in Patients With Crohn's Disease. | Kwak MS, Cha JM, Shin HP, Jeon JW, Yoon JY. | Front Microbiol | 10.3389/fmicb.2020.01162 | 2020 | |
| Metabolism | Targeting the Gut Microbiome to Improve Immunotherapy Outcomes: A Review. | David A, Lev-Ari S. | Integr Cancer Ther | 10.1177/15347354241269870 | 2024 | |
| Seasonal Variations in Production Performance, Health Status, and Gut Microbiota of Meat Rabbit Reared in Semi-Confined Conditions. | Ye D, Ding X, Pang S, Gan Y, Li Z, Gan Q, Fang S. | Animals (Basel) | 10.3390/ani14010113 | 2023 | ||
| Microbial Species that Initially Colonize the Human Gut at Birth or in Early Childhood Can Stay in Human Body for Lifetime. | Li W, Nelson KE. | Microb Ecol | 10.1007/s00248-020-01636-0 | 2021 | ||
| Clinical effectiveness of fecal microbial transplantation for metabolic syndrome: Advances in clinical efficacy and multi-omics research. | Wang H, Tian J, Mi J. | Curr Res Microb Sci | 10.1016/j.crmicr.2025.100415 | 2025 | ||
| Perforation of sigmoid neovagina in a patient with Mayer-Rokitansky-Küster-Hauser syndrome. | Kamath A, Butt S. | IDCases | 10.1016/j.idcr.2021.e01110 | 2021 | ||
| In Vitro Activity of Tedizolid Compared to Linezolid and Five Other Antimicrobial Agents against 332 Anaerobic Isolates, Including Bacteroides fragilis Group, Prevotella, Porphyromonas, and Veillonella Species. | Goldstein EJC, Merriam CV, Citron DM. | Antimicrob Agents Chemother | 10.1128/aac.01088-20 | 2020 | ||
| Enzymology | Impact of ginsenoside Rb1 on gut microbiome and associated changes in pharmacokinetics in rats. | Chen Y, Zhang KX, Liu H, Zhu Y, Bu QY, Song SX, Li YC, Zou H, You XY, Zhao GP. | Sci Rep | 10.1038/s41598-024-72225-1 | 2024 | |
| Characterization of Gut Microbiome Composition in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy. | Vernaci G, Savarino EV, Patuzzi I, Facchin S, Zingone F, Massa D, Faggioni G, Giarratano T, Miglietta F, Griguolo G, Fassan M, Lo Mele M, Gasparini E, Bisagni G, Guarneri V, Dieci MV. | Oncologist | 10.1093/oncolo/oyad060 | 2023 | ||
| Harnessing gut-derived bioactives and AI diagnostics for the next generation of type 2 diabetes solutions. | Tseyslyer Y, Malyi V, Saifullina M, Tsyryuk O, Shvets Y, Penchuk Y, Kovalchuk I, Kovalchuk O, Korotkyi O, Bulda V, Lazarieva O. | Front Endocrinol (Lausanne) | 10.3389/fendo.2025.1699954 | 2025 | ||
| Fangyukangsuan granules ameliorate hyperuricemia and modulate gut microbiota in rats. | Zhang QZ, Zhang JR, Li X, Yin JL, Jin LM, Xun ZR, Xue H, Yang WQ, Zhang H, Qu J, Xing ZK, Wang XM. | Front Immunol | 10.3389/fimmu.2024.1362642 | 2024 | ||
| Effects of Konjaku Flour on the Gut Microbiota of Obese Patients. | Li Y, Kang Y, Du Y, Chen M, Guo L, Huang X, Li T, Chen S, Yang F, Yu F, Hong J, Kong X. | Front Cell Infect Microbiol | 10.3389/fcimb.2022.771748 | 2022 | ||
| The gut microbiome, chronic kidney disease, and sarcopenia. | Zheng G, Cao J, Wang XH, He W, Wang B. | Cell Commun Signal | 10.1186/s12964-024-01922-1 | 2024 | ||
| Pathogenicity | Supplementation with Lactobacillus helveticus NS8 alleviated behavioral, neural, endocrine, and microbiota abnormalities in an endogenous rat model of depression. | Alatan H, Liang S, Shimodaira Y, Wu X, Hu X, Wang T, Luo J, Iijima K, Jin F. | Front Immunol | 10.3389/fimmu.2024.1407620 | 2024 | |
| Sarecycline Demonstrated Reduced Activity Compared to Minocycline against Microbial Species Representing Human Gastrointestinal Microbiota. | Ghannoum MA, Long L, Bunick CG, Del Rosso JQ, Gamal A, Tyring SK, McCormick TS, Grada A. | Antibiotics (Basel) | 10.3390/antibiotics11030324 | 2022 | ||
| The gut microbiota modifies antibody durability and booster responses after SARS-CoV-2 vaccination. | Seong H, Yoon JG, Nham E, Choi YJ, Noh JY, Cheong HJ, Kim WJ, Kim EH, Kim C, Han YH, Lim S, Song JY. | J Transl Med | 10.1186/s12967-024-05637-2 | 2024 | ||
| Colorectal cancer-specific microbiome in peripheral circulation and cancer tissues. | Yan S, Liu T, Zhao H, Zhao C, Zhu Y, Dai W, Sun W, Wang H, Sun J, Zhao L, Xu D. | Front Microbiol | 10.3389/fmicb.2024.1422536 | 2024 | ||
| Bacteroidetes Species Are Correlated with Disease Activity in Ulcerative Colitis. | Nomura K, Ishikawa D, Okahara K, Ito S, Haga K, Takahashi M, Arakawa A, Shibuya T, Osada T, Kuwahara-Arai K, Kirikae T, Nagahara A. | J Clin Med | 10.3390/jcm10081749 | 2021 | ||
| Enzymology | A widespread hydrogenase supports fermentative growth of gut bacteria in healthy people. | Welsh C, Cabotaje PR, Marcelino VR, Watts TD, Kountz DJ, Jespersen M, Gould JA, Doan NQ, Lingford JP, Koralegedara T, Solari J, D'Adamo GL, Huang P, Bong N, Gulliver EL, Young RB, Land H, Walter K, Cann I, Pereira GV, Martens EC, Wolf PG, Ridlon JM, Gaskins HR, Giles EM, Lyras D, Lappan R, Berggren G, Forster SC, Greening C. | Nat Microbiol | 10.1038/s41564-025-02154-w | 2025 | |
| Bifidobacterium species serve as key gut microbiome regulators after intervention in gestational diabetes mellitus. | Cui Z, Wang S, Niu J, Ma J, Yang H. | BMC Microbiol | 10.1186/s12866-024-03680-z | 2024 | ||
| Gut microbiome features associated with liver fibrosis in Hispanics, a population at high risk for fatty liver disease. | Kwan SY, Jiao J, Joon A, Wei P, Petty LE, Below JE, Daniel CR, Wu X, Zhang J, Jenq RR, Futreal PA, Hawk ET, McCormick JB, Fisher-Hoch SP, Beretta L. | Hepatology | 10.1002/hep.32197 | 2022 | ||
| Prebiotics improve frailty status in community-dwelling older individuals in a double-blind, randomized, controlled trial. | Yang J, Hou L, Wang A, Shang L, Jia X, Xu R, Wang X. | J Clin Invest | 10.1172/jci176507 | 2024 | ||
| Alterations in the Gut Microbiota in Pregnant Women with Pregestational Type 2 Diabetes Mellitus. | Ren Y, Hao L, Liu J, Wang P, Ding Q, Chen C, Song Y. | mSystems | 10.1128/msystems.01146-22 | 2023 | ||
| Genetics | Gut resistome of NSCLC patients treated with immunotherapy. | Iwan E, Grenda A, Bomba A, Bielinska K, Wasyl D, Kieszko R, Rolska-Kopinska A, Chmielewska I, Krawczyk P, Rybczynska-Tkaczyk K, Olejnik M, Milanowski J. | Front Genet | 10.3389/fgene.2024.1378900 | 2024 | |
| Phylogeny | Uncovering specific taxonomic and functional alteration of gut microbiota in chronic kidney disease through 16S rRNA data. | Zhang Y, Zhong W, Liu W, Wang X, Lin G, Lin J, Fang J, Mou X, Jiang S, Huang J, Zhao W, Zheng Z. | Front Cell Infect Microbiol | 10.3389/fcimb.2024.1363276 | 2024 | |
| Genetics | Gut microbiota dysbiosis induced by alcohol exposure in pubertal and adult mice. | Yang J, Wang H, Lin X, Liu J, Feng Y, Bai Y, Liang H, Hu T, Wu Z, Lai J, Liu J, Zou Y, Wei S, Yan P. | mSystems | 10.1128/msystems.01366-24 | 2024 | |
| Pathogenicity | Signature changes in gut microbiome are associated with increased susceptibility to HIV-1 infection in MSM. | Chen Y, Lin H, Cole M, Morris A, Martinson J, Mckay H, Mimiaga M, Margolick J, Fitch A, Methe B, Srinivas VR, Peddada S, Rinaldo CR. | Microbiome | 10.1186/s40168-021-01168-w | 2021 | |
| Influence of Microbiome and Antibiotics on the Efficacy of Immune Checkpoint Inhibitors. | Patel P, Poudel A, Kafle S, Thapa Magar M, Cancarevic I. | Cureus | 10.7759/cureus.16829 | 2021 | ||
| Impact of cigarette smoking on gut microbial dysbiosis: a structured literature review. | Imade EE, Obayagbona NO. | Gut Microbiome (Camb) | 10.1017/gmb.2024.3 | 2024 | ||
| Genetics | Unraveling the microbial diversity of bovine liver abscesses: isolation, identification, and genomic characterization of the Bacteroides found in hepatic lesions. | Gruninger RJ, McCormack ML, Chomistek NC, Zaheer R, McAllister TA. | Microbiol Spectr | 10.1128/spectrum.00423-25 | 2025 | |
| Genetics | Physical activity, sedentary behavior and microbiome: A systematic review and meta-analysis. | Perez-Prieto I, Plaza-Florido A, Ubago-Guisado E, Ortega FB, Altmae S. | J Sci Med Sport | 10.1016/j.jsams.2024.07.003 | 2024 | |
| Phylogeny | Improved DNA Extraction and Amplification Strategy for 16S rRNA Gene Amplicon-Based Microbiome Studies. | Hong BY, Driscoll M, Gratalo D, Jarvie T, Weinstock GM. | Int J Mol Sci | 10.3390/ijms25052966 | 2024 | |
| Myricetin alleviates diabetic cardiomyopathy by regulating gut microbiota and their metabolites. | Zhu J, Bao Z, Hu Z, Wu S, Tian C, Zhou Y, Ding Z, Tan X. | Nutr Diabetes | 10.1038/s41387-024-00268-4 | 2024 | ||
| Gut microbiota composition and type 2 diabetes: Are these subjects linked Together? | Razavi S, Amirmozafari N, Zahedi Bialvaei A, Navab-Moghadam F, Khamseh ME, Alaei-Shahmiri F, Sedighi M. | Heliyon | 10.1016/j.heliyon.2024.e39464 | 2024 | ||
| Pharmacomicrobiomics: a new field contributing to optimizing drug therapy in Parkinson's disease. | Zhang Y, Mo C, Ai P, He X, Xiao Q, Yang X. | Gut Microbes | 10.1080/19490976.2025.2454937 | 2025 | ||
| Human gut bacteria bioaccumulate per- and polyfluoroalkyl substances. | Lindell AE, Griesshammer A, Michaelis L, Papagiannidis D, Ochner H, Kamrad S, Guan R, Blasche S, Ventimiglia LN, Ramachandran B, Ozgur H, Zelezniak A, Beristain-Covarrubias N, Yam-Puc JC, Roux I, Barron LP, Richardson AK, Martin MG, Benes V, Morone N, Thaventhiran JED, Bharat TAM, Savitski MM, Maier L, Patil KR. | Nat Microbiol | 10.1038/s41564-025-02032-5 | 2025 | ||
| Carrot RG-I Reduces Interindividual Differences between 24 Adults through Consistent Effects on Gut Microbiota Composition and Function Ex Vivo. | Van den Abbeele P, Deyaert S, Albers R, Baudot A, Mercenier A. | Nutrients | 10.3390/nu15092090 | 2023 | ||
| The Gut Microbiome and Cancer Immunotherapy: Can We Use the Gut Microbiome as a Predictive Biomarker for Clinical Response in Cancer Immunotherapy? | Oh B, Boyle F, Pavlakis N, Clarke S, Eade T, Hruby G, Lamoury G, Carroll S, Morgia M, Kneebone A, Stevens M, Liu W, Corless B, Molloy M, Kong B, Libermann T, Rosenthal D, Back M. | Cancers (Basel) | 10.3390/cancers13194824 | 2021 | ||
| How resistant is anammox biofilm against antibiotics: A special insight into anammox response towards fluoroquinolones. | Mamun FA, Kumar R, Anwuta KU, Das S, Jaagura M, Herodes K, Kyrpel T, Borzyszkowska AF, Zielinska-Jurek A, Vincevica-Gaile Z, Burlakovs J, Krauklis AE, Azra MN, Salauddin M, Zhong J, Tenno T, Bester K, Zekker I. | Heliyon | 10.1016/j.heliyon.2024.e41339 | 2025 | ||
| The gut microbiota in persistent post-operative pain following breast cancer surgery. | Masaud K, Collins JM, Rubio RC, Corrigan M, Cotter PD, O'Brien N, Bluett R, Jimenez CK, O'Mahony SM, Shorten GD. | Sci Rep | 10.1038/s41598-024-62397-1 | 2024 | ||
| Gut-on-a-Chip for the Analysis of Bacteria-Bacteria Interactions in Gut Microbial Community: What Would Be Needed for Bacterial Co-Culture Study to Explore the Diet-Microbiota Relationship? | Lee KW, Shin JS, Lee CM, Han HY, O Y, Kim HW, Cho TJ. | Nutrients | 10.3390/nu15051131 | 2023 | ||
| Identification of novel fructo-oligosaccharide bacterial consumers by pulse metatranscriptomics in a human stool sample. | Prattico C, Gonzalez E, Dridi L, Jazestani S, Low KE, Abbott DW, Maurice CF, Castagner B. | mSphere | 10.1128/msphere.00668-24 | 2025 | ||
| Non-stochastic reassembly of a metabolically cohesive gut consortium shaped by N-acetyl-lactosamine-enriched fibers. | Moore M, Whittington HD, Knickmeyer R, Azcarate-Peril MA, Bruno-Barcena JM. | Gut Microbes | 10.1080/19490976.2024.2440120 | 2025 | ||
| Effects of Ecologically Relevant Concentrations of Cadmium on the Microbiota, Short-Chain Fatty Acids, and FFAR2 Expression in Zebrafish. | Yang J, Li J, Zhang X, Zhou Q, Wang J, Chen Q, Meng X, Xia Y. | Metabolites | 10.3390/metabo13050657 | 2023 | ||
| Identifying Gut Microbiota associated with Gastrointestinal Symptoms upon Roux-en-Y Gastric Bypass. | Wijdeveld M, van Olst N, van der Vossen EWJ, de Brauw M, Acherman YIZ, de Goffau MC, Gerdes VEA, Nieuwdorp M. | Obes Surg | 10.1007/s11695-023-06610-6 | 2023 | ||
| Altered Nasal Microbiome in Atrophic Rhinitis: A Novel Theory of Etiopathogenesis and Therapy. | Sarkar S, Magne F, Venugopal G, Purkait S, Mutha NVR, Maiti R, Sharma P, Ramadass B. | Microorganisms | 10.3390/microorganisms10112092 | 2022 | ||
| Sulfated and non-sulfated chondroitin affect the composition and metabolism of human colonic microbiota simulated in an in vitro fermentation system. | Inokuma K, Sasaki D, Kurata K, Ichikawa M, Otsuka Y, Kondo A. | Sci Rep | 10.1038/s41598-023-38849-5 | 2023 | ||
| The Impact of Integrating a Low-Lectin Diet with Traditional ADHD Treatments on Gut Microbiota Composition and Symptom Improvement in Children - A Cohort Study. | Long L, Peng H, Chen X, Wang F, Long W, Cheng M, Ma J. | Neuropsychiatr Dis Treat | 10.2147/ndt.s449186 | 2024 | ||
| Identifying Microbiome Dynamics in Pediatric IBD: More than a Family Matter. | Dovrolis N, Moschoviti A, Fessatou S, Karamanolis G, Kolios G, Gazouli M. | Biomedicines | 10.3390/biomedicines11071979 | 2023 | ||
| The gut microbial diversity of colon cancer patients and the clinical significance. | He T, Cheng X, Xing C. | Bioengineered | 10.1080/21655979.2021.1972077 | 2021 | ||
| Genetics | Exploring the dynamics of gut microbiota, antibiotic resistance, and chemotherapy impact in acute leukemia patients: A comprehensive metagenomic analysis. | Luo Y, Sheikh TMM, Li X, Yuan Y, Yao F, Wang M, Guo X, Wu J, Shafiq M, Xie Q, Jiao X. | Virulence | 10.1080/21505594.2024.2428843 | 2024 | |
| Genetics | Alterations of the Gut Microbiome in Patients With Pituitary Adenoma. | Hu J, Yang J, Chen L, Meng X, Zhang X, Li W, Li Z, Huang G. | Pathol Oncol Res | 10.3389/pore.2022.1610402 | 2022 | |
| Multi-omics analysis reveals the interaction of gut microbiome and host microRNAs in ulcerative colitis. | Ma L, Hou C, Yang H, Chen Q, Lyu W, Wang Z, Wang J, Xiao Y. | Ann Med | 10.1080/07853890.2023.2261477 | 2023 | ||
| Pathogenicity | Effects of Smoking on Inflammatory Markers in a Healthy Population as Analyzed via the Gut Microbiota. | Yan S, Ma Z, Jiao M, Wang Y, Li A, Ding S. | Front Cell Infect Microbiol | 10.3389/fcimb.2021.633242 | 2021 | |
| Pathogenicity | Alteration of the gut microbiota in patients with lung cancer accompanied by chronic obstructive pulmonary diseases. | Wang T, Su W, Li L, Wu H, Huang H, Li Z. | Heliyon | 10.1016/j.heliyon.2024.e30380 | 2024 | |
| The impact of antibiotics on the gut microbiota of children recovering from watery diarrhoea. | Le SH, Nguyen Ngoc Minh C, de Sessions PF, Jie S, Tran Thi Hong C, Thwaites GE, Baker S, Pham DT, Chung The H. | NPJ Antimicrob Resist | 10.1038/s44259-024-00030-x | 2024 | ||
| Temporal relationship among adiposity, gut microbiota, and insulin resistance in a longitudinal human cohort. | Deng K, Shuai M, Zhang Z, Jiang Z, Fu Y, Shen L, Zheng JS, Chen YM. | BMC Med | 10.1186/s12916-022-02376-3 | 2022 | ||
| Metabolism | Sulfoquinovose is exclusively metabolized by the gut microbiota and degraded differently in mice and humans. | Krasenbrink J, Hanson BT, Weiss AS, Borusak S, Tanabe TS, Lang M, Aichinger G, Hausmann B, Berry D, Richter A, Marko D, Mussmann M, Schleheck D, Stecher B, Loy A. | Microbiome | 10.1186/s40168-025-02175-x | 2025 | |
| Genetics | Type 1 diabetes in pregnancy is associated with distinct changes in the composition and function of the gut microbiome. | Roth-Schulze AJ, Penno MAS, Ngui KM, Oakey H, Bandala-Sanchez E, Smith AD, Allnutt TR, Thomson RL, Vuillermin PJ, Craig ME, Rawlinson WD, Davis EA, Harris M, Soldatos G, Colman PG, Wentworth JM, Haynes A, Barry SC, Sinnott RO, Morahan G, Bediaga NG, Smyth GK, Papenfuss AT, Couper JJ, Harrison LC, ENDIA Study Group. | Microbiome | 10.1186/s40168-021-01104-y | 2021 | |
| The Role of Gut Microbiota in Various Neurological and Psychiatric Disorders-An Evidence Mapping Based on Quantified Evidence. | Zang Y, Lai X, Li C, Ding D, Wang Y, Zhu Y. | Mediators Inflamm | 10.1155/2023/5127157 | 2023 | ||
| Phylogeny | Absolute quantification of viable bacteria abundances in food by next-generation sequencing: Quantitative NGS of viable microbes. | Kallastu A, Malv E, Aro V, Meikas A, Vendelin M, Kattel A, Nahku R, Kazantseva J. | Curr Res Food Sci | 10.1016/j.crfs.2023.100443 | 2023 | |
| Transcriptome | Characterization of liver, adipose, and fecal microbiome in obese patients with MASLD: links with disease severity and metabolic dysfunction parameters. | Schwenger KJP, Copeland JK, Ghorbani Y, Chen L, Comelli EM, Guttman DS, Fischer SE, Jackson TD, Okrainec A, Allard JP. | Microbiome | 10.1186/s40168-024-02004-7 | 2025 | |
| Pathogenicity | Function-based selection of synthetic communities enables mechanistic microbiome studies. | Hitch TCA, Bosch J, Bolsega S, Deschamps C, Etienne-Mesmin L, Treichel N, Blanquet-Diot S, Ocvirk S, Basic M, Clavel T. | ISME J | 10.1093/ismejo/wraf209 | 2025 | |
| Genetics | Alterations in the gut virome are associated with type 2 diabetes and diabetic nephropathy. | Fan G, Cao F, Kuang T, Yi H, Zhao C, Wang L, Peng J, Zhuang Z, Xu T, Luo Y, Xie Y, Li H, Zhang K, Zeng Y, Zhang X, Peng S, Qiu X, Zhou D, Liang H, Yang B, Kang J, Liu Y, Zhang Y. | Gut Microbes | 10.1080/19490976.2023.2226925 | 2023 | |
| Alteration in the gut microbiome is associated with changes in bone metabolism after laparoscopic sleeve gastrectomy. | Wu KC, McCauley KE, Lynch SV, Nayak RR, King NJ, Patel S, Kim TY, Condra K, Fadrosh D, Nguyen D, Lin DL, Lynch K, Rogers SJ, Carter JT, Posselt AM, Stewart L, Schafer AL. | J Bone Miner Res | 10.1093/jbmr/zjad017 | 2024 | ||
| First Study on profiling of gut microbiome in wild and captive Sumatran orangutans (Pongo abelii). | Safika S, Indrawati A, Afiff U, Hastuti YT, Zureni Z, Jati AP. | Vet World | 10.14202/vetworld.2023.717-727 | 2023 | ||
| Traditional Chinese Medicine: An Exogenous Regulator of Crosstalk between the Gut Microbial Ecosystem and CKD. | Sun X, Sun W, Huang Y, Chen J. | Evid Based Complement Alternat Med | 10.1155/2022/7940684 | 2022 | ||
| Snapshot into the Type-2-Diabetes-Associated Microbiome of a Romanian Cohort. | Gradisteanu Pircalabioru G, Chifiriuc MC, Picu A, Petcu LM, Trandafir M, Savu O. | Int J Mol Sci | 10.3390/ijms232315023 | 2022 | ||
| Genetics | Case-Control Study of the Effects of Gut Microbiota Composition on Neurotransmitter Metabolic Pathways in Children With Attention Deficit Hyperactivity Disorder. | Wan L, Ge WR, Zhang S, Sun YL, Wang B, Yang G. | Front Neurosci | 10.3389/fnins.2020.00127 | 2020 | |
| Pathogenicity | Sexual behavior is linked to changes in gut microbiome and systemic inflammation that lead to HIV-1 infection in men who have sex with men. | Lin H, Chen Y, Abror-Lacks G, Price M, Morris A, Sun J, Palella F, Chew KW, Brown TT, Rinaldo CR, Peddada SD. | Commun Biol | 10.1038/s42003-024-06816-z | 2024 | |
| Immunological design of commensal communities to treat intestinal infection and inflammation. | Brown RL, Larkinson MLY, Clarke TB. | PLoS Pathog | 10.1371/journal.ppat.1009191 | 2021 | ||
| Infection leaves a genetic and functional mark on the gut population of a commensal bacterium. | Tawk C, Lim B, Bencivenga-Barry NA, Lees HJ, Ramos RJF, Cross J, Goodman AL. | Cell Host Microbe | 10.1016/j.chom.2023.04.005 | 2023 | ||
| Microbial Dysbiosis Linked to Metabolic Dysfunction-Associated Fatty Liver Disease in Asians: Prevotella copri Promotes Lipopolysaccharide Biosynthesis and Network Instability in the Prevotella Enterotype. | Yuan H, Wu X, Wang X, Zhou JY, Park S. | Int J Mol Sci | 10.3390/ijms25042183 | 2024 | ||
| New insights into the links between anti-diabetes drugs and gut microbiota. | Hu R, Yuan Y, Liu C, Zhou J, Ji L, Jiang G. | Endocr Connect | 10.1530/ec-20-0431 | 2021 | ||
| The inconsistent pathogenesis of endometriosis and adenomyosis: insights from endometrial metabolome and microbiome. | Li C, Xu X, Zhao X, Du B. | mSystems | 10.1128/msystems.00202-25 | 2025 | ||
| The diagnostic and prognostic potential of gut bacteria in inflammatory bowel disease. | Wiredu Ocansey DK, Hang S, Yuan X, Qian H, Zhou M, Valerie Olovo C, Zhang X, Mao F. | Gut Microbes | 10.1080/19490976.2023.2176118 | 2023 | ||
| Pathogenicity | The Role of Host Genetics and Intestinal Microbiota and Metabolome as a New Insight into IBD Pathogenesis. | Zakerska-Banaszak O, Zuraszek-Szymanska J, Eder P, Ladziak K, Slomski R, Skrzypczak-Zielinska M. | Int J Mol Sci | 10.3390/ijms25179589 | 2024 | |
| [Necrotizing fasciitis after a cat bite: a case report]. | Hosoda T, Yanagisawa N, Morioka H, Suganuma A, Imamura A, Ajisawa A. | Kansenshogaku Zasshi | 10.11150/kansenshogakuzasshi.87.211 | 2013 | ||
| The effect of intestinal flora on immune checkpoint inhibitors in tumor treatment: a narrative review. | Wang D, Hao H, Li X, Wang Z. | Ann Transl Med | 10.21037/atm-20-4535 | 2020 | ||
| Metabolism | Comprehensive metagenomic and lipidomic analysis showed that baicalin could improve depressive behaviour in atherosclerotic mice by inhibiting nerve cell ferroptosis. | Ren P, Zhao Y, Li X, Xie J, Liao X, Luo Q, Liu X, Li J, Fan Y, Cheng X, Fu X, Zhou J, Wu X. | Front Immunol | 10.3389/fimmu.2025.1599570 | 2025 | |
| Comparative time-series analyses of gut microbiome profiles in genetically and chemically induced lupus-prone mice and the impacts of fecal transplantation. | Chatthanathon P, Leelahavanichkul A, Cheibchalard T, Wilantho A, Hirankarn N, Somboonna N. | Sci Rep | 10.1038/s41598-024-77672-4 | 2024 | ||
| Genetics | The gut microbiome as a potential source of non-invasive biomarkers of chronic obstructive pulmonary disease. | Li N, Yi X, Chen C, Dai Z, Deng Z, Pu J, Zhou Y, Li B, Wang Z, Ran P. | Front Microbiol | 10.3389/fmicb.2023.1173614 | 2023 | |
| The Gut Microbiome May Help Address Mental Health Disparities in Hispanics: A Narrative Review. | Vera-Urbina F, Dos Santos-Torres MF, Godoy-Vitorino F, Torres-Hernandez BA. | Microorganisms | 10.3390/microorganisms10040763 | 2022 | ||
| The gut microbiome is associated with susceptibility to febrile malaria in Malian children. | Van Den Ham KM, Bower LK, Li S, Lorenzi H, Doumbo S, Doumtabe D, Kayentao K, Ongoiba A, Traore B, Crompton PD, Schmidt NW. | Nat Commun | 10.1038/s41467-024-52953-8 | 2024 | ||
| Genetics | Strain-resolved microbiome sequencing reveals mobile elements that drive bacterial competition on a clinical timescale. | Zlitni S, Bishara A, Moss EL, Tkachenko E, Kang JB, Culver RN, Andermann TM, Weng Z, Wood C, Handy C, Ji HP, Batzoglou S, Bhatt AS. | Genome Med | 10.1186/s13073-020-00747-0 | 2020 | |
| Gut Microbiota and Host Cometabolism Are Altered by Patiromer-Induced Changes in Serum and Stool Potassium. | Gao B, Friedman ES, Regunathan R, Shrivastava A, Barrows IR, Amdur RL, Andrews SC, Barrows ED, Raj DS. | Kidney Int Rep | 10.1016/j.ekir.2020.12.026 | 2021 | ||
| Postbiotics Enhance NK Cell Activation in Stress-Induced Mice through Gut Microbiome Regulation. | Jung YJ, Kim HS, Jaygal G, Cho HR, Lee KB, Song IB, Kim JH, Kwak MS, Han KH, Bae MJ, Sung MH. | J Microbiol Biotechnol | 10.4014/jmb.2111.11027 | 2022 | ||
| Identifying microbial signatures for patients with postmenopausal osteoporosis using gut microbiota analyses and feature selection approaches. | Huang D, Wang J, Zeng Y, Li Q, Wang Y. | Front Microbiol | 10.3389/fmicb.2023.1113174 | 2023 | ||
| Metabolism | Metabolites with SARS-CoV-2 Inhibitory Activity Identified from Human Microbiome Commensals. | Piscotta FJ, Hoffmann HH, Choi YJ, Small GI, Ashbrook AW, Koirala B, Campbell EA, Darst SA, Rice CM, Brady SF. | mSphere | 10.1128/msphere.00711-21 | 2021 | |
| Characteristics of gut microbiota in patients with metabolic associated fatty liver disease. | Yang C, Xu J, Xu X, Xu W, Tong B, Wang S, Ji R, Tan Y, Zhu Y. | Sci Rep | 10.1038/s41598-023-37163-4 | 2023 | ||
| Big data analytics frameworks for the influence of gut microbiota on the development of tic disorder. | Fan F, Bian Z, Zhang X, Wu H, Wang S, Zhang S, Wang Q, Han F. | Front Comput Neurosci | 10.3389/fncom.2022.986591 | 2022 | ||
| Effects of prebiotic oligofructose-enriched inulin on gut-derived uremic toxins and disease progression in rats with adenine-induced chronic kidney disease. | Melekoglu E, Cetinkaya MA, Kepekci-Tekkeli SE, Kul O, Samur G. | PLoS One | 10.1371/journal.pone.0258145 | 2021 | ||
| Phylogeny | Can longer lifespan be associated with gut microbiota involvement in lipid metabolism? | Sardzikova S, Gajewska M, Galka N, Stefanek M, Balaz A, Garaiova M, Holic R, Swiderek W, Soltys K. | FEMS Microbiol Ecol | 10.1093/femsec/fiae135 | 2024 | |
| The functional landscape of the appendix microbiome under conditions of health and disease | Sagor M, Islam T, Tamanna N, Bappy M, Danishuddin, Haque M, Lackner M. | Gut Pathog | 2025 | |||
| Phylogeny | Distinct gut microbiomes in Thai patients with colorectal polyps. | Intarajak T, Udomchaiprasertkul W, Khoiri AN, Sutheeworapong S, Kusonmano K, Kittichotirat W, Thammarongtham C, Cheevadhanarak S. | World J Gastroenterol | 10.3748/wjg.v30.i27.3336 | 2024 | |
| D-methionine alleviates cisplatin-induced mucositis by restoring the gut microbiota structure and improving intestinal inflammation. | Wu CH, Ko JL, Liao JM, Huang SS, Lin MY, Lee LH, Chang LY, Ou CC. | Ther Adv Med Oncol | 10.1177/1758835918821021 | 2019 | ||
| Diet-gut microbiome interaction and its impact on host blood glucose homeostasis: a series of nutritional n-of-1 trials. | Fu Y, Gou W, Zhong H, Tian Y, Zhao H, Liang X, Shuai M, Zhuo LB, Jiang Z, Tang J, Ordovas JM, Chen YM, Zheng JS. | EBioMedicine | 10.1016/j.ebiom.2024.105483 | 2025 | ||
| Metabolism | Interrelationship of Stress, Environment, and Herpes Simplex Virus Type-1 on Behçet's Disease: Using a Mouse Model. | Islam SMS, Ryu HM, Sayeed HM, Sohn S. | Front Immunol | 10.3389/fimmu.2021.607768 | 2021 | |
| Genetics | Characteristics of intestinal flora in patients with cerebral infarction complicated with Type 2 diabetes mellitus. | Cheng X, Zhang Z, Dong W, Lun Y, Liu B. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 10.11817/j.issn.1672-7347.2023.220558 | 2023 | |
| Enzymology | Structure and function of microbial alpha-l-fucosidases: a mini review. | Wu H, Owen CD, Juge N. | Essays Biochem | 10.1042/ebc20220158 | 2023 | |
| Creation of a non-Western humanized gnotobiotic mouse model through the transplantation of rural African fecal microbiota. | Van Den Ham KM, Little MR, Bednarski OJ, Fusco EM, Mandal RK, Mitra R, Li S, Doumbo S, Doumtabe D, Kayentao K, Ongoiba A, Traore B, Crompton PD, Schmidt NW. | Microbiol Spectr | 10.1128/spectrum.01554-23 | 2023 | ||
| Microbiome features associated with performance measures in athletic and non-athletic individuals: A case-control study. | Huminska-Lisowska K, Zielinska K, Mieszkowski J, Michalowska-Sawczyn M, Cieszczyk P, Labaj PP, Wasag B, Fraczek B, Grzywacz A, Kochanowicz A, Kosciolek T. | PLoS One | 10.1371/journal.pone.0297858 | 2024 | ||
| Hermetia illucens Fermented with Lactobacillus plantarum KCCM12757P Alleviates Dextran Sodium Sulfate-Induced Colitis in Mice. | Son SJ, Han AR, Sung MJ, Hong SM, Lee SH. | Antioxidants (Basel) | 10.3390/antiox12101822 | 2023 | ||
| Metabolism | Therapeutic Potential of Metabolites from Lactobacillus rhamnosus and Mare's Milk in the Treatment of Dysbiosis. | Kozhakhmetov S, Babenko D, Kozhakhmetova S, Tuyakova A, Nurgaziyev M, Nurgozhina A, Muhanbetganov N, Chulenbayeva L, Sergazy S, Gulyayev A, Aljofan M, Kushugulova A. | Biomed Res Int | 10.1155/2022/3851478 | 2022 | |
| Nutraceuticals and Herbal Food Supplements for Weight Loss: Is There a Prebiotic Role in the Mechanism of Action? | Bertuccioli A, Cardinali M, Biagi M, Moricoli S, Morganti I, Zonzini GB, Rigillo G. | Microorganisms | 10.3390/microorganisms9122427 | 2021 | ||
| Attributes of intestinal microbiota composition and their correlation with clinical primary non-response to anti-TNF-alpha agents in inflammatory bowel disease patients. | Alatawi H, Mosli M, Saadah OI, Annese V, Al-Hindi R, Alatawy M, Al-Amrah H, Alshehri D, Bahieldin A, Edris S. | Bosn J Basic Med Sci | 10.17305/bjbms.2021.6436 | 2022 | ||
| Genetics | Nasal Microbiome and Its Interaction with the Host in Childhood Asthma. | Zeng Y, Liang JQ. | Cells | 10.3390/cells11193155 | 2022 | |
| Carbohydrate-active enzymes from Akkermansia muciniphila break down mucin O-glycans to completion. | Bakshani CR, Ojuri TO, Pilgaard B, Holck J, McInnes R, Kozak RP, Zakhour M, Cakaj S, Kerouedan M, Newton E, Bolam DN, Crouch LI. | Nat Microbiol | 10.1038/s41564-024-01911-7 | 2025 | ||
| Metabolism | A Soluble Fiber Diet Increases Bacteroides fragilis Group Abundance and Immunoglobulin A Production in the Gut. | Nakajima A, Sasaki T, Itoh K, Kitahara T, Takema Y, Hiramatsu K, Ishikawa D, Shibuya T, Kobayashi O, Osada T, Watanabe S, Nagahara A. | Appl Environ Microbiol | 10.1128/aem.00405-20 | 2020 | |
| Association between Dietary Habits and Fecal Microbiota Composition in Irritable Bowel Syndrome Patients: A Pilot Study. | Altomare A, Del Chierico F, Rocchi G, Emerenziani S, Nuglio C, Putignani L, Angeletti S, Lo Presti A, Ciccozzi M, Russo A, Cocca S, Ribolsi M, Muscaritoli M, Cicala M, Guarino MPL. | Nutrients | 10.3390/nu13051479 | 2021 | ||
| Group A Streptococci-Associated Necrotizing Fasciitis following Cat Bite in an Immunocompromised Patient. | Nambiar S, Karippot A, Devasahayam J, Oliver T. | Case Rep Crit Care | 10.1155/2017/3718360 | 2017 | ||
| Exploring the presence of oral bacteria in non-oral sites of patients with cardiovascular diseases using whole metagenomic data. | Chopra A, Franco-Duarte R, Rajagopal A, Choowong P, Soares P, Rito T, Eberhard J, Jayasinghe TN. | Sci Rep | 10.1038/s41598-023-50891-x | 2024 | ||
| Akkermansia muciniphila Improves Depressive-Like Symptoms by Modulating the Level of 5-HT Neurotransmitters in the Gut and Brain of Mice. | Guo H, Liu X, Chen T, Wang X, Zhang X. | Mol Neurobiol | 10.1007/s12035-023-03602-6 | 2024 | ||
| Genetics | When old metagenomic data meet newly sequenced genomes, a case study. | Li X, Naser SA, Khaled A, Hu H, Li X. | PLoS One | 10.1371/journal.pone.0198773 | 2018 | |
| Gut commensals-derived succinate impels colonic inflammation in ulcerative colitis. | Dalal R, Sadhu S, Batra A, Goswami S, Dandotiya J, K V V, Yadav R, Singh V, Chaturvedi K, Kannan R, Kumar S, Kumar Y, Rathore DK, Salunke DB, Ahuja V, Awasthi A. | NPJ Biofilms Microbiomes | 10.1038/s41522-025-00672-3 | 2025 | ||
| Simulated digestions of free oligosaccharides and mucin-type O-glycans reveal a potential role for Clostridium perfringens. | McDonald AG, Lisacek F. | Sci Rep | 10.1038/s41598-023-51012-4 | 2024 | ||
| Microbial succinate promotes the response to metformin by upregulating secretory immunoglobulin a in intestinal immunity. | Zhang Y, Wang A, Zhao W, Qin J, Zhang Y, Liu B, Yao C, Long J, Yuan M, Yan D. | Gut Microbes | 10.1080/19490976.2025.2450871 | 2025 | ||
| Genetics | Temporal colonization and metabolic regulation of the gut microbiome in neonatal oxen at single nucleotide resolution. | Dong Q, Hua D, Wang X, Jiao Y, Liu L, Deng Q, Wu T, Zou H, Zhao C, Wang C, Reng J, Ding L, Hu S, Shi J, Wang Y, Zhang H, Sheng Y, Sun W, Shen Y, Tang L, Kong X, Chen L. | ISME J | 10.1093/ismejo/wrad022 | 2024 | |
| Pathogenicity | Intestinal microbiome and metabolome signatures in patients with chronic granulomatous disease. | Chandrasekaran P, Han Y, Zerbe CS, Heller T, DeRavin SS, Kreuzberg SA, Marciano BE, Siu Y, Jones DR, Abraham RS, Stephens MC, Tsou AM, Snapper S, Conlan S, Subramanian P, Quinones M, Grou C, Calderon V, Deming C, Leiding JW, Arnold DE, Logan BR, Griffith LM, Petrovic A, Mousallem TI, Kapoor N, Heimall JR, Barnum JL, Kapadia M, Wright N, Rayes A, Chandra S, Broglie LA, Chellapandian D, Deal CL, Grunebaum E, Lim SS, Mallhi K, Marsh RA, Murguia-Favela L, Parikh S, Touzot F, Cowan MJ, Dvorak CC, Haddad E, Kohn DB, Notarangelo LD, Pai SY, Puck JM, Pulsipher MA, Torgerson TR, Kang EM, Malech HL, Segre JA, Bryant CE, Holland SM, Falcone EL. | J Allergy Clin Immunol | 10.1016/j.jaci.2023.07.022 | 2023 | |
| Fecal microbiota transplantation and its repercussions in patients with melanoma refractory to anti-PD-1 therapy: scope review. | Barbosa EC, Bucar EEC, Jube GR, Silveira LB, Silva NCD, Faria PCC, Ramos PLC, Moraes VRY, Barros JOB. | Rev Col Bras Cir | 10.1590/0100-6991e-20233490-en | 2023 | ||
| Enzymology | [Bacteria isolated from surgical infections and its susceptibilities to antimicrobial agents - Special references to bacteria isolated between April 2011 and March 2012]. | Shinagawa N, Taniguchi M, Hirata K, Furuhata T, Mizuguchi T, Osanai H, Yanai Y, Hata F, Kihara C, Sasaki K, Oono K, Nakamura M, Shibuya H, Hasegawa I, Kimura M, Watabe K, Hoshikawa T, Oshima H, Aikawa N, Sasaki J, Suzuki M, Sekine K, Abe S, Takeyama H, Wakasugi T, Mashita K, Tanaka M, Mizuno A, Ishikawa M, Iwai A, Saito T, Muramoto M, Kubo S, Lee S, Fukuhara K, Kobayashi Y, Yamaue H, Hirono S, Takesue Y, Fujiwara T, Shinoura S, Kimura H, Iwagaki H, Tokunaga N, Sueda T, Hiyama E, Murakami Y, Ohge H, Uemura K, Tsumura H, Kanehiro T, Takeuchi H, Tanakaya K, Iwasaki M. | Jpn J Antibiot | 2014 | ||
| Multi-level analysis of gut microbiome extracellular vesicles-host interaction reveals a connection to gut-brain axis signaling. | Mottawea W, Yousuf B, Sultan S, Ahmed T, Yeo J, Huttmann N, Li Y, Bouhlel NE, Hassan H, Zhang X, Minic Z, Hammami R. | Microbiol Spectr | 10.1128/spectrum.01368-24 | 2025 | ||
| Systematic review of the impact of intestinal microbiota on vaccine responses. | Ardura-Garcia C, Curtis N, Zimmermann P. | NPJ Vaccines | 10.1038/s41541-024-01000-0 | 2024 | ||
| Genetics | Integration analysis of tumor metagenome and peripheral immunity data of diffuse large-B cell lymphoma. | Zhang Y, Han S, Xiao X, Zheng L, Chen Y, Zhang Z, Gao X, Zhou S, Yu K, Huang L, Fu J, Hong Y, Jiang J, Qian W, Yang H, Shen J. | Front Immunol | 10.3389/fimmu.2023.1146861 | 2023 | |
| Genetics | A metagenomics pipeline reveals insertion sequence-driven evolution of the microbiota. | Kirsch JM, Hryckowian AJ, Duerkop BA. | Cell Host Microbe | 10.1016/j.chom.2024.03.005 | 2024 | |
| Genetics | Differential Effects of Western and Mediterranean-Type Diets on Gut Microbiota: A Metagenomics and Metabolomics Approach. | Barber C, Mego M, Sabater C, Vallejo F, Bendezu RA, Masihy M, Guarner F, Espin JC, Margolles A, Azpiroz F. | Nutrients | 10.3390/nu13082638 | 2021 | |
| Immunotherapy and Microbiota for Targeting of Liver Tumor-Initiating Stem-like Cells. | Machida K, Tahara SM. | Cancers (Basel) | 10.3390/cancers14102381 | 2022 | ||
| Structures of the Skin Microbiome and Mycobiome Depending on Skin Sensitivity. | Keum HL, Kim H, Kim HJ, Park T, Kim S, An S, Sul WJ. | Microorganisms | 10.3390/microorganisms8071032 | 2020 | ||
| Metabolism | Analysis of correlations between gut microbiota, stool short chain fatty acids, calprotectin and cardiometabolic risk factors in postmenopausal women with obesity: a cross-sectional study. | Loniewski I, Szulinska M, Kaczmarczyk M, Podsiadlo K, Styburski D, Skonieczna-Zydecka K, Bogdanski P. | J Transl Med | 10.1186/s12967-022-03801-0 | 2022 | |
| Effect and Potential Mechanism of Lactobacillus plantarum Q7 on Hyperuricemia in vitro and in vivo. | Cao J, Bu Y, Hao H, Liu Q, Wang T, Liu Y, Yi H. | Front Nutr | 10.3389/fnut.2022.954545 | 2022 | ||
| Examining the immunoepigenetic-gut microbiome axis in the context of self-esteem among Native Hawaiians and other Pacific Islanders. | Becerra CY, Wells RK, Kunihiro BP, Lee RH, Umeda L, Allan NP, Rubas NC, McCracken TA, Nunokawa CKL, Lee MH, Pidlaoan FGS, Phankitnirondorn K, Dye CK, Yamamoto BY, Peres R, Juarez R, Maunakea AK. | Front Genet | 10.3389/fgene.2023.1125217 | 2023 | ||
| The Local Microbiome in Esophageal Cancer and Treatment Response: A Review of Emerging Data and Future Directions. | Pandey A, Lieu CH, Kim SS. | Cancers (Basel) | 10.3390/cancers15143562 | 2023 | ||
| Perturbed Microbiota/Immune Homeostasis in Multiple Sclerosis. | Sterlin D, Larsen M, Fadlallah J, Parizot C, Vignes M, Autaa G, Dorgham K, Juste C, Lepage P, Aboab J, Vicart S, Maillart E, Gout O, Lubetzki C, Deschamps R, Papeix C, Gorochov G. | Neurol Neuroimmunol Neuroinflamm | 10.1212/nxi.0000000000000997 | 2021 | ||
| Pathogenicity | COVID-19 Infection Alters the Microbiome: Elite Athletes and Sedentary Patients Have Similar Bacterial Flora. | Babszky G, Torma F, Aczel D, Bakonyi P, Gombos Z, Feher J, Szabo D, Ligeti B, Pongor S, Balogh L, Posa A, Radak Z. | Genes (Basel) | 10.3390/genes12101577 | 2021 | |
| Dynamics of the gut microbiota in rats after hypobaric hypoxia exposure. | Han Y, Xu J, Yan Y, Zhao X. | PeerJ | 10.7717/peerj.14090 | 2022 | ||
| Pea hull fiber supplementation does not modulate uremic metabolites in adults receiving hemodialysis: a randomized, double-blind, controlled trial. | Fatani AMN, Suh JH, Auger J, Alabasi KM, Wang Y, Segal MS, Dahl WJ. | Front Nutr | 10.3389/fnut.2023.1179295 | 2023 | ||
| Short term supplementation with cranberry extract modulates gut microbiota in human and displays a bifidogenic effect. | Lessard-Lord J, Roussel C, Lupien-Meilleur J, Genereux P, Richard V, Guay V, Roy D, Desjardins Y. | NPJ Biofilms Microbiomes | 10.1038/s41522-024-00493-w | 2024 | ||
| Phylogeny | Gut Microbiome Changes Associated With HIV Infection and Sexual Orientation. | Zhou J, Zhang Y, Cui P, Luo L, Chen H, Liang B, Jiang J, Ning C, Tian L, Zhong X, Ye L, Liang H, Huang J. | Front Cell Infect Microbiol | 10.3389/fcimb.2020.00434 | 2020 | |
| Gut bacterial metabolism contributes to host global purine homeostasis. | Kasahara K, Kerby RL, Zhang Q, Pradhan M, Mehrabian M, Lusis AJ, Bergstrom G, Backhed F, Rey FE. | Cell Host Microbe | 10.1016/j.chom.2023.05.011 | 2023 | ||
| Dysbiosis signatures of gut microbiota and the progression of type 2 diabetes: a machine learning approach in a Mexican cohort. | Neri-Rosario D, Martinez-Lopez YE, Esquivel-Hernandez DA, Sanchez-Castaneda JP, Padron-Manrique C, Vazquez-Jimenez A, Giron-Villalobos D, Resendis-Antonio O. | Front Endocrinol (Lausanne) | 10.3389/fendo.2023.1170459 | 2023 | ||
| Phylogeny | Maternal microbiota and gestational diabetes: impact on infant health. | Singh P, Elhaj DAI, Ibrahim I, Abdullahi H, Al Khodor S. | J Transl Med | 10.1186/s12967-023-04230-3 | 2023 | |
| Lactobacillus gasseri LG08 and Leuconostoc mesenteroides LM58 exert preventive effect on the development of hyperuricemia by repairing antioxidant system and intestinal flora balance. | Liang L, Meng Z, Zhang F, Jianguo Z, Fang S, Hu Q, Tang X, Li Y. | Front Microbiol | 10.3389/fmicb.2023.1211831 | 2023 | ||
| The global RNA-binding protein RbpB is a regulator of polysaccharide utilization in Bacteroides thetaiotaomicron. | Ruttiger AS, Ryan D, Spiga L, Lamm-Schmidt V, Prezza G, Reichardt S, Langford M, Barquist L, Faber F, Zhu W, Westermann AJ. | Nat Commun | 10.1038/s41467-024-55383-8 | 2025 | ||
| Influence of Bifidobacterium breve on the Glycaemic Control, Lipid Profile and Microbiome of Type 2 Diabetic Subjects: A Preliminary Randomized Clinical Trial. | Chaiyasut C, Sivamaruthi BS, Lailerd N, Sirilun S, Thangaleela S, Khongtan S, Bharathi M, Kesika P, Saelee M, Choeisoongnern T, Fukngoen P, Peerajan S, Sittiprapaporn P. | Pharmaceuticals (Basel) | 10.3390/ph16050695 | 2023 | ||
| Early microbial markers of celiac disease. | Viitasalo L, Niemi L, Ashorn M, Ashorn S, Braun J, Huhtala H, Collin P, Maki M, Kaukinen K, Kurppa K, Iltanen S. | J Clin Gastroenterol | 10.1097/mcg.0000000000000089 | 2014 | ||
| Antimicrobial Resistance Profile and Nim Gene Detection among Bacteroides fragilis Group Isolates in a University Hospital in South India. | Vishwanath S, Shenoy PA, Chawla K. | J Glob Infect Dis | 10.4103/jgid.jgid_116_18 | 2019 | ||
| In vitro digestive characteristics and microbial degradation of polysaccharides from lotus leaves and related effects on the modulation of intestinal microbiota. | Wu DT, Feng KL, Li F, Hu YC, Wang SP, Gan RY, Zou L. | Curr Res Food Sci | 10.1016/j.crfs.2022.04.004 | 2022 | ||
| Association of antimicrobial resistance and gut microbiota composition in human and non-human primates at an urban ecotourism site. | Chong CW, Alkatheeri AHS, Ali N, Tay ZH, Lee YL, Paramasivam SJ, Jeevaratnam K, Low WY, Lim SHE. | Gut Pathog | 10.1186/s13099-020-00352-x | 2020 | ||
| GH136-encoding gene (perB) is involved in gut colonization and persistence by Bifidobacterium bifidum PRL2010. | Rizzo SM, Vergna LM, Alessandri G, Lee C, Fontana F, Lugli GA, Carnevali L, Bianchi MG, Barbetti M, Taurino G, Sgoifo A, Bussolati O, Turroni F, van Sinderen D, Ventura M. | Microb Biotechnol | 10.1111/1751-7915.14406 | 2024 | ||
| Multi-omics of the gut microbial ecosystem in patients with microsatellite-instability-high gastrointestinal cancer resistant to immunotherapy. | Cheng S, Han Z, Dai D, Li F, Zhang X, Lu M, Lu Z, Wang X, Zhou J, Li J, Guo X, Song P, Qiu C, Shen W, Zhang Q, Zhu N, Wang X, Tan Y, Kou Y, Yin X, Shen L, Peng Z. | Cell Rep Med | 10.1016/j.xcrm.2023.101355 | 2024 | ||
| Exploring the Involvement of Gut Microbiota in Cancer Therapy-Induced Cardiotoxicity. | Kunika, Frey N, Rangrez AY. | Int J Mol Sci | 10.3390/ijms24087261 | 2023 | ||
| Higher pathogen load in children from Mozambique vs. USA revealed by comparative fecal microbiome profiling. | Kim M, Rodriguez-R LM, Hatt JK, Kayali O, Nala R, Dunlop AL, Brennan PA, Corwin E, Smith AK, Brown J, Konstantinidis KT. | ISME Commun | 10.1038/s43705-022-00154-z | 2022 | ||
| HMOs Exert Marked Bifidogenic Effects on Children's Gut Microbiota Ex Vivo, Due to Age-Related Bifidobacterium Species Composition. | Bajic D, Wiens F, Wintergerst E, Deyaert S, Baudot A, Van den Abbeele P. | Nutrients | 10.3390/nu15071701 | 2023 | ||
| Enzymology | Design of species-specific oligonucleotide probes for the detection of Bacteroides and Parabacteroides by fluorescence in situ hybridization and their application to the analysis of mouse caecal Bacteroides-Parabacteroides microbiota. | Momose Y, Park SH, Miyamoto Y, Itoh K. | J Appl Microbiol | 10.1111/j.1365-2672.2011.05039.x | 2011 | |
| Metabolism | Sex differences in the phylum-level human gut microbiota composition. | Koliada A, Moseiko V, Romanenko M, Lushchak O, Kryzhanovska N, Guryanov V, Vaiserman A. | BMC Microbiol | 10.1186/s12866-021-02198-y | 2021 | |
| Phylogeny | Application of quantitative real-time PCR for rapid identification of Bacteroides fragilis group and related organisms in human wound samples. | Tong J, Liu C, Summanen P, Xu H, Finegold SM. | Anaerobe | 10.1016/j.anaerobe.2011.03.004 | 2011 | |
| Host-Population Microbial Diversity Scaling of Chinese Gut Microbiomes in Gout Patients. | Zhou J, Yuan Y, Xu P, Yi B, Chen H, Su W. | Evol Bioinform Online | 10.1177/11769343221095858 | 2022 | ||
| Metabolism | Analysis of the gut microbiome in obese native Tibetan children living at different altitudes: A case-control study. | Du W, Liu L, Ma Y, Zhu Q, Jia R, Han Y, Wu Z, Yan X, Ailizire A, Zhang W. | Front Public Health | 10.3389/fpubh.2022.963202 | 2022 | |
| Changes in Gut Microbiome upon Orchiectomy and Testosterone Administration in AOM/DSS-Induced Colon Cancer Mouse Model. | Song CH, Kim N, Nam RH, Choi SI, Jang JY, Lee HN. | Cancer Res Treat | 10.4143/crt.2022.080 | 2023 | ||
| Human Fecal Microbiota Transplantation Reduces the Susceptibility to Dextran Sulfate Sodium-Induced Germ-Free Mouse Colitis. | Yang Y, Zheng X, Wang Y, Tan X, Zou H, Feng S, Zhang H, Zhang Z, He J, Cui B, Zhang X, Wu Z, Dong M, Cheng W, Tao S, Wei H. | Front Immunol | 10.3389/fimmu.2022.836542 | 2022 | ||
| Enzymology | Prosthetic joint infections present diverse and unique microbial communities using combined whole-genome shotgun sequencing and culturing methods. | Weaver AA, Hasan NA, Klaassen M, Karathia H, Colwell RR, Shrout JD. | J Med Microbiol | 10.1099/jmm.0.001068 | 2019 | |
| Genetics | SARS-CoV-2 triggered oxidative stress and abnormal energy metabolism in gut microbiota. | Zhou T, Wu J, Zeng Y, Li J, Yan J, Meng W, Han H, Feng F, He J, Zhao S, Zhou P, Wu Y, Yang Y, Han R, Jin W, Li X, Yang Y, Li X. | MedComm (2020) | 10.1002/mco2.112 | 2022 | |
| Metaproteomics reveals parallel utilization of colonic mucin glycans and dietary fibers by the human gut microbiota. | Raba G, Luis AS, Schneider H, Morell I, Jin C, Adamberg S, Hansson GC, Adamberg K, Arike L. | iScience | 10.1016/j.isci.2024.110093 | 2024 | ||
| Potential Gut Microbiota Features for Non-Invasive Detection of Schistosomiasis. | Lin D, Song Q, Liu J, Chen F, Zhang Y, Wu Z, Sun X, Wu X. | Front Immunol | 10.3389/fimmu.2022.941530 | 2022 | ||
| Lactobacillus paracasei X11 Ameliorates Hyperuricemia and Modulates Gut Microbiota in Mice. | Cao J, Liu Q, Hao H, Bu Y, Tian X, Wang T, Yi H. | Front Immunol | 10.3389/fimmu.2022.940228 | 2022 | ||
| Modeling spatial interaction networks of the gut microbiota. | Cao X, Dong A, Kang G, Wang X, Duan L, Hou H, Zhao T, Wu S, Liu X, Huang H, Wu R. | Gut Microbes | 10.1080/19490976.2022.2106103 | 2022 | ||
| Dynamics of bacterial recombination in the human gut microbiome. | Liu Z, Good BH. | PLoS Biol | 10.1371/journal.pbio.3002472 | 2024 | ||
| Do proton pump inhibitors alter the response to immune checkpoint inhibitors in cancer patients? A meta-analysis. | Lopes S, Pabst L, Dory A, Klotz M, Gourieux B, Michel B, Mascaux C. | Front Immunol | 10.3389/fimmu.2023.1070076 | 2023 | ||
| Vaccination with an HIV T-cell immunogen induces alterations in the mouse gut microbiota. | Borgognone A, Elizalde-Torrent A, Casadella M, Romero L, Escriba T, Parera M, Catala-Moll F, Noguera-Julian M, Brander C, Olvera A, Paredes R. | NPJ Biofilms Microbiomes | 10.1038/s41522-022-00368-y | 2022 | ||
| Metabolism | Gut microbes impact stroke severity via the trimethylamine N-oxide pathway. | Zhu W, Romano KA, Li L, Buffa JA, Sangwan N, Prakash P, Tittle AN, Li XS, Fu X, Androjna C, DiDonato AJ, Brinson K, Trapp BD, Fischbach MA, Rey FE, Hajjar AM, DiDonato JA, Hazen SL. | Cell Host Microbe | 10.1016/j.chom.2021.05.002 | 2021 | |
| Gut microbiota is involved in male reproductive function: a review. | Lv S, Huang J, Luo Y, Wen Y, Chen B, Qiu H, Chen H, Yue T, He L, Feng B, Yu Z, Zhao M, Yang Q, He M, Xiao W, Zou X, Gu C, Lu R. | Front Microbiol | 10.3389/fmicb.2024.1371667 | 2024 | ||
| Microbiota composition effect on immunotherapy outcomes in colorectal cancer patients: A systematic review. | Ajab SM, Zoughbor SH, Labania LA, Ostlundh LM, Orsud HS, Olanda MA, Alkaabi O, Alkuwaiti SH, Alnuaimi SM, Al Rasbi Z. | PLoS One | 10.1371/journal.pone.0307639 | 2024 | ||
| Nutritional composition, heavy metal content and in vitro effect on the human gut microbiota of Talitrus saltator, an underutilized crustacean from the Atlantic coast. | Lopez-Santamarina A, Cardelle-Cobas A, Lamas A, Mondragon-Portocarrero A, Cepeda A, Miranda JM. | Front Nutr | 10.3389/fnut.2022.943133 | 2022 | ||
| Metabolism | Combining functional metagenomics and glycoanalytics to identify enzymes that facilitate structural characterization of sulfated N-glycans. | Chuzel L, Fossa SL, Boisvert ML, Cajic S, Hennig R, Ganatra MB, Reichl U, Rapp E, Taron CH. | Microb Cell Fact | 10.1186/s12934-021-01652-w | 2021 | |
| Baseline gut microbiota and metabolome predict durable immunogenicity to SARS-CoV-2 vaccines. | Peng Y, Zhang L, Mok CKP, Ching JYL, Zhao S, Wong MKL, Zhu J, Chen C, Wang S, Yan S, Qin B, Liu Y, Zhang X, Cheung CP, Cheong PK, Ip KL, Fung ACH, Wong KKY, Hui DSC, Chan FKL, Ng SC, Tun HM. | Signal Transduct Target Ther | 10.1038/s41392-023-01629-8 | 2023 | ||
| Adhesive intestinal obstruction increases the risk of intestinal perforation in peritoneal dialysis patients: a case report. | Fujii K, Washida N, Arai E, Tsuruta M, Wakino S, Itoh H. | BMC Nephrol | 10.1186/s12882-018-0954-x | 2018 | ||
| Determinants of raffinose family oligosaccharide use in Bacteroides species. | Basu A, Adams AND, Degnan PH, Vanderpool CK. | J Bacteriol | 10.1128/jb.00235-24 | 2024 | ||
| Enzymology | Human-specific fecal bacteria in wastewater treatment plant effluents. | Wery N, Monteil C, Pourcher AM, Godon JJ. | Water Res | 10.1016/j.watres.2009.11.027 | 2010 | |
| Ruminococcus torques is a keystone degrader of intestinal mucin glycoprotein, releasing oligosaccharides used by Bacteroides thetaiotaomicron. | Schaus SR, Vasconcelos Pereira G, Luis AS, Madlambayan E, Terrapon N, Ostrowski MP, Jin C, Henrissat B, Hansson GC, Martens EC. | mBio | 10.1128/mbio.00039-24 | 2024 | ||
| Phylogeny | Microbiome Profiling from Fecal Immunochemical Test Reveals Microbial Signatures with Potential for Colorectal Cancer Screening. | Khannous-Lleiffe O, Willis JR, Saus E, Moreno V, Castellvi-Bel S, Gabaldon T, On Behalf Of The Criprev Consortium. | Cancers (Basel) | 10.3390/cancers15010120 | 2022 | |
| Use of Changestat for Growth Rate Studies of Gut Microbiota. | Adamberg K, Raba G, Adamberg S. | Front Bioeng Biotechnol | 10.3389/fbioe.2020.00024 | 2020 | ||
| Immunotherapy in Colorectal Cancer: Potential of Fecal Transplant and Microbiota-augmented Clinical Trials. | Park R, Umar S, Kasi A. | Curr Colorectal Cancer Rep | 10.1007/s11888-020-00456-1 | 2020 | ||
| High Antioxidant Capacity of Lacticaseibacillus paracasei TDM-2 and Pediococcus pentosaceus TCM-3 from Qinghai Tibetan Plateau and Their Function towards Gut Modulation. | Yang T, Fan X, Li D, Zhao T, Wu D, Liu Z, Long D, Li B, Huang X. | Foods | 10.3390/foods12091814 | 2023 | ||
| Effects of Ramadan intermittent fasting on gut microbiome: is the diet key? | Saglam D, Colak GA, Sahin E, Ekren BY, Sezerman U, Bas M. | Front Microbiol | 10.3389/fmicb.2023.1203205 | 2023 | ||
| Gut Microbiota Markers in Obese Adolescent and Adult Patients: Age-Dependent Differential Patterns. | Del Chierico F, Abbatini F, Russo A, Quagliariello A, Reddel S, Capoccia D, Caccamo R, Ginanni Corradini S, Nobili V, De Peppo F, Dallapiccola B, Leonetti F, Silecchia G, Putignani L. | Front Microbiol | 10.3389/fmicb.2018.01210 | 2018 | ||
| Pathogenicity | A Six-Day, Lifestyle-Based Immersion Program Mitigates Cardiovascular Risk Factors and Induces Shifts in Gut Microbiota, Specifically Lachnospiraceae, Ruminococcaceae, Faecalibacterium prausnitzii: A Pilot Study. | Ahrens AP, Culpepper T, Saldivar B, Anton S, Stoll S, Handberg EM, Xu K, Pepine C, Triplett EW, Aggarwal M. | Nutrients | 10.3390/nu13103459 | 2021 | |
| The Intricate Connection between Bacterial alpha-Diversity and Fungal Engraftment in the Human Gut of Healthy and Impaired Individuals as Studied Using the In Vitro SHIME® Model. | Marsaux B, Moens F, Marzorati M, Van de Wiele T. | J Fungi (Basel) | 10.3390/jof9090877 | 2023 | ||
| The genomic landscape of reference genomes of cultivated human gut bacteria. | Lin X, Hu T, Chen J, Liang H, Zhou J, Wu Z, Ye C, Jin X, Xu X, Zhang W, Jing X, Yang T, Wang J, Yang H, Kristiansen K, Xiao L, Zou Y. | Nat Commun | 10.1038/s41467-023-37396-x | 2023 | ||
| Multimodal metagenomic analysis reveals microbial single nucleotide variants as superior biomarkers for early detection of colorectal cancer. | Gao W, Gao X, Zhu L, Gao S, Sun R, Feng Z, Wu D, Liu Z, Zhu R, Jiao N. | Gut Microbes | 10.1080/19490976.2023.2245562 | 2023 | ||
| Detection and characterization of bacterial nucleic acids in culture-negative synovial tissue and fluid samples from rheumatoid arthritis or osteoarthritis patients. | Zhao Y, Chen B, Li S, Yang L, Zhu D, Wang Y, Wang H, Wang T, Shi B, Gai Z, Yang J, Heng X, Yang J, Zhang L. | Sci Rep | 10.1038/s41598-018-32675-w | 2018 | ||
| Metabolism | Silicon-Enriched Meat Ameliorates Diabetic Dyslipidemia by Improving Cholesterol, Bile Acid Metabolism and Ileal Barrier Integrity in Rats with Late-Stage Type 2 Diabetes. | Hernandez-Martin M, Garcimartin A, Bocanegra A, Macho-Gonzalez A, Garcia-Fernandez RA, de Pascual-Teresa S, Redondo-Castillejo R, Bastida S, Sanchez-Muniz FJ, Benedi J, Lopez-Oliva ME. | Int J Mol Sci | 10.3390/ijms252111405 | 2024 | |
| Reduced gut microbiota diversity in patients with congenital generalized lipodystrophy. | Montenegro Junior RM, Ponte CMM, Castelo MHCG, de Oliveira Silveira AC, Fernandes VO, D'Alva CB, Oliveira LFV, Hristov AD, Bandeira SP, da Cruz Paiva GE, Levi JE. | Diabetol Metab Syndr | 10.1186/s13098-022-00908-8 | 2022 | ||
| Alterations in co-abundant bacteriome in colorectal cancer and its persistence after surgery: a pilot study. | Png CW, Chua YK, Law JH, Zhang Y, Tan KK. | Sci Rep | 10.1038/s41598-022-14203-z | 2022 | ||
| Pathogenicity | Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. | Yeoh YK, Zuo T, Lui GC, Zhang F, Liu Q, Li AY, Chung AC, Cheung CP, Tso EY, Fung KS, Chan V, Ling L, Joynt G, Hui DS, Chow KM, Ng SSS, Li TC, Ng RW, Yip TC, Wong GL, Chan FK, Wong CK, Chan PK, Ng SC. | Gut | 10.1136/gutjnl-2020-323020 | 2021 | |
| Mechanisms of Hormonal, Genetic, and Temperature Regulation of Germ Cell Proliferation, Differentiation, and Death During Spermatogenesis. | Maroto M, Torvisco SN, Garcia-Merino C, Fernandez-Gonzalez R, Pericuesta E. | Biomolecules | 10.3390/biom15040500 | 2025 | ||
| Distinct Gut Microbiota in Patients with Asymptomatic Hyperuricemia: A Potential Protector against Gout Development. | Kim HW, Yoon EJ, Jeong SH, Park MC. | Yonsei Med J | 10.3349/ymj.2022.63.3.241 | 2022 | ||
| Systematic review of donor and recipient predictive biomarkers of response to faecal microbiota transplantation in patients with ulcerative colitis. | Rees NP, Shaheen W, Quince C, Tselepis C, Horniblow RD, Sharma N, Beggs AD, Iqbal TH, Quraishi MN. | EBioMedicine | 10.1016/j.ebiom.2022.104088 | 2022 | ||
| Airway Fusobacterium is Associated with Poor Response to Immunotherapy in Lung Cancer. | Chu S, Cheng Z, Yin Z, Xu J, Wu F, Jin Y, Yang G. | Onco Targets Ther | 10.2147/ott.s348382 | 2022 | ||
| Deep metagenomic characterization of gut microbial community and function in preeclampsia. | Lv LJ, Li SH, Wen JY, Wang GY, Li H, He TW, Lv QB, Xiao MC, Duan HL, Chen MC, Yi ZT, Yan QL, Yin AH. | Front Cell Infect Microbiol | 10.3389/fcimb.2022.933523 | 2022 | ||
| A randomized pilot trial assessing the reduction of gout episodes in hyperuricemic patients by oral administration of Ligilactobacillus salivarius CECT 30632, a strain with the ability to degrade purines. | Rodriguez JM, Garranzo M, Segura J, Orgaz B, Arroyo R, Alba C, Beltran D, Fernandez L. | Front Microbiol | 10.3389/fmicb.2023.1111652 | 2023 | ||
| Genetics | Alterations of the Composition and Neurometabolic Profile of Human Gut Microbiota in Major Depressive Disorder. | Kovtun AS, Averina OV, Angelova IY, Yunes RA, Zorkina YA, Morozova AY, Pavlichenko AV, Syunyakov TS, Karpenko OA, Kostyuk GP, Danilenko VN. | Biomedicines | 10.3390/biomedicines10092162 | 2022 | |
| The Roles of Gut Microbiome and Plasma Metabolites in the Associations between ABO Blood Groups and Insulin Homeostasis: The Microbiome and Insulin Longitudinal Evaluation Study (MILES). | Li-Gao R, Grubbs K, Bertoni AG, Hoffman KL, Petrosino JF, Ramesh G, Wu M, Rotter JI, Chen YI, Evans AM, Robinson RJ, Sommerville L, Mook-Kanamori D, Goodarzi MO, Michelotti GA, Sheridan PA. | Metabolites | 10.3390/metabo12090787 | 2022 | ||
| Infant gut microbiota and environment associate with juvenile idiopathic arthritis many years prior to disease onset, especially in genetically vulnerable children. | Kindgren E, Ahrens AP, Triplett EW, Ludvigsson J. | EBioMedicine | 10.1016/j.ebiom.2023.104654 | 2023 | ||
| Dietary fibers boost gut microbiota-produced B vitamin pool and alter host immune landscape. | Grant ET, Parrish A, Boudaud M, Hunewald O, Hirayama A, Ollert M, Fukuda S, Desai MS. | Microbiome | 10.1186/s40168-024-01898-7 | 2024 | ||
| Global status and trends in gout research from 2012 to 2021: a bibliometric and visual analysis. | Wang Y, Li W, Wu H, Han Y, Wu H, Lin Z, Zhang B. | Clin Rheumatol | 10.1007/s10067-023-06508-9 | 2023 | ||
| Genetics | Meta-Analysis and Validation of a Colorectal Cancer Risk Prediction Model Using Deep Sequenced Fecal Metagenomes. | Obon-Santacana M, Mas-Lloret J, Bars-Cortina D, Criado-Mesas L, Carreras-Torres R, Diez-Villanueva A, Moratalla-Navarro F, Guino E, Ibanez-Sanz G, Rodriguez-Alonso L, Mulet-Margalef N, Mata A, Garcia-Rodriguez A, Duell EJ, Pimenoff VN, Moreno V. | Cancers (Basel) | 10.3390/cancers14174214 | 2022 | |
| Pathogenicity | Food as Treatment of Inflammatory Bowel Diseases. | Maldonado-Contreras A. | Infect Immun | 10.1128/iai.00583-21 | 2022 | |
| Pathogenicity | Uremic Toxin-Producing Bacteroides Species Prevail in the Gut Microbiota of Taiwanese CKD Patients: An Analysis Using the New Taiwan Microbiome Baseline. | Shivani S, Kao CY, Chattopadhyay A, Chen JW, Lai LC, Lin WH, Lu TP, Huang IH, Tsai MH, Teng CH, Wu JJ, Hsieh YH, Wang MC, Chuang EY. | Front Cell Infect Microbiol | 10.3389/fcimb.2022.726256 | 2022 | |
| Melatonin in the colon modulates intestinal microbiota in response to stress and sleep deprivation. | Park YS, Kim SH, Park JW, Kho Y, Seok PR, Shin JH, Choi YJ, Jun JH, Jung HC, Kim EK. | Intest Res | 10.5217/ir.2019.00093 | 2020 | ||
| Phage Targeting Neonatal Meningitis E. coli K1 In Vitro in the Intestinal Microbiota of Pregnant Donors and Impact on Bacterial Populations. | Antoine C, Laforet F, Goya-Jorge E, Gonza I, Lebrun S, Douny C, Duprez JN, Fall A, Taminiau B, Scippo ML, Daube G, Thiry D, Delcenserie V. | Int J Mol Sci | 10.3390/ijms241310580 | 2023 | ||
| Microbiome and cancer: from mechanistic implications in disease progression and treatment to development of novel antitumoral strategies. | Constantin M, Chifiriuc MC, Mihaescu G, Corcionivoschi N, Burlibasa L, Bleotu C, Tudorache S, Mitache MM, Filip R, Munteanu SG, Gradisteanu Pircalabioru G. | Front Immunol | 10.3389/fimmu.2024.1373504 | 2024 | ||
| Modulation of gut microbiota with Ayurveda diet and lifestyle: A review on its possible way to treat type 2 diabetes. | Chauhan A, Semwal DK, Semwal RB, Joshi SK, Adhana RK, Goswami MS. | Ayu | 10.4103/ayu.ayu_7_20 | 2022 | ||
| Genetics | Gut metagenome profile of the Nunavik Inuit youth is distinct from industrial and non-industrial counterparts. | Abed JY, Godon T, Mehdaoui F, Plante PL, Boissinot M, Bergeron MG, Belanger RE, Muckle G, Poliakova N, Ayotte P, Corbeil J, Rousseau E. | Commun Biol | 10.1038/s42003-022-04372-y | 2022 | |
| Microbiota-Focused Dietary Approaches to Support Health: A Systematic Review. | Hindle VK, Veasley NM, Holscher HD. | J Nutr | 10.1016/j.tjnut.2024.10.043 | 2025 | ||
| Using fluorescent promoter-reporters to study sugar utilization control in Bifidobacterium longum NCC 2705. | Duboux S, Muller JA, De Franceschi F, Mercenier A, Kleerebezem M. | Sci Rep | 10.1038/s41598-022-14638-4 | 2022 | ||
| Analysis of Effector and Immunity Proteins of the GA2 Type VI Secretion Systems of Gut Bacteroidales. | Bao H, Coyne MJ, Garcia-Bayona L, Comstock LE. | J Bacteriol | 10.1128/jb.00122-22 | 2022 | ||
| Impact of the Synbiotics and Urate-Lowering Therapy on Gut Microbiota and Cytokine Profile in Patients with Chronic Gouty Arthritis. | Kondratiuk VE, Tarasenko OM, Karmazina OM, Taranchuk VV. | J Med Life | 10.25122/jml-2020-0065 | 2020 | ||
| Enzymology | Structural and Functional Alterations of Gut Microbiota in Males With Hyperuricemia and High Levels of Liver Enzymes. | Sheng S, Chen J, Zhang Y, Qin Q, Li W, Yan S, Wang Y, Li T, Gao X, Tang L, Li A, Ding S. | Front Med (Lausanne) | 10.3389/fmed.2021.779994 | 2021 | |
| A Method for Isolation and Proteomic Analysis of Outer Membrane Vesicles from Fecal Samples by LC-MS/MS. | Wu J, An M, Zhu J, Tan Z, Chen GY, Stidham RW, Lubman DM. | J Proteomics Bioinform | 10.4172/0974-276x.1000494 | 2019 | ||
| Is stool frequency associated with the richness and community composition of gut microbiota? | Kwon HJ, Lim JH, Kang D, Lim S, Park SJ, Kim JH. | Intest Res | 10.5217/ir.2018.00149 | 2019 | ||
| Reconstruction of intestinal microecology of type 2 diabetes by fecal microbiota transplantation: Why and how. | Hou K, Zhang S, Wu Z, Zhu D, Chen F, Lei ZN, Liu W, Xiao C, Chen ZS. | Bosn J Basic Med Sci | 10.17305/bjbms.2021.6323 | 2022 | ||
| Pathogenicity | Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007). | Snydman DR, Jacobus NV, McDermott LA, Golan Y, Hecht DW, Goldstein EJ, Harrell L, Jenkins S, Newton D, Pierson C, Rihs JD, Yu VL, Venezia R, Finegold SM, Rosenblatt JE, Gorbach SL. | Clin Infect Dis | 10.1086/647940 | 2010 | |
| Characterizing the mucin-degrading capacity of the human gut microbiota. | Glover JS, Ticer TD, Engevik MA. | Sci Rep | 10.1038/s41598-022-11819-z | 2022 | ||
| Advanced Organotypic In Vitro Model Systems for Host-Microbial Coculture. | Kim R. | Biochip J | 10.1007/s13206-023-00103-5 | 2023 | ||
| Enzymology | Intestinal Microbiota Distinguish Gout Patients from Healthy Humans. | Guo Z, Zhang J, Wang Z, Ang KY, Huang S, Hou Q, Su X, Qiao J, Zheng Y, Wang L, Koh E, Danliang H, Xu J, Lee YK, Zhang H. | Sci Rep | 10.1038/srep20602 | 2016 | |
| Sodium acetate/sodium butyrate alleviates lipopolysaccharide-induced diarrhea in mice via regulating the gut microbiota, inflammatory cytokines, antioxidant levels, and NLRP3/Caspase-1 signaling. | Chen X, Kong Q, Zhao X, Zhao C, Hao P, Irshad I, Lei H, Kulyar MF, Bhutta ZA, Ashfaq H, Sha Q, Li K, Wu Y. | Front Microbiol | 10.3389/fmicb.2022.1036042 | 2022 | ||
| Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial. | de Groot P, Nikolic T, Pellegrini S, Sordi V, Imangaliyev S, Rampanelli E, Hanssen N, Attaye I, Bakker G, Duinkerken G, Joosten A, Prodan A, Levin E, Levels H, Potter van Loon B, van Bon A, Brouwer C, van Dam S, Simsek S, van Raalte D, Stam F, Gerdes V, Hoogma R, Diekman M, Gerding M, Rustemeijer C, de Bakker B, Hoekstra J, Zwinderman A, Bergman J, Holleman F, Piemonti L, De Vos W, Roep B, Nieuwdorp M. | Gut | 10.1136/gutjnl-2020-322630 | 2021 | ||
| Genetics | Variations in the Relative Abundance of Gut Bacteria Correlate with Lipid Profiles in Healthy Adults. | Kalnina I, Gudra D, Silamikelis I, Viksne K, Roga A, Skinderskis E, Fridmanis D, Klovins J. | Microorganisms | 10.3390/microorganisms11112656 | 2023 | |
| Inflammatory pseudotumor of the liver: A case report and literature review. | Zhang Y, Lu H, Ji H, Li Y. | Intractable Rare Dis Res | 10.5582/irdr.2015.01021 | 2015 | ||
| Genetics | Probiotics maintain the intestinal microbiome homeostasis of the sailors during a long sea voyage. | Zhang J, Zhao J, Jin H, Lv R, Shi H, De G, Yang B, Sun Z, Zhang H. | Gut Microbes | 10.1080/19490976.2020.1722054 | 2020 | |
| Gut dysbiosis and inflammatory blood markers precede HIV with limited changes after early seroconversion. | Fulcher JA, Li F, Tobin NH, Zabih S, Elliott J, Clark JL, D'Aquila R, Mustanski B, Kipke MD, Shoptaw S, Gorbach PM, Aldrovandi GM. | EBioMedicine | 10.1016/j.ebiom.2022.104286 | 2022 | ||
| Uncovering the role of the gut microbiota in immune checkpoint blockade therapy: A mini-review. | Halsey T, Ologun G, Wargo J, Jenq RR. | Semin Hematol | 10.1053/j.seminhematol.2020.05.002 | 2020 | ||
| Effects of Shenling Baizhu powder on intestinal microflora metabolites and liver mitochondrial energy metabolism in nonalcoholic fatty liver mice. | Yao Z, Guo J, Du B, Hong L, Zhu Y, Feng X, Hou Y, Shi A. | Front Microbiol | 10.3389/fmicb.2023.1147067 | 2023 | ||
| Sex Differences in Fecal Microbiota Correlation With Physiological and Biochemical Indices Associated With End-Stage Renal Disease Caused by Immunoglobulin a Nephropathy or Diabetes. | Zhang P, Fang J, Li G, Zhang L, Lai X, Xu L, Liu L, Xiong Y, Li L, Zhang T, Wan J, Xu H, Chen R, Zhang W, Ma J, Chen Z. | Front Microbiol | 10.3389/fmicb.2021.752393 | 2021 | ||
| Gut Microbial Succession Patterns and Metabolic Profiling during Pregnancy and Lactation in a Goat Model. | Zhang K, Liu G, Wu Y, Zhang T, Guo M, Lei Y, Cao X, Suo L, Brugger D, Wang X, Yang Y, Chen Y. | Microbiol Spectr | 10.1128/spectrum.02955-22 | 2023 | ||
| Network Analysis of Gut Microbiome and Metabolome to Discover Microbiota-Linked Biomarkers in Patients Affected by Non-Small Cell Lung Cancer. | Vernocchi P, Gili T, Conte F, Del Chierico F, Conta G, Miccheli A, Botticelli A, Paci P, Caldarelli G, Nuti M, Marchetti P, Putignani L. | Int J Mol Sci | 10.3390/ijms21228730 | 2020 | ||
| Elevated serum anti-I2 and anti-OmpW antibody levels in children with IBD. | Iltanen S, Tervo L, Halttunen T, Wei B, Braun J, Rantala I, Honkanen T, Kronenberg M, Cheroutre H, Turovskaya O, Autio V, Ashorn M. | Inflamm Bowel Dis | 10.1097/01.mib.0000218765.84087.42 | 2006 | ||
| Genetics | Dysbiosis and relapse-related microbiome in inflammatory bowel disease: A shotgun metagenomic approach. | Serrano-Gomez G, Mayorga L, Oyarzun I, Roca J, Borruel N, Casellas F, Varela E, Pozuelo M, Machiels K, Guarner F, Vermeire S, Manichanh C. | Comput Struct Biotechnol J | 10.1016/j.csbj.2021.11.037 | 2021 | |
| Microbiota Changes in Fathers Consuming a High Prebiotic Fiber Diet Have Minimal Effects on Male and Female Offspring in Rats. | Chleilat F, Schick A, Reimer RA. | Nutrients | 10.3390/nu13030820 | 2021 | ||
| Association of the characteristics of the blood metabolome and gut microbiome with the outcome of methotrexate therapy in psoriasis. | Qiu Q, Deng J, Deng H, Yao D, Yan Y, Ye S, Shang X, Deng Y, Han L, Zheng G, Roy B, Chen Y, Han L, Huang R, Fang X, Lu C. | Front Immunol | 10.3389/fimmu.2022.937539 | 2022 | ||
| A comparative study of the gut microbiome in Egyptian patients with Type I and Type II diabetes. | Radwan S, Gilfillan D, Eklund B, Radwan HM, El Menofy NG, Lee J, Kapuscinski M, Abdo Z. | PLoS One | 10.1371/journal.pone.0238764 | 2020 | ||
| The immunomodulatory effects of Qushi Jianpi Hewei Decoction (QJHD) for patients with COVID-19 by metagenomics and transcriptomic sequencing | Li J, Yang Y, Xiong B, Lu J, Zhou Y, Li C, Hu X. | Pharmacological Research - Modern Chinese Medicine | 2022 | |||
| Phage-encoded carbohydrate-interacting proteins in the human gut. | Rothschild-Rodriguez D, Hedges M, Kaplan M, Karav S, Nobrega FL. | Front Microbiol | 10.3389/fmicb.2022.1083208 | 2022 | ||
| Metabolism | Fermentation of pectin and glucose, and activity of pectin-degrading enzymes in the rabbit caecal bacterium Bacteroides caccae. | Sirotek K, Slovakova L, Kopecny J, Marounek M. | Lett Appl Microbiol | 10.1111/j.1472-765x.2004.01492.x | 2004 | |
| Changes to the Gut Microbiome in Young Children Showing Early Behavioral Signs of Autism. | Jones J, Reinke SN, Mousavi-Derazmahalleh M, Palmer DJ, Christophersen CT. | Front Microbiol | 10.3389/fmicb.2022.905901 | 2022 | ||
| Source Tracking and Global Distribution of the Tigecycline Non-Susceptible tet(X). | Zhang RM, Sun J, Sun RY, Wang MG, Cui CY, Fang LX, Liao MN, Lu XQ, Liu YX, Liao XP, Liu YH. | Microbiol Spectr | 10.1128/spectrum.01164-21 | 2021 | ||
| Pathogenicity | The gut microbiome stability is altered by probiotic ingestion and improved by the continuous supplementation of galactooligosaccharide. | Ma C, Wasti S, Huang S, Zhang Z, Mishra R, Jiang S, You Z, Wu Y, Chang H, Wang Y, Huo D, Li C, Sun Z, Sun Z, Zhang J. | Gut Microbes | 10.1080/19490976.2020.1785252 | 2020 | |
| Grazing and Supplementation of Dietary Yeast Probiotics Shape the Gut Microbiota and Improve the Immunity of Black Fattening Goats (Capra hircus). | Emu Q, Guan H, Zhu J, Zhang L, Fan J, Ji Y, Lin Y, Li C, Dan X, Aguo Y, Wei X, Zhang M, Zhang B, Yang C, Li B, Xiong C. | Front Microbiol | 10.3389/fmicb.2021.666837 | 2021 | ||
| Paediatric Inflammatory Bowel Disease and its Relationship with the Microbiome. | Fitzgerald RS, Sanderson IR, Claesson MJ. | Microb Ecol | 10.1007/s00248-021-01697-9 | 2021 | ||
| Pathogenicity | [Bacteria isolated from surgical infections and their susceptibility to antimicrobial agents--special reference to bacteria isolated between April 2007 and March 2008]. | Shinagawa N, Hasegawa M, Hirata K, Katsuramaki T, Mizukuchi T, Ushijima Y, Ushida T, Aikawa N, Yo K, Yura J, Takeyama H, Wakasugi T, Taniguchi M, Mizuno I, Mashita K, Ishikawa S, Mizuno A, Tsumura H, Yokoyama T, Moori N, Sumita N, Kubo S, Lee S, Oomura T, Kobayashi Y, Tsuji T, Yamaue H, Kawai M, Takesue Y, Tanaka N, Kimura H, Iwagaki H, Sueda T, Hiyama E, Murakami Y, Ooge H, Uemura K, Takeuchi H, Yasui Y, Yasunami Y, Ryu S. | Jpn J Antibiot | 2009 | ||
| Predictive Factors in Metastatic Melanoma Treated with Immune Checkpoint Inhibitors: From Clinical Practice to Future Perspective. | Poletto S, Paruzzo L, Nepote A, Caravelli D, Sangiolo D, Carnevale-Schianca F. | Cancers (Basel) | 10.3390/cancers16010101 | 2023 | ||
| Genetics | Modulation of Gut Microbiota and Metabolites by Berberine in Treating Mice With Disturbances in Glucose and Lipid Metabolism. | Fang X, Wu H, Wang X, Lian F, Li M, Miao R, Wei J, Tian J. | Front Pharmacol | 10.3389/fphar.2022.870407 | 2022 | |
| Cultivation | Metabolic modelling as a powerful tool to identify critical components of Pneumocystis growth medium. | Nev OA, Zamaraeva E, De Oliveira R, Ryzhkov I, Duvenage L, Abou-Jaoude W, Ouattara DA, Hoving JC, Gudelj I, Brown AJP. | PLoS Comput Biol | 10.1371/journal.pcbi.1012545 | 2024 | |
| Programming bacteria for multiplexed DNA detection. | Cheng YY, Chen Z, Cao X, Ross TD, Falbel TG, Burton BM, Venturelli OS. | Nat Commun | 10.1038/s41467-023-37582-x | 2023 | ||
| Pathogenicity | Effects of ondansetron and [6]-gingerol on pica and gut microbiota in rats treated with cisplatin. | Feng X, Cheng Q, Meng Q, Yang Y, Nie K. | Drug Des Devel Ther | 10.2147/dddt.s211845 | 2019 | |
| Divergent maturational patterns of the infant bacterial and fungal gut microbiome in the first year of life are associated with inter-kingdom community dynamics and infant nutrition. | Mercer EM, Ramay HR, Moossavi S, Laforest-Lapointe I, Reyna ME, Becker AB, Simons E, Mandhane PJ, Turvey SE, Moraes TJ, Sears MR, Subbarao P, Azad MB, Arrieta MC. | Microbiome | 10.1186/s40168-023-01735-3 | 2024 | ||
| Personalized Paths: Unlocking Alzheimer's via the Gut-Brain Axis. | Ceccon M, Kantsjo JB, Ronchi F. | Visc Med | 10.1159/000535869 | 2024 | ||
| Metabolism | Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients. | Frankel AE, Coughlin LA, Kim J, Froehlich TW, Xie Y, Frenkel EP, Koh AY. | Neoplasia | 10.1016/j.neo.2017.08.004 | 2017 | |
| Probiotic Bifidobacterium lactis V9 Regulates the Secretion of Sex Hormones in Polycystic Ovary Syndrome Patients through the Gut-Brain Axis. | Zhang J, Sun Z, Jiang S, Bai X, Ma C, Peng Q, Chen K, Chang H, Fang T, Zhang H. | mSystems | 10.1128/msystems.00017-19 | 2019 | ||
| Pathogenicity | Maternal PBDE exposure disrupts gut microbiome and promotes hepatic proinflammatory signaling in humanized PXR-transgenic mouse offspring over time. | Kim S, Li H, Jin Y, Armad J, Gu H, Mani S, Cui JY. | Toxicol Sci | 10.1093/toxsci/kfad056 | 2023 | |
| Preliminary evidence for an influence of exposure to polycyclic aromatic hydrocarbons on the composition of the gut microbiota and neurodevelopment in three-year-old healthy children. | Zhang W, Sun Z, Zhang Q, Sun Z, Su Y, Song J, Wang B, Gao R. | BMC Pediatr | 10.1186/s12887-021-02539-w | 2021 | ||
| Gut microbiome composition may be an indicator of preclinical Alzheimer's disease. | Ferreiro AL, Choi J, Ryou J, Newcomer EP, Thompson R, Bollinger RM, Hall-Moore C, Ndao IM, Sax L, Benzinger TLS, Stark SL, Holtzman DM, Fagan AM, Schindler SE, Cruchaga C, Butt OH, Morris JC, Tarr PI, Ances BM, Dantas G. | Sci Transl Med | 10.1126/scitranslmed.abo2984 | 2023 | ||
| Genetics | Metagenome Sequencing Reveals the Midgut Microbiota Makeup of Culex pipiens quinquefasciatus and Its Possible Relationship With Insecticide Resistance. | Wang YT, Shen RX, Xing D, Zhao CP, Gao HT, Wu JH, Zhang N, Zhang HD, Chen Y, Zhao TY, Li CX. | Front Microbiol | 10.3389/fmicb.2021.625539 | 2021 | |
| Age-related changes in the gut microbiota and the core gut microbiome of healthy Thai humans. | La-Ongkham O, Nakphaichit M, Nakayama J, Keawsompong S, Nitisinprasert S. | 3 Biotech | 10.1007/s13205-020-02265-7 | 2020 | ||
| Enzymology | [Bacteria isolated from surgical infections and its susceptibilities to antimicrobial agents--special references to bacteria isolated between April 2006 and March 2007]. | Shinagawa N, Hirata K, Katsuramaki T, Mizukuchi T, Ushijima Y, Ushida T, Aikawa N, Yo K, Mashita K, Ishikawa S, Mizuno A, Kubo S, Lee S, Fujimoto M, Higaki K, Taniguchi K, Tsuji T, Ohnishi H, Yamaue H, Kawai M, Takesue Y, Tanaka N, Iwagaki H, Takayama T, Sato T, Kato K, Yura J, Takeyama H, Wakasugi T, Taniguchi M, Mizuno I, Kimura H, Fuchimoto S, Sueda T, Hiyama E, Murakami Y, Ooge H, Uemura K, Tsumura H, Yokoyama T, Takeuchi H, Yasui Y, Ikeda S, Yasunami Y, Ryu S. | Jpn J Antibiot | 2008 | ||
| Identifying glycan consumers in human gut microbiota samples using metabolic labeling coupled with fluorescence-activated cell sorting. | Dridi L, Altamura F, Gonzalez E, Lui O, Kubinski R, Pidgeon R, Montagut A, Chong J, Xia J, Maurice CF, Castagner B. | Nat Commun | 10.1038/s41467-023-36365-8 | 2023 | ||
| Pathogenicity | In vitro interactions of Alternaria mycotoxins, an emerging class of food contaminants, with the gut microbiota: a bidirectional relationship. | Crudo F, Aichinger G, Mihajlovic J, Varga E, Dellafiora L, Warth B, Dall'Asta C, Berry D, Marko D. | Arch Toxicol | 10.1007/s00204-021-03043-x | 2021 | |
| Muscle strength is increased in mice that are colonized with microbiota from high-functioning older adults. | Fielding RA, Reeves AR, Jasuja R, Liu C, Barrett BB, Lustgarten MS. | Exp Gerontol | 10.1016/j.exger.2019.110722 | 2019 | ||
| Relationship between changes in microbiota induced by resveratrol and its anti-diabetic effect on type 2 diabetes. | Fernandez-Quintela A, Macarulla MT, Gomez-Zorita S, Gonzalez M, Milton-Laskibar I, Portillo MP. | Front Nutr | 10.3389/fnut.2022.1084702 | 2022 | ||
| Identifying oral microbiome alterations in adult betel quid chewing population of Delhi, India. | Bahuguna M, Hooda S, Mohan L, Gupta RK, Diwan P. | PLoS One | 10.1371/journal.pone.0278221 | 2023 | ||
| Phylogeny | Reanalysis of the Mars500 experiment reveals common gut microbiome alterations in astronauts induced by long-duration confinement. | Brereton NJB, Pitre FE, Gonzalez E. | Comput Struct Biotechnol J | 10.1016/j.csbj.2021.03.040 | 2021 | |
| Robust cross-cohort gut microbiome associations with COVID-19 severity. | Li J, Li J, Ghosh TS, McCann R, Mallon P, Hill C, Draper L, Schult D, Fanning LJ, Shannon R, Sadlier C, Horgan M, O'Mahony L, O'Toole PW. | Gut Microbes | 10.1080/19490976.2023.2242615 | 2023 | ||
| Persistence of birth mode-dependent effects on gut microbiome composition, immune system stimulation and antimicrobial resistance during the first year of life. | Busi SB, de Nies L, Habier J, Wampach L, Fritz JV, Heintz-Buschart A, May P, Halder R, de Beaufort C, Wilmes P. | ISME Commun | 10.1038/s43705-021-00003-5 | 2021 | ||
| Drastic Effects on the Microbiome of a Young Rower Engaged in High-Endurance Exercise After a Month Usage of a Dietary Fiber Supplement. | Jaago M, Timmusk US, Timmusk T, Palm K. | Front Nutr | 10.3389/fnut.2021.654008 | 2021 | ||
| Genetics | Composition and Functions of the Gut Microbiome in Pediatric Obesity: Relationships with Markers of Insulin Resistance. | Orsso CE, Peng Y, Deehan EC, Tan Q, Field CJ, Madsen KL, Walter J, Prado CM, Tun HM, Haqq AM. | Microorganisms | 10.3390/microorganisms9071490 | 2021 | |
| Rapid change of fecal microbiome and disappearance of Clostridium difficile in a colonized infant after transition from breast milk to cow milk. | Davis MY, Zhang H, Brannan LE, Carman RJ, Boone JH. | Microbiome | 10.1186/s40168-016-0198-6 | 2016 | ||
| Metabolism | Human intestinal models to study interactions between intestine and microbes. | Aguilar-Rojas A, Olivo-Marin JC, Guillen N. | Open Biol | 10.1098/rsob.200199 | 2020 | |
| Genetics | Alleviation of Metabolic Disturbance by Substituting Kanjang High in Bacillus for Salt through Modulation of Gut Microbiota in Estrogen-Deficient Rats. | Park S, Zhang T, Yue Y, Jeong SJ, Ryu MS, Wu X, Yang HJ, Jeong DY. | Foods | 10.3390/foods11131951 | 2022 | |
| Metabolism | Concentrated Raw Fibers Enhance the Fiber-Degrading Capacity of a Synthetic Human Gut Microbiome. | Steimle A, Neumann M, Grant ET, Turner JD, Desai MS. | Int J Mol Sci | 10.3390/ijms22136855 | 2021 | |
| Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events. | Ng SC, Peng Y, Zhang L, Mok CK, Zhao S, Li A, Ching JY, Liu Y, Yan S, Chan DLS, Zhu J, Chen C, Fung AC, Wong KK, Hui DS, Chan FK, Tun HM. | Gut | 10.1136/gutjnl-2021-326563 | 2022 | ||
| An untargeted fecal and urine metabolomics analysis of the interplay between the gut microbiome, diet and human metabolism in Indian and Chinese adults. | Jain A, Li XH, Chen WN. | Sci Rep | 10.1038/s41598-019-45640-y | 2019 | ||
| Phylogeny | Major Lipids, Apolipoproteins, and Alterations of Gut Microbiota. | Yun KE, Kim J, Kim MH, Park E, Kim HL, Chang Y, Ryu S, Kim HN. | J Clin Med | 10.3390/jcm9051589 | 2020 | |
| Pathogenicity | Oral Supplements of Combined Bacillus licheniformis Zhengchangsheng® and Xylooligosaccharides Improve High-Fat Diet-Induced Obesity and Modulate the Gut Microbiota in Rats. | Li Y, Liu M, Liu H, Wei X, Su X, Li M, Yuan J. | Biomed Res Int | 10.1155/2020/9067821 | 2020 | |
| Pathogenicity | Early-Life Microbial Restitution Reduces Colitis Risk Promoted by Antibiotic-Induced Gut Dysbiosis in Interleukin 10-/- Mice. | Miyoshi J, Miyoshi S, Delmont TO, Cham C, Lee STM, Sakatani A, Yang K, Shan Y, Kennedy M, Kiefl E, Yousef M, Crosson S, Sogin M, Antonopoulos DA, Eren AM, Leone V, Chang EB. | Gastroenterology | 10.1053/j.gastro.2021.05.054 | 2021 | |
| Metabolism | 1-Kestose supplementation mitigates the progressive deterioration of glucose metabolism in type 2 diabetes OLETF rats. | Watanabe A, Kadota Y, Kamio R, Tochio T, Endo A, Shimomura Y, Kitaura Y. | Sci Rep | 10.1038/s41598-020-72773-2 | 2020 | |
| Phylogeny | Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome. | Nagy-Szakal D, Williams BL, Mishra N, Che X, Lee B, Bateman L, Klimas NG, Komaroff AL, Levine S, Montoya JG, Peterson DL, Ramanan D, Jain K, Eddy ML, Hornig M, Lipkin WI. | Microbiome | 10.1186/s40168-017-0261-y | 2017 | |
| Enzymology | Oral and Gut Microbial Carbohydrate-Active Enzymes Landscape in Health and Disease. | Onyango SO, Juma J, De Paepe K, Van de Wiele T. | Front Microbiol | 10.3389/fmicb.2021.653448 | 2021 | |
| Pathogenicity | 16S rRNA Sequencing and Metagenomics Study of Gut Microbiota: Implications of BDB on Type 2 Diabetes Mellitus. | Zhang L, Luo J, Li X, Guo S, Shi D. | Mar Drugs | 10.3390/md18090469 | 2020 | |
| Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors. | Rezasoltani S, Yadegar A, Asadzadeh Aghdaei H, Reza Zali M. | Cancer Med | 10.1002/cam4.3694 | 2021 | ||
| Metabolism | Potential role of ovomucin and its peptides in modulation of intestinal health: A review. | Tu A, Zhao X, Shan Y, Lu X. | Int J Biol Macromol | 10.1016/j.ijbiomac.2020.06.148 | 2020 | |
| Pathogenicity | Analysis of Gut Microbiota in Rheumatoid Arthritis Patients: Disease-Related Dysbiosis and Modifications Induced by Etanercept. | Picchianti-Diamanti A, Panebianco C, Salemi S, Sorgi ML, Di Rosa R, Tropea A, Sgrulletti M, Salerno G, Terracciano F, D'Amelio R, Lagana B, Pazienza V. | Int J Mol Sci | 10.3390/ijms19102938 | 2018 | |
| Phylogeny | Distribution of different species of the Bacteroides fragilis group in individuals with Japanese cedar pollinosis. | Odamaki T, Xiao JZ, Sakamoto M, Kondo S, Yaeshima T, Iwatsuki K, Togashi H, Enomoto T, Benno Y. | Appl Environ Microbiol | 10.1128/aem.01106-08 | 2008 | |
| Metabolism | High-resolution temporal profiling of the human gut microbiome reveals consistent and cascading alterations in response to dietary glycans. | Creswell R, Tan J, Leff JW, Brooks B, Mahowald MA, Thieroff-Ekerdt R, Gerber GK. | Genome Med | 10.1186/s13073-020-00758-x | 2020 | |
| Metabolism | Probiotic Bifidobacterium longum alters gut luminal metabolism through modification of the gut microbial community. | Sugahara H, Odamaki T, Fukuda S, Kato T, Xiao JZ, Abe F, Kikuchi J, Ohno H. | Sci Rep | 10.1038/srep13548 | 2015 | |
| Gut-on-a-Chip Research for Drug Development: Implications of Chip Design on Preclinical Oral Bioavailability or Intestinal Disease Studies. | Donkers JM, van der Vaart JI, van de Steeg E. | Biomimetics (Basel) | 10.3390/biomimetics8020226 | 2023 | ||
| Pathogenicity | Berberine Slows the Progression of Prediabetes to Diabetes in Zucker Diabetic Fatty Rats by Enhancing Intestinal Secretion of Glucagon-Like Peptide-2 and Improving the Gut Microbiota. | Wang Y, Liu H, Zheng M, Yang Y, Ren H, Kong Y, Wang S, Wang J, Jiang Y, Yang J, Shan C. | Front Endocrinol (Lausanne) | 10.3389/fendo.2021.609134 | 2021 | |
| Targeting gut microbiota: a potential promising therapy for diabetic kidney disease. | Chen Z, Zhu S, Xu G. | Am J Transl Res | 2016 | |||
| Enzymology | Novel 3-O-alpha-d-Galactosyl-alpha-l-Arabinofuranosidase for the Assimilation of Gum Arabic Arabinogalactan Protein in Bifidobacterium longum subsp. longum. | Sasaki Y, Horigome A, Odamaki T, Xiao JZ, Ishiwata A, Ito Y, Kitahara K, Fujita K. | Appl Environ Microbiol | 10.1128/aem.02690-20 | 2021 | |
| Measuring the Antimicrobial Activity of Lauric Acid against Various Bacteria in Human Gut Microbiota Using a New Method. | Matsue M, Mori Y, Nagase S, Sugiyama Y, Hirano R, Ogai K, Ogura K, Kurihara S, Okamoto S. | Cell Transplant | 10.1177/0963689719881366 | 2019 | ||
| FiberGrowth Pipeline: A Framework Toward Predicting Fiber-Specific Growth From Human Gut Bacteroidetes Genomes. | Colnet B, Sieber CMK, Perraudeau F, Leclerc M. | Front Microbiol | 10.3389/fmicb.2021.632567 | 2021 | ||
| Pathogenicity | The Roles of Probiotics in the Gut Microbiota Composition and Metabolic Outcomes in Asymptomatic Post-Gestational Diabetes Women: A Randomized Controlled Trial. | Hasain Z, Raja Ali RA, Ahmad HF, Abdul Rauf UF, Oon SF, Mokhtar NM. | Nutrients | 10.3390/nu14183878 | 2022 | |
| Genetics | Longitudinal flux balance analyses of a patient with episodic colonic inflammation reveals microbiome metabolic dynamics. | Basile A, Heinken A, Hertel J, Smarr L, Li W, Treu L, Valle G, Campanaro S, Thiele I. | Gut Microbes | 10.1080/19490976.2023.2226921 | 2023 | |
| Pathogenicity | Inulin supplementation ameliorates hyperuricemia and modulates gut microbiota in Uox-knockout mice. | Guo Y, Yu Y, Li H, Ding X, Li X, Jing X, Chen J, Liu G, Lin Y, Jiang C, Liu Z, He Y, Li C, Tian Z. | Eur J Nutr | 10.1007/s00394-020-02414-x | 2021 | |
| Pathogenicity | Probiotic-directed modulation of gut microbiota is basal microbiome dependent. | Hou Q, Zhao F, Liu W, Lv R, Khine WWT, Han J, Sun Z, Lee YK, Zhang H. | Gut Microbes | 10.1080/19490976.2020.1736974 | 2020 | |
| Metabolism | Elevated serum anti-Saccharomyces cerevisiae, anti-I2 and anti-OmpW antibody levels in patients with suspicion of celiac disease. | Ashorn S, Raukola H, Valineva T, Ashorn M, Wei B, Braun J, Rantala I, Kaukinen K, Luukkaala T, Collin P, Maki M, Iltanen S. | J Clin Immunol | 10.1007/s10875-008-9200-9 | 2008 | |
| Serological responses to microbial antigens in celiac disease patients during a gluten-free diet. | Ashorn S, Valineva T, Kaukinen K, Ashorn M, Braun J, Raukola H, Rantala I, Collin P, Maki M, Luukkaala T, Iltanen S. | J Clin Immunol | 10.1007/s10875-008-9255-7 | 2009 | ||
| Enzymology | The Fecal Metagenomics of Malayan Pangolins Identifies an Extensive Adaptation to Myrmecophagy. | Ma JE, Jiang HY, Li LM, Zhang XJ, Li GY, Li HM, Jin XJ, Chen JP. | Front Microbiol | 10.3389/fmicb.2018.02793 | 2018 | |
| Pathogenicity | Eubacterium rectale Attenuates HSV-1 Induced Systemic Inflammation in Mice by Inhibiting CD83. | Islam SMS, Ryu HM, Sayeed HM, Byun HO, Jung JY, Kim HA, Suh CH, Sohn S. | Front Immunol | 10.3389/fimmu.2021.712312 | 2021 | |
| Phylogeny | Gut Microbiota Composition Associated With Clostridium difficile-Positive Diarrhea and C. difficile Type in ICU Patients. | Duan J, Meng X, Liu S, Zhou P, Zeng C, Fu C, Dou Q, Wu A, Li C. | Front Cell Infect Microbiol | 10.3389/fcimb.2020.00190 | 2020 | |
| Controlled Complexity: Optimized Systems to Study the Role of the Gut Microbiome in Host Physiology. | Glowacki RWP, Engelhart MJ, Ahern PP. | Front Microbiol | 10.3389/fmicb.2021.735562 | 2021 | ||
| Advances in clinical laboratory tests for inflammatory bowel disease. | Nakamura RM, Matsutani M, Barry M. | Clin Chim Acta | 10.1016/s0009-8981(03)00286-9 | 2003 | ||
| Fecal calprotectin levels and serological responses to microbial antigens among children and adolescents with inflammatory bowel disease. | Ashorn S, Honkanen T, Kolho KL, Ashorn M, Valineva T, Wei B, Braun J, Rantala I, Luukkaala T, Iltanen S. | Inflamm Bowel Dis | 10.1002/ibd.20535 | 2009 | ||
| Phylogeny | Rapid identification of the species of the Bacteroides fragilis group by multiplex PCR assays using group- and species-specific primers. | Liu C, Song Y, McTeague M, Vu AW, Wexler H, Finegold SM. | FEMS Microbiol Lett | 10.1016/s0378-1097(03)00296-9 | 2003 | |
| Microbiota profile in new-onset pediatric Crohn's disease: data from a non-Western population. | El Mouzan MI, Winter HS, Assiri AA, Korolev KS, Al Sarkhy AA, Dowd SE, Al Mofarreh MA, Menon R. | Gut Pathog | 10.1186/s13099-018-0276-3 | 2018 | ||
| Ecological memory of prior nutrient exposure in the human gut microbiome. | Letourneau J, Holmes ZC, Dallow EP, Durand HK, Jiang S, Carrion VM, Gupta SK, Mincey AC, Muehlbauer MJ, Bain JR, David LA. | ISME J | 10.1038/s41396-022-01292-x | 2022 | ||
| Anaerobes in diabetic foot infections: pathophysiology, epidemiology, virulence, and management. | Villa F, Marchandin H, Lavigne J-P, Schuldiner S, Cellier N, Sotto A, Loubet P. | Clin Microbiol Rev | 10.1128/cmr.00143-23 | 2024 | ||
| Transplantation of an obesity-associated human gut microbiota to mice induces vascular dysfunction and glucose intolerance. | Trikha SRJ, Lee DM, Ecton KE, Wrigley SD, Vazquez AR, Litwin NS, Thomas KN, Wei Y, Battson ML, Johnson SA, Kuhn KA, Colgan SP, Gentile CL, Weir TL. | Gut Microbes | 10.1080/19490976.2021.1940791 | 2021 | ||
| Human gut microbial communities dictate efficacy of anti-PD-1 therapy in a humanized microbiome mouse model of glioma. | Dees KJ, Koo H, Humphreys JF, Hakim JA, Crossman DK, Crowley MR, Nabors LB, Benveniste EN, Morrow CD, McFarland BC. | Neurooncol Adv | 10.1093/noajnl/vdab023 | 2021 | ||
| The gut microbiome and response to immune checkpoint inhibitors: preclinical and clinical strategies. | Gong J, Chehrazi-Raffle A, Placencio-Hickok V, Guan M, Hendifar A, Salgia R. | Clin Transl Med | 10.1186/s40169-019-0225-x | 2019 | ||
| Analysis of 1135 gut metagenomes identifies sex-specific resistome profiles. | Sinha T, Vich Vila A, Garmaeva S, Jankipersadsing SA, Imhann F, Collij V, Bonder MJ, Jiang X, Gurry T, Alm EJ, D'Amato M, Weersma RK, Scherjon S, Wijmenga C, Fu J, Kurilshikov A, Zhernakova A. | Gut Microbes | 10.1080/19490976.2018.1528822 | 2019 | ||
| Phylogeny | Discovering Potential Taxonomic Biomarkers of Type 2 Diabetes From Human Gut Microbiota via Different Feature Selection Methods. | Bakir-Gungor B, Bulut O, Jabeer A, Nalbantoglu OU, Yousef M. | Front Microbiol | 10.3389/fmicb.2021.628426 | 2021 | |
| Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy. | Thomas AM, Fidelle M, Routy B, Kroemer G, Wargo JA, Segata N, Zitvogel L. | Nat Rev Clin Oncol | 10.1038/s41571-023-00785-8 | 2023 | ||
| The Digestive Health among Participants of the Woodstock Rock Festival in Poland-A Cross-Sectional Survey. | Skonieczna-Zydecka K, Stachowska E, Maciejewska D, Ryterska K, Palma J, Czerwinska-Rogowska M, Kaczmarczyk M, Gudan A, Mruk H, Swiniarska B, Kaldunska J, Stachowska Z, Mijal P, Mazur T, Kupczynski M, Marlicz W. | Int J Environ Res Public Health | 10.3390/ijerph15102256 | 2018 | ||
| Metabolism | MMinte: an application for predicting metabolic interactions among the microbial species in a community. | Mendes-Soares H, Mundy M, Soares LM, Chia N. | BMC Bioinformatics | 10.1186/s12859-016-1230-3 | 2016 | |
| Genetics | Enabling rational gut microbiome manipulations by understanding gut ecology through experimentally-evidenced in silico models. | Molina Ortiz JP, McClure DD, Shanahan ER, Dehghani F, Holmes AJ, Read MN. | Gut Microbes | 10.1080/19490976.2021.1965698 | 2021 | |
| Antidiabetic Function of Lactobacillus fermentum MF423-Fermented Rice Bran and Its Effect on Gut Microbiota Structure in Type 2 Diabetic Mice. | Ai X, Wu C, Yin T, Zhur O, Liu C, Yan X, Yi C, Liu D, Xiao L, Li W, Xie B, He H. | Front Microbiol | 10.3389/fmicb.2021.682290 | 2021 | ||
| Phylogeny | Mucosa-associated bacteria in two middle-aged women diagnosed with collagenous colitis. | Gustafsson RJ, Ohlsson B, Benoni C, Jeppsson B, Olsson C. | World J Gastroenterol | 10.3748/wjg.v18.i14.1628 | 2012 | |
| Enzymology | Gut-on-chip: Recreating human intestine in vitro. | Xiang Y, Wen H, Yu Y, Li M, Fu X, Huang S. | J Tissue Eng | 10.1177/2041731420965318 | 2020 | |
| Gut microbiota in regulatory T cell generation and function: mechanisms and health implications. | Sharma A, Sharma G, Im SH. | Gut Microbes | 10.1080/19490976.2025.2516702 | 2025 | ||
| Pathogenicity | Beneficial Actions of Essential Fatty Acids in Streptozotocin-Induced Type 1 Diabetes Mellitus. | Shen J, Zhang L, Wang Y, Chen Z, Ma J, Fang X, Das UN, Yao K. | Front Nutr | 10.3389/fnut.2022.890277 | 2022 | |
| Revealing links between gut microbiome and its fungal community in Type 2 Diabetes Mellitus among Emirati subjects: A pilot study. | Al Bataineh MT, Dash NR, Bel Lassen P, Banimfreg BH, Nada AM, Belda E, Clement K. | Sci Rep | 10.1038/s41598-020-66598-2 | 2020 | ||
| A compendium of 32,277 metagenome-assembled genomes and over 80 million genes from the early-life human gut microbiome. | Zeng S, Patangia D, Almeida A, Zhou Z, Mu D, Paul Ross R, Stanton C, Wang S. | Nat Commun | 10.1038/s41467-022-32805-z | 2022 | ||
| Prolonged Impairment of Short-Chain Fatty Acid and L-Isoleucine Biosynthesis in Gut Microbiome in Patients With COVID-19. | Zhang F, Wan Y, Zuo T, Yeoh YK, Liu Q, Zhang L, Zhan H, Lu W, Xu W, Lui GCY, Li AYL, Cheung CP, Wong CK, Chan PKS, Chan FKL, Ng SC. | Gastroenterology | 10.1053/j.gastro.2021.10.013 | 2022 | ||
| Enzymology | Urinary TMAO Levels Are Associated with the Taxonomic Composition of the Gut Microbiota and with the Choline TMA-Lyase Gene (cutC) Harbored by Enterobacteriaceae. | Dalla Via A, Gargari G, Taverniti V, Rondini G, Velardi I, Gambaro V, Visconti GL, De Vitis V, Gardana C, Ragg E, Pinto A, Riso P, Guglielmetti S. | Nutrients | 10.3390/nu12010062 | 2019 | |
| Competitive exclusion culture for swine | Nisbet DJ, Corrier DE, Stanker LH. | United States Department of Agriculture patents. | 1999 | |||
| Pathogenicity | In vitro activity of telithromycin (HMR 3647) and seven other antimicrobial agents against anaerobic bacteria. | Ackermann G, Schaumann R, Pless B, Claros MC, Rodloff AC. | J Antimicrob Chemother | 10.1093/jac/46.1.115 | 2000 | |
| Pathogenicity | The Relationship between Frequently Used Glucose-Lowering Agents and Gut Microbiota in Type 2 Diabetes Mellitus. | Lv Y, Zhao X, Guo W, Gao Y, Yang S, Li Z, Wang G. | J Diabetes Res | 10.1155/2018/1890978 | 2018 | |
| Proteome | Distinct factors associated with short-term and long-term weight loss induced by low-fat or low-carbohydrate diet intervention. | Li X, Perelman D, Leong AK, Fragiadakis G, Gardner CD, Snyder MP. | Cell Rep Med | 10.1016/j.xcrm.2022.100870 | 2022 | |
| Metabolism | A commensal-encoded genotoxin drives restriction of Vibrio cholerae colonization and host gut microbiome remodeling. | Chen J, Byun H, Liu R, Jung IJ, Pu Q, Zhu CY, Tanchoco E, Alavi S, Degnan PH, Ma AT, Roggiani M, Beld J, Goulian M, Hsiao A, Zhu J. | Proc Natl Acad Sci U S A | 10.1073/pnas.2121180119 | 2022 | |
| Changes of saliva microbiota in the onset and after the treatment of diabetes in patients with periodontitis. | Yang Y, Liu S, Wang Y, Wang Z, Ding W, Sun X, He K, Feng Q, Zhang X. | Aging (Albany NY) | 10.18632/aging.103399 | 2020 | ||
| Transmission and dynamics of mother-infant gut viruses during pregnancy and early life. | Garmaeva S, Sinha T, Gulyaeva A, Kuzub N, Spreckels JE, Andreu-Sanchez S, Gacesa R, Vich Vila A, Brushett S, Kruk M, Lifelines NEXT cohort study, Dekens J, Sikkema J, Kuipers F, Shkoporov AN, Hill C, Scherjon S, Wijmenga C, Fu J, Kurilshikov A, Zhernakova A. | Nat Commun | 10.1038/s41467-024-45257-4 | 2024 | ||
| Socioeconomic disparities and household crowding in association with the fecal microbiome of school-age children. | Lapidot Y, Reshef L, Maya M, Cohen D, Gophna U, Muhsen K. | NPJ Biofilms Microbiomes | 10.1038/s41522-022-00271-6 | 2022 | ||
| Akkermansia muciniphila exacerbates food allergy in fibre-deprived mice. | Parrish A, Boudaud M, Grant ET, Willieme S, Neumann M, Wolter M, Craig SZ, De Sciscio A, Cosma A, Hunewald O, Ollert M, Desai MS. | Nat Microbiol | 10.1038/s41564-023-01464-1 | 2023 | ||
| Pathogenicity | Effects of Synbiotic Supplementation on Chronic Inflammation and the Gut Microbiota in Obese Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Study. | Kanazawa A, Aida M, Yoshida Y, Kaga H, Katahira T, Suzuki L, Tamaki S, Sato J, Goto H, Azuma K, Shimizu T, Takahashi T, Yamashiro Y, Watada H. | Nutrients | 10.3390/nu13020558 | 2021 | |
| Metabolism | Carbohydrates great and small, from dietary fiber to sialic acids: How glycans influence the gut microbiome and affect human health. | Coker JK, Moyne O, Rodionov DA, Zengler K. | Gut Microbes | 10.1080/19490976.2020.1869502 | 2021 | |
| Genetics | A cryptic plasmid is among the most numerous genetic elements in the human gut. | Fogarty EC, Schechter MS, Lolans K, Sheahan ML, Veseli I, Moore RM, Kiefl E, Moody T, Rice PA, Yu MK, Mimee M, Chang EB, Ruscheweyh HJ, Sunagawa S, Mclellan SL, Willis AD, Comstock LE, Eren AM. | Cell | 10.1016/j.cell.2024.01.039 | 2024 | |
| Advances in modelling the human microbiome-gut-brain axis in vitro. | Moysidou CM, Owens RM. | Biochem Soc Trans | 10.1042/bst20200338 | 2021 | ||
| Enteric Phageome Alterations in Patients With Type 2 Diabetes. | Chen Q, Ma X, Li C, Shen Y, Zhu W, Zhang Y, Guo X, Zhou J, Liu C. | Front Cell Infect Microbiol | 10.3389/fcimb.2020.575084 | 2020 | ||
| Inflammatory pseudotumor of the liver: a case report and review of the literature. | Ntinas A, Kardassis D, Miliaras D, Tsinoglou K, Dimitriades A, Vrochides D. | J Med Case Rep | 10.1186/1752-1947-5-196 | 2011 | ||
| Metabolism | Host DNA contents in fecal metagenomics as a biomarker for intestinal diseases and effective treatment. | Jiang P, Lai S, Wu S, Zhao XM, Chen WH, Chen WH. | BMC Genomics | 10.1186/s12864-020-6749-z | 2020 | |
| Metabolism | Identification of Allobaculum mucolyticum as a novel human intestinal mucin degrader. | van Muijlwijk GH, van Mierlo G, Jansen PWTC, Vermeulen M, Bleumink-Pluym NMC, Palm NW, van Putten JPM, de Zoete MR. | Gut Microbes | 10.1080/19490976.2021.1966278 | 2021 | |
| Treatment of a chronic recurrent fistulized tibial osteomyelitis: administration of a novel antibiotic-loaded bone substitute combined with a pedicular muscle flap sealing. | Franceschini M, Di Matteo A, Bosebeck H, Buchner H, Vogt S. | Eur J Orthop Surg Traumatol | 10.1007/s00590-012-0956-5 | 2012 | ||
| Phylogeny | Genotypic diversity of anaerobic isolates from bloodstream infections. | Simmon KE, Mirrett S, Reller LB, Petti CA. | J Clin Microbiol | 10.1128/jcm.02469-07 | 2008 | |
| Gut microbiota varies by opioid use, circulating leptin and oxytocin in African American men with diabetes and high burden of chronic disease. | Barengolts E, Green SJ, Eisenberg Y, Akbar A, Reddivari B, Layden BT, Dugas L, Chlipala G. | PLoS One | 10.1371/journal.pone.0194171 | 2018 | ||
| Safety and efficacy of probiotic supplementation in 8 types of inflammatory arthritis: A systematic review and meta-analysis of 34 randomized controlled trials. | Zeng L, Deng Y, He Q, Yang K, Li J, Xiang W, Liu H, Zhu X, Chen H. | Front Immunol | 10.3389/fimmu.2022.961325 | 2022 | ||
| Metabolism | Identification of phenol- and p-cresol-producing intestinal bacteria by using media supplemented with tyrosine and its metabolites. | Saito Y, Sato T, Nomoto K, Tsuji H. | FEMS Microbiol Ecol | 10.1093/femsec/fiy125 | 2018 | |
| Genetics | Variation and transmission of the human gut microbiota across multiple familial generations. | Valles-Colomer M, Bacigalupe R, Vieira-Silva S, Suzuki S, Darzi Y, Tito RY, Yamada T, Segata N, Raes J, Falony G. | Nat Microbiol | 10.1038/s41564-021-01021-8 | 2022 | |
| The gut microbiome, immune check point inhibition and immune-related adverse events in non-small cell lung cancer. | Bredin P, Naidoo J. | Cancer Metastasis Rev | 10.1007/s10555-022-10039-1 | 2022 | ||
| Combined Signature of the Fecal Microbiome and Metabolome in Patients with Gout. | Shao T, Shao L, Li H, Xie Z, He Z, Wen C. | Front Microbiol | 10.3389/fmicb.2017.00268 | 2017 | ||
| Mapping the early life gut microbiome in neonates with critical congenital heart disease: multiomics insights and implications for host metabolic and immunological health. | Huang Y, Lu W, Zeng M, Hu X, Su Z, Liu Y, Liu Z, Yuan J, Li L, Zhang X, Huang L, Hu W, Wang X, Li S, Zhang H. | Microbiome | 10.1186/s40168-022-01437-2 | 2022 | ||
| The effect of body mass index at diagnosis on clinical outcome in children with newly diagnosed acute lymphoblastic leukemia. | Eissa HM, Zhou Y, Panetta JC, Browne EK, Jeha S, Cheng C, Relling MV, Campana D, Pui CH, Inaba H. | Blood Cancer J | 10.1038/bcj.2017.11 | 2017 | ||
| Pathogenicity | Comparative activity of moxifloxacin in vitro against obligately anaerobic bacteria. | Ackermann G, Schaumann R, Pless B, Claros MC, Goldstein EJ, Rodloff AC. | Eur J Clin Microbiol Infect Dis | 10.1007/s100960050465 | 2000 | |
| Phylogeny | Gut Microbiome Profiles Are Associated With Type 2 Diabetes in Urban Africans. | Doumatey AP, Adeyemo A, Zhou J, Lei L, Adebamowo SN, Adebamowo C, Rotimi CN. | Front Cell Infect Microbiol | 10.3389/fcimb.2020.00063 | 2020 | |
| Lactobacillus rhamnosus GG ameliorates hyperuricemia in a novel model. | Fu Y, Chen YS, Xia DY, Luo XD, Luo HT, Pan J, Ma WQ, Li JZ, Mo QY, Tu Q, Li MM, Zhao Y, Li Y, Huang YT, Chen ZX, Li ZJ, Bernard L, Dione M, Zhang YM, Miao K, Chen JY, Zhu SS, Ren J, Zhou LJ, Jiang XZ, Chen J, Lin ZP, Chen JP, Ye H, Cao QY, Zhu YW, Yang L, Wang X, Wang WC. | NPJ Biofilms Microbiomes | 10.1038/s41522-024-00486-9 | 2024 | ||
| Pathogenicity | Gut Microbiota-Mediated Inflammation and Gut Permeability in Patients with Obesity and Colorectal Cancer. | Sanchez-Alcoholado L, Ordonez R, Otero A, Plaza-Andrade I, Laborda-Illanes A, Medina JA, Ramos-Molina B, Gomez-Millan J, Queipo-Ortuno MI. | Int J Mol Sci | 10.3390/ijms21186782 | 2020 | |
| Bacteroides ovatus colonization influences the abundance of intestinal short chain fatty acids and neurotransmitters. | Horvath TD, Ihekweazu FD, Haidacher SJ, Ruan W, Engevik KA, Fultz R, Hoch KM, Luna RA, Oezguen N, Spinler JK, Haag AM, Versalovic J, Engevik MA. | iScience | 10.1016/j.isci.2022.104158 | 2022 | ||
| Metabolism | Vancomycin relieves mycophenolate mofetil-induced gastrointestinal toxicity by eliminating gut bacterial beta-glucuronidase activity. | Taylor MR, Flannigan KL, Rahim H, Mohamud A, Lewis IA, Hirota SA, Greenway SC. | Sci Adv | 10.1126/sciadv.aax2358 | 2019 | |
| Phenotype | Temporal evolution of the microbiome, immune system and epigenome with disease progression in ALS mice. | Figueroa-Romero C, Guo K, Murdock BJ, Paez-Colasante X, Bassis CM, Mikhail KA, Pawlowski KD, Evans MC, Taubman GF, McDermott AJ, O'Brien PD, Savelieff MG, Hur J, Feldman EL. | Dis Model Mech | 10.1242/dmm.041947 | 2019 | |
| Pathogenicity | Epidemiology and antimicrobial susceptibilities of wound isolates of obligate anaerobes from combat casualties. | White BK, Mende K, Weintrob AC, Beckius ML, Zera WC, Lu D, Bradley W, Tribble DR, Schnaubelt ER, Murray CK, Infectious Disease Clinical Research Program Trauma Infectious Disease Outcome Study Group. | Diagn Microbiol Infect Dis | 10.1016/j.diagmicrobio.2015.10.010 | 2016 | |
| Mucolytic bacteria license pathobionts to acquire host-derived nutrients during dietary nutrient restriction. | Sugihara K, Kitamoto S, Saraithong P, Nagao-Kitamoto H, Hoostal M, McCarthy C, Rosevelt A, Muraleedharan CK, Gillilland MG, Imai J, Omi M, Bishu S, Kao JY, Alteri CJ, Barnich N, Schmidt TM, Nusrat A, Inohara N, Golob JL, Kamada N. | Cell Rep | 10.1016/j.celrep.2022.111093 | 2022 | ||
| Pathogenicity | Deconstructing Mechanisms of Diet-Microbiome-Immune Interactions. | Alexander M, Turnbaugh PJ. | Immunity | 10.1016/j.immuni.2020.07.015 | 2020 | |
| Inflammatory pseudotumor of the colon causing intussusception: a case report and literature review. | Huang Y, Li LP, Wang J, Lun ZJ, Li W, Yang Z. | World J Gastroenterol | 10.3748/wjg.v21.i2.704 | 2015 | ||
| A comprehensive overview of advanced dynamic in vitro intestinal and hepatic cell culture models. | Leal F, Zeiringer S, Jeitler R, Costa PF, Roblegg E. | Tissue Barriers | 10.1080/21688370.2022.2163820 | 2024 | ||
| Bacteroides uniformis and its preferred substrate, alpha-cyclodextrin, enhance endurance exercise performance in mice and human males. | Morita H, Kano C, Ishii C, Kagata N, Ishikawa T, Hirayama A, Uchiyama Y, Hara S, Nakamura T, Fukuda S. | Sci Adv | 10.1126/sciadv.add2120 | 2023 | ||
| Clinical features, image findings, and prognosis of inflammatory pseudotumor of the liver: a multicenter experience of 45 cases. | Park JY, Choi MS, Lim YS, Park JW, Kim SU, Min YW, Gwak GY, Paik YH, Lee JH, Koh KC, Paik SW, Yoo BC. | Gut Liver | 10.5009/gnl.2014.8.1.58 | 2014 | ||
| Inulin diet uncovers complex diet-microbiota-immune cell interactions remodeling the gut epithelium. | Correa RO, Castro PR, Fachi JL, Nirello VD, El-Sahhar S, Imada S, Pereira GV, Pral LP, Araujo NVP, Fernandes MF, Matheus VA, de Souza Felipe J, Dos Santos Pereira Gomes AB, de Oliveira S, de Rezende Rodovalho V, de Oliveira SRM, de Assis HC, Oliveira SC, Dos Santos Martins F, Martens E, Colonna M, Varga-Weisz P, Vinolo MAR. | Microbiome | 10.1186/s40168-023-01520-2 | 2023 | ||
| Phylogeny | Bacteroides thetaiotaomicron-Infecting Bacteriophage Isolates Inform Sequence-Based Host Range Predictions. | Hryckowian AJ, Merrill BD, Porter NT, Van Treuren W, Nelson EJ, Garlena RA, Russell DA, Martens EC, Sonnenburg JL. | Cell Host Microbe | 10.1016/j.chom.2020.06.011 | 2020 | |
| Metabolism | Gastrointestinal microbiota contributes to the development of murine transfusion-related acute lung injury. | Kapur R, Kim M, Rebetz J, Hallstrom B, Bjorkman JT, Takabe-French A, Kim N, Liu J, Shanmugabhavananthan S, Milosevic S, McVey MJ, Speck ER, Semple JW. | Blood Adv | 10.1182/bloodadvances.2018018903 | 2018 | |
| Genetics | Metagenomic analysis revealed the potential role of gut microbiome in gout. | Chu Y, Sun S, Huang Y, Gao Q, Xie X, Wang P, Li J, Liang L, He X, Jiang Y, Wang M, Yang J, Chen X, Zhou C, Zhao Y, Ding F, Zhang Y, Wu X, Bai X, Wu J, Wei X, Chen X, Yue Z, Fang X, Huang Q, Wang Z, Huang R. | NPJ Biofilms Microbiomes | 10.1038/s41522-021-00235-2 | 2021 | |
| Single Donor FMT Reverses Microbial/Immune Dysbiosis and Induces Clinical Remission in a Rat Model of Acute Colitis. | Adamkova P, Hradicka P, Gancarcikova S, Kassayova M, Ambro L, Bertkova I, Maronek M, Farkasova Iannaccone S, Demeckova V. | Pathogens | 10.3390/pathogens10020152 | 2021 | ||
| Pathogenicity | A Novel Non-Digestible, Carrot-Derived Polysaccharide (cRG-I) Selectively Modulates the Human Gut Microbiota while Promoting Gut Barrier Integrity: An Integrated in Vitro Approach. | Van den Abbeele P, Verstrepen L, Ghyselinck J, Albers R, Marzorati M, Mercenier A. | Nutrients | 10.3390/nu12071917 | 2020 | |
| Benign inflammatory pseudotumour mimicking extrahepatic bile duct cholangiocarcinoma in an adult man presenting with painless obstructive jaundice. | Abu-Wasel B, Eltawil KM, Molinari M. | BMJ Case Rep | 10.1136/bcr-2012-006514 | 2012 | ||
| Transcriptome | Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patients. | Peters BA, Wilson M, Moran U, Pavlick A, Izsak A, Wechter T, Weber JS, Osman I, Ahn J. | Genome Med | 10.1186/s13073-019-0672-4 | 2019 | |
| Akkermansia muciniphila upregulates genes involved in maintaining the intestinal barrier function via ADP-heptose-dependent activation of the ALPK1/TIFA pathway. | Martin-Gallausiaux C, Garcia-Weber D, Lashermes A, Larraufie P, Marinelli L, Teixeira V, Rolland A, Beguet-Crespel F, Brochard V, Quatremare T, Jamet A, Dore J, Gray-Owen SD, Blottiere HM, Arrieumerlou C, Lapaque N. | Gut Microbes | 10.1080/19490976.2022.2110639 | 2022 | ||
| Metabolism | Host-centric proteomics of stool: a novel strategy focused on intestinal responses to the gut microbiota. | Lichtman JS, Marcobal A, Sonnenburg JL, Elias JE. | Mol Cell Proteomics | 10.1074/mcp.m113.029967 | 2013 | |
| Phylogeny | Structure and Function of the Fecal Microbiota in Diarrheic Neonatal Piglets. | Yang Q, Huang X, Zhao S, Sun W, Yan Z, Wang P, Li S, Huang W, Zhang S, Liu L, Gun S. | Front Microbiol | 10.3389/fmicb.2017.00502 | 2017 | |
| Loss of Diurnal Oscillatory Rhythms in Gut Microbiota Correlates with Changes in Circulating Metabolites in Type 2 Diabetic db/db Mice. | Beli E, Prabakaran S, Krishnan P, Evans-Molina C, Grant MB. | Nutrients | 10.3390/nu11102310 | 2019 | ||
| Phylogeny | Fecal Microbiome Characteristics and the Resistome Associated With Acquisition of Multidrug-Resistant Organisms Among Elderly Subjects. | Araos R, Battaglia T, Ugalde JA, Rojas-Herrera M, Blaser MJ, D'Agata EMC. | Front Microbiol | 10.3389/fmicb.2019.02260 | 2019 | |
| Metabolism | A Novel Family of RNA-Binding Proteins Regulate Polysaccharide Metabolism in Bacteroides thetaiotaomicron. | Adams AND, Azam MS, Costliow ZA, Ma X, Degnan PH, Vanderpool CK. | J Bacteriol | 10.1128/jb.00217-21 | 2021 | |
| Genetics | Massive expansion of human gut bacteriophage diversity. | Camarillo-Guerrero LF, Almeida A, Rangel-Pineros G, Finn RD, Lawley TD. | Cell | 10.1016/j.cell.2021.01.029 | 2021 | |
| Current Perspectives on Gastrointestinal Models to Assess Probiotic-Pathogen Interactions. | Anjum M, Laitila A, Ouwehand AC, Forssten SD. | Front Microbiol | 10.3389/fmicb.2022.831455 | 2022 | ||
| Metagenomic analysis of bacterial community structure and diversity of lignocellulolytic bacteria in Vietnamese native goat rumen. | Do TH, Dao TK, Nguyen KHV, Le NG, Nguyen TMP, Le TL, Phung TN, van Straalen NM, Roelofs D, Truong NH. | Asian-Australas J Anim Sci | 10.5713/ajas.17.0174 | 2018 | ||
| Phylogeny | Metagenomic reconstructions of gut microbial metabolism in weanling pigs. | Wang W, Hu H, Zijlstra RT, Zheng J, Ganzle MG. | Microbiome | 10.1186/s40168-019-0662-1 | 2019 | |
| Microbiome Analytics of the Gut Microbiota in Patients With Juvenile Idiopathic Arthritis: A Longitudinal Observational Cohort Study. | van Dijkhuizen EHP, Del Chierico F, Malattia C, Russo A, Pires Marafon D, Ter Haar NM, Magni-Manzoni S, Vastert SJ, Dallapiccola B, Prakken B, Martini A, De Benedetti F, Putignani L, Model Driven Paediatric European Digital Repository Consortium. | Arthritis Rheumatol | 10.1002/art.40827 | 2019 | ||
| Pathogenicity | The Gut Microbiome, Aging, and Longevity: A Systematic Review. | Badal VD, Vaccariello ED, Murray ER, Yu KE, Knight R, Jeste DV, Nguyen TT. | Nutrients | 10.3390/nu12123759 | 2020 | |
| Pathogenicity | Expansion and persistence of antibiotic-specific resistance genes following antibiotic treatment. | Kang K, Imamovic L, Misiakou MA, Bornakke Sorensen M, Heshiki Y, Ni Y, Zheng T, Li J, Ellabaan MMH, Colomer-Lluch M, Rode AA, Bytzer P, Panagiotou G, Sommer MOA. | Gut Microbes | 10.1080/19490976.2021.1900995 | 2021 | |
| Leukemoid reaction in epidermal squamous cell carcinoma. | Kiyosawa T, Hirano S, Nakamura J, Murata S, Demitsu T, Kato H, Yaoita H. | J Dermatol | 10.1111/j.1346-8138.1996.tb02648.x | 1996 | ||
| Inflammatory pseudotumor of the liver associated with extrahepatic infection. | White JE, Chase CW, Kelley JE, Brock WB, Clark MO. | South Med J | 10.1097/00007611-199701000-00005 | 1997 | ||
| The AT1 Receptor Blocker Telmisartan Reduces Intestinal Mucus Thickness in Obese Mice. | Nickel L, Sunderhauf A, Rawish E, Stolting I, Derer S, Thorns C, Matschl U, Othman A, Sina C, Raasch W. | Front Pharmacol | 10.3389/fphar.2022.815353 | 2022 | ||
| Pathogenicity | First national survey of antibiotic susceptibility of the Bacteroides fragilis group: emerging resistance to carbapenems in Argentina. | Fernandez-Canigia L, Litterio M, Legaria MC, Castello L, Predari SC, Di Martino A, Rossetti A, Rollet R, Carloni G, Bianchini H, Cejas D, Radice M, Gutkind G, Anaerobe Surveillance Team. | Antimicrob Agents Chemother | 10.1128/aac.05622-11 | 2012 | |
| Genetics | The development of metabolic endotoxemia is dependent on the type of sweetener and the presence of saturated fat in the diet. | Sanchez-Tapia M, Miller AW, Granados-Portillo O, Tovar AR, Torres N. | Gut Microbes | 10.1080/19490976.2020.1801301 | 2020 | |
| The Emerging Role of Microbiota and Microbiome in Pancreatic Ductal Adenocarcinoma. | Ciernikova S, Novisedlakova M, Cholujova D, Stevurkova V, Mego M. | Biomedicines | 10.3390/biomedicines8120565 | 2020 | ||
| Genetics | A human gut bacterial genome and culture collection for improved metagenomic analyses. | Forster SC, Kumar N, Anonye BO, Almeida A, Viciani E, Stares MD, Dunn M, Mkandawire TT, Zhu A, Shao Y, Pike LJ, Louie T, Browne HP, Mitchell AL, Neville BA, Finn RD, Lawley TD. | Nat Biotechnol | 10.1038/s41587-018-0009-7 | 2019 | |
| Remodeling of colon plasma cell repertoire within ulcerative colitis patients. | Scheid JF, Eraslan B, Hudak A, Brown EM, Sergio D, Delorey TM, Phillips D, Lefkovith A, Jess AT, Duck LW, Elson CO, Vlamakis H, Plichta DR, Deguine J, Ananthakrishnan AN, Graham DB, Regev A, Xavier RJ. | J Exp Med | 10.1084/jem.20220538 | 2023 | ||
| Phylogeny | Identification of clinically important anaerobic bacteria by an oligonucleotide array. | Lin YT, Vaneechoutte M, Huang AH, Teng LJ, Chen HM, Su SL, Chang TC. | J Clin Microbiol | 10.1128/jcm.01620-09 | 2010 | |
| A microfluidics-based in vitro model of the gastrointestinal human-microbe interface. | Shah P, Fritz JV, Glaab E, Desai MS, Greenhalgh K, Frachet A, Niegowska M, Estes M, Jager C, Seguin-Devaux C, Zenhausern F, Wilmes P. | Nat Commun | 10.1038/ncomms11535 | 2016 | ||
| Pathogenicity | Porphyromonas gingivalis RagB is a proinflammatory signal transducer and activator of transcription 4 agonist. | Hutcherson JA, Bagaitkar J, Nagano K, Yoshimura F, Wang H, Scott DA. | Mol Oral Microbiol | 10.1111/omi.12089 | 2015 | |
| Metabolism | ICOS ligand and IL-10 synergize to promote host-microbiota mutualism. | Landuyt AE, Klocke BJ, Duck LW, Kemp KM, Muir RQ, Jennings MS, Blum SI, Tse HM, Lee G, Morrow CD, Elson CO, Maynard CL. | Proc Natl Acad Sci U S A | 10.1073/pnas.2018278118 | 2021 | |
| Enzymology | Dissecting the human gut microbiome to better decipher drug liability: A once-forgotten organ takes center stage. | Cai J, Auster A, Cho S, Lai Z. | J Adv Res | 10.1016/j.jare.2023.07.002 | 2023 | |
| Metabolism | Dietary supplementation with inulin-propionate ester or inulin improves insulin sensitivity in adults with overweight and obesity with distinct effects on the gut microbiota, plasma metabolome and systemic inflammatory responses: a randomised cross-over trial. | Chambers ES, Byrne CS, Morrison DJ, Murphy KG, Preston T, Tedford C, Garcia-Perez I, Fountana S, Serrano-Contreras JI, Holmes E, Reynolds CJ, Roberts JF, Boyton RJ, Altmann DM, McDonald JAK, Marchesi JR, Akbar AN, Riddell NE, Wallis GA, Frost GS. | Gut | 10.1136/gutjnl-2019-318424 | 2019 | |
| Infection-related complications during treatment for childhood acute lymphoblastic leukemia. | Inaba H, Pei D, Wolf J, Howard SC, Hayden RT, Go M, Varechtchouk O, Hahn T, Buaboonnam J, Metzger ML, Rubnitz JE, Ribeiro RC, Sandlund JT, Jeha S, Cheng C, Evans WE, Relling MV, Pui CH. | Ann Oncol | 10.1093/annonc/mdw557 | 2017 | ||
| Genetics | Phenotypic and Genomic Diversification in Complex Carbohydrate-Degrading Human Gut Bacteria. | Pudlo NA, Urs K, Crawford R, Pirani A, Atherly T, Jimenez R, Terrapon N, Henrissat B, Peterson D, Ziemer C, Snitkin E, Martens EC. | mSystems | 10.1128/msystems.00947-21 | 2022 | |
| Pathogenicity | Treatment-Specific Composition of the Gut Microbiota Is Associated With Disease Remission in a Pediatric Crohn's Disease Cohort. | Sprockett D, Fischer N, Boneh RS, Turner D, Kierkus J, Sladek M, Escher JC, Wine E, Yerushalmi B, Dias JA, Shaoul R, Kori M, Snapper SB, Holmes S, Bousvaros A, Levine A, Relman DA. | Inflamm Bowel Dis | 10.1093/ibd/izz130 | 2019 | |
| Pathogenicity | Total Lipopolysaccharide from the Human Gut Microbiome Silences Toll-Like Receptor Signaling. | d'Hennezel E, Abubucker S, Murphy LO, Cullen TW. | mSystems | 10.1128/msystems.00046-17 | 2017 | |
| Sex differences in NSAID-induced perturbation of human intestinal barrier function and microbiota. | Edogawa S, Peters SA, Jenkins GD, Gurunathan SV, Sundt WJ, Johnson S, Lennon RJ, Dyer RB, Camilleri M, Kashyap PC, Farrugia G, Chen J, Singh RJ, Grover M. | FASEB J | 10.1096/fj.201800560r | 2018 | ||
| Modulation of cytokine patterns and microbiome during pregnancy in IBD. | van der Giessen J, Binyamin D, Belogolovski A, Frishman S, Tenenbaum-Gavish K, Hadar E, Louzoun Y, Peppelenbosch MP, van der Woude CJ, Koren O, Fuhler GM. | Gut | 10.1136/gutjnl-2019-318263 | 2020 | ||
| Metabolism | Pregnane X receptor exacerbates nonalcoholic fatty liver disease accompanied by obesity- and inflammation-prone gut microbiome signature. | Kim S, Choi S, Dutta M, Asubonteng JO, Polunas M, Goedken M, Gonzalez FJ, Cui JY, Gyamfi MA. | Biochem Pharmacol | 10.1016/j.bcp.2021.114698 | 2021 | |
| Enzymology | Co-evolution of HAD phosphatase and hotdog-fold thioesterase domain function in the menaquinone-pathway fusion proteins BF1314 and PG1653. | Wang M, Song F, Wu R, Allen KN, Mariano PS, Dunaway-Mariano D. | FEBS Lett | 10.1016/j.febslet.2013.07.009 | 2013 | |
| Genetics | CD44 deletion leading to attenuation of experimental autoimmune encephalomyelitis results from alterations in gut microbiome in mice. | Chitrala KN, Guan H, Singh NP, Busbee B, Gandy A, Mehrpouya-Bahrami P, Ganewatta MS, Tang C, Chatterjee S, Nagarkatti P, Nagarkatti M. | Eur J Immunol | 10.1002/eji.201646792 | 2017 | |
| Link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLD. | Caussy C, Hsu C, Lo MT, Liu A, Bettencourt R, Ajmera VH, Bassirian S, Hooker J, Sy E, Richards L, Schork N, Schnabl B, Brenner DA, Sirlin CB, Chen CH, Loomba R, Genetics of NAFLD in Twins Consortium. | Hepatology | 10.1002/hep.29892 | 2018 | ||
| Biotechnology | Lifestyle and the presence of helminths is associated with gut microbiome composition in Cameroonians. | Rubel MA, Abbas A, Taylor LJ, Connell A, Tanes C, Bittinger K, Ndze VN, Fonsah JY, Ngwang E, Essiane A, Fokunang C, Njamnshi AK, Bushman FD, Tishkoff SA. | Genome Biol | 10.1186/s13059-020-02020-4 | 2020 | |
| Chitooligosaccharides Prevents the Development of Colitis-Associated Colorectal Cancer by Modulating the Intestinal Microbiota and Mycobiota. | Wu M, Li J, An Y, Li P, Xiong W, Li J, Yan D, Wang M, Zhong G. | Front Microbiol | 10.3389/fmicb.2019.02101 | 2019 | ||
| Pathogenicity | Colon Cancer: From Epidemiology to Prevention. | Katsaounou K, Nicolaou E, Vogazianos P, Brown C, Stavrou M, Teloni S, Hatzis P, Agapiou A, Fragkou E, Tsiaoussis G, Potamitis G, Zaravinos A, Andreou C, Antoniades A, Shiammas C, Apidianakis Y. | Metabolites | 10.3390/metabo12060499 | 2022 | |
| Genetics | Distinct gut metagenomics and metaproteomics signatures in prediabetics and treatment-naïve type 2 diabetics. | Zhong H, Ren H, Lu Y, Fang C, Hou G, Yang Z, Chen B, Yang F, Zhao Y, Shi Z, Zhou B, Wu J, Zou H, Zi J, Chen J, Bao X, Hu Y, Gao Y, Zhang J, Xu X, Hou Y, Yang H, Wang J, Liu S, Jia H, Madsen L, Brix S, Kristiansen K, Liu F, Li J. | EBioMedicine | 10.1016/j.ebiom.2019.08.048 | 2019 | |
| Transcriptome | The colitis-associated transcriptional profile of commensal Bacteroides thetaiotaomicron enhances adaptive immune responses to a bacterial antigen. | Hansen JJ, Huang Y, Peterson DA, Goeser L, Fan TJ, Chang EB, Sartor RB. | PLoS One | 10.1371/journal.pone.0042645 | 2012 | |
| Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn's disease. | Suskind DL, Brittnacher MJ, Wahbeh G, Shaffer ML, Hayden HS, Qin X, Singh N, Damman CJ, Hager KR, Nielson H, Miller SI. | Inflamm Bowel Dis | 10.1097/mib.0000000000000307 | 2015 | ||
| Metabolism | Distinct microbes, metabolites, and ecologies define the microbiome in deficient and proficient mismatch repair colorectal cancers. | Hale VL, Jeraldo P, Chen J, Mundy M, Yao J, Priya S, Keeney G, Lyke K, Ridlon J, White BA, French AJ, Thibodeau SN, Diener C, Resendis-Antonio O, Gransee J, Dutta T, Petterson XM, Sung J, Blekhman R, Boardman L, Larson D, Nelson H, Chia N. | Genome Med | 10.1186/s13073-018-0586-6 | 2018 | |
| Phylogeny | Inflammatory bowel disease unclassified. | Zhou N, Chen WX, Chen SH, Xu CF, Li YM. | J Zhejiang Univ Sci B | 10.1631/jzus.b1000172 | 2011 | |
| A Multicenter Clinical Study To Demonstrate the Diagnostic Accuracy of the GenMark Dx ePlex Blood Culture Identification Gram-Negative Panel. | Wolk DM, Young S, Whitfield NN, Reid JL, Thornberg A, Carroll KC, Buchan BW, Davis TE, Salimnia H. | J Clin Microbiol | 10.1128/jcm.02484-20 | 2021 | ||
| Pathogenicity | Household triclosan and triclocarban effects on the infant and maternal microbiome. | Ribado JV, Ley C, Haggerty TD, Tkachenko E, Bhatt AS, Parsonnet J. | EMBO Mol Med | 10.15252/emmm.201707882 | 2017 | |
| Utility of platforms Viteks MS and Microflex LT for the identification of complex clinical isolates that require molecular methods for their taxonomic classification. | Rocca MF, Barrios R, Zintgraff J, Martinez C, Irazu L, Vay C, Prieto M. | PLoS One | 10.1371/journal.pone.0218077 | 2019 | ||
| Early-Life Events, Including Mode of Delivery and Type of Feeding, Siblings and Gender, Shape the Developing Gut Microbiota. | Martin R, Makino H, Cetinyurek Yavuz A, Ben-Amor K, Roelofs M, Ishikawa E, Kubota H, Swinkels S, Sakai T, Oishi K, Kushiro A, Knol J. | PLoS One | 10.1371/journal.pone.0158498 | 2016 | ||
| From obesity through gut microbiota to cardiovascular diseases: a dangerous journey. | Marzullo P, Di Renzo L, Pugliese G, De Siena M, Barrea L, Muscogiuri G, Colao A, Savastano S, Obesity Programs of nutrition, Education, Research and Assessment (OPERA) Group. | Int J Obes Suppl | 10.1038/s41367-020-0017-1 | 2020 | ||
| Phylogeny | The underlying microbial mechanism of epizootic rabbit enteropathy triggered by a low fiber diet. | Jin DX, Zou HW, Liu SQ, Wang LZ, Xue B, Wu, Tian G, Cai J, Yan TH, Wang ZS, Peng QH. | Sci Rep | 10.1038/s41598-018-30178-2 | 2018 | |
| Pathogenicity | Interspecies Competition Impacts Targeted Manipulation of Human Gut Bacteria by Fiber-Derived Glycans. | Patnode ML, Beller ZW, Han ND, Cheng J, Peters SL, Terrapon N, Henrissat B, Le Gall S, Saulnier L, Hayashi DK, Meynier A, Vinoy S, Giannone RJ, Hettich RL, Gordon JI. | Cell | 10.1016/j.cell.2019.08.011 | 2019 | |
| Diagnosis of inflammatory bowel disease: Potential role of molecular biometrics. | M'Koma AE. | World J Gastrointest Surg | 10.4240/wjgs.v6.i11.208 | 2014 | ||
| Pathogenicity | Commensal-derived metabolites govern Vibrio cholerae pathogenesis in host intestine. | You JS, Yong JH, Kim GH, Moon S, Nam KT, Ryu JH, Yoon MY, Yoon SS. | Microbiome | 10.1186/s40168-019-0746-y | 2019 | |
| Genetics | An Integrated Outlook on the Metagenome and Metabolome of Intestinal Diseases. | Aw W, Fukuda S. | Diseases | 10.3390/diseases3040341 | 2015 | |
| Pathogenicity | Colon Targeting of Naringin for Enhanced Cytoprotection Against Indomethacin-Induced Colitis in Rabbits. | El Naggar EE, Mohamed EA, Borg TM, El-Sheakh AR, Hamed MF. | Drug Des Devel Ther | 10.2147/dddt.s218357 | 2020 | |
| Changes in Microbial Community Composition Related to Sex and Colon Cancer by Nrf2 Knockout. | Song CH, Kim N, Nam RH, Choi SI, Yu JE, Nho H, Surh YJ. | Front Cell Infect Microbiol | 10.3389/fcimb.2021.636808 | 2021 | ||
| Bioengineered Systems and Designer Matrices That Recapitulate the Intestinal Stem Cell Niche. | Wang Y, Kim R, Hinman SS, Zwarycz B, Magness ST, Allbritton NL. | Cell Mol Gastroenterol Hepatol | 10.1016/j.jcmgh.2018.01.008 | 2018 | ||
| In Vitro and In Vivo Models for Evaluating the Oral Toxicity of Nanomedicines. | Lama S, Merlin-Zhang O, Yang C. | Nanomaterials (Basel) | 10.3390/nano10112177 | 2020 | ||
| Metabolism | Structure of RagB, a major immunodominant outer-membrane surface receptor antigen of Porphyromonas gingivalis. | Goulas T, Garcia-Ferrer I, Hutcherson JA, Potempa BA, Potempa J, Scott DA, Gomis-Ruth FX. | Mol Oral Microbiol | 10.1111/omi.12140 | 2016 | |
| Celiac disease. | Rubio-Tapia A, Murray JA. | Curr Opin Gastroenterol | 10.1097/mog.0b013e3283365263 | 2010 | ||
| Metabolism | Fecal metatranscriptomics of macaques with idiopathic chronic diarrhea reveals altered mucin degradation and fucose utilization. | Westreich ST, Ardeshir A, Alkan Z, Kable ME, Korf I, Lemay DG. | Microbiome | 10.1186/s40168-019-0664-z | 2019 | |
| The role of bacteria in the pathogenesis of ulcerative colitis. | Sasaki M, Klapproth JM. | J Signal Transduct | 10.1155/2012/704953 | 2012 | ||
| Transcriptome | Simplified Intestinal Microbiota to Study Microbe-Diet-Host Interactions in a Mouse Model. | Kovatcheva-Datchary P, Shoaie S, Lee S, Wahlstrom A, Nookaew I, Hallen A, Perkins R, Nielsen J, Backhed F. | Cell Rep | 10.1016/j.celrep.2019.02.090 | 2019 | |
| Genetics | More than just a gut feeling: constraint-based genome-scale metabolic models for predicting functions of human intestinal microbes. | van der Ark KCH, van Heck RGA, Martins Dos Santos VAP, Belzer C, de Vos WM. | Microbiome | 10.1186/s40168-017-0299-x | 2017 | |
| Interaction between microbiota and immunity and its implication in colorectal cancer. | Xing C, Du Y, Duan T, Nim K, Chu J, Wang HY, Wang RF. | Front Immunol | 10.3389/fimmu.2022.963819 | 2022 | ||
| Pathogenicity | Prevalence of antimicrobial resistance among clinical isolates of Bacteroides fragilis group in Canada in 2010-2011: CANWARD surveillance study. | Karlowsky JA, Walkty AJ, Adam HJ, Baxter MR, Hoban DJ, Zhanel GG. | Antimicrob Agents Chemother | 10.1128/aac.05823-11 | 2012 | |
| Pathogenicity | Antrodia cinnamomea reduces obesity and modulates the gut microbiota in high-fat diet-fed mice. | Chang CJ, Lu CC, Lin CS, Martel J, Ko YF, Ojcius DM, Wu TR, Tsai YH, Yeh TS, Lu JJ, Lai HC, Young JD. | Int J Obes (Lond) | 10.1038/ijo.2017.149 | 2018 | |
| Identification of Specific Oral and Gut Pathogens in Full Thickness Colon of Colitis Patients: Implications for Colon Motility. | Dinakaran V, Mandape SN, Shuba K, Pratap S, Sakhare SS, Tabatabai MA, Smoot DT, Farmer-Dixon CM, Kesavalu LN, Adunyah SE, Southerland JH, Gangula PR. | Front Microbiol | 10.3389/fmicb.2018.03220 | 2018 | ||
| Metabolism | A family of anti-Bacteroidales peptide toxins wide-spread in the human gut microbiota. | Coyne MJ, Bechon N, Matano LM, McEneany VL, Chatzidaki-Livanis M, Comstock LE. | Nat Commun | 10.1038/s41467-019-11494-1 | 2019 | |
| Metabolism | Structural robustness of the gut mucosal microbiota is associated with Crohn's disease remission after surgery. | Mondot S, Lepage P, Seksik P, Allez M, Treton X, Bouhnik Y, Colombel JF, Leclerc M, Pochart P, Dore J, Marteau P, GETAID. | Gut | 10.1136/gutjnl-2015-309184 | 2016 | |
| Metabolism | Interactions between Roseburia intestinalis and diet modulate atherogenesis in a murine model. | Kasahara K, Krautkramer KA, Org E, Romano KA, Kerby RL, Vivas EI, Mehrabian M, Denu JM, Backhed F, Lusis AJ, Rey FE. | Nat Microbiol | 10.1038/s41564-018-0272-x | 2018 | |
| Phylogeny | Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study. | Odamaki T, Kato K, Sugahara H, Hashikura N, Takahashi S, Xiao JZ, Abe F, Osawa R. | BMC Microbiol | 10.1186/s12866-016-0708-5 | 2016 | |
| Gut-educated IgA plasma cells defend the meningeal venous sinuses. | Fitzpatrick Z, Frazer G, Ferro A, Clare S, Bouladoux N, Ferdinand J, Tuong ZK, Negro-Demontel ML, Kumar N, Suchanek O, Tajsic T, Harcourt K, Scott K, Bashford-Rogers R, Helmy A, Reich DS, Belkaid Y, Lawley TD, McGavern DB, Clatworthy MR. | Nature | 10.1038/s41586-020-2886-4 | 2020 | ||
| Pathogenicity | Impact of genistein on the gut microbiome of humanized mice and its role in breast tumor inhibition. | Paul B, Royston KJ, Li Y, Stoll ML, Skibola CF, Wilson LS, Barnes S, Morrow CD, Tollefsbol TO. | PLoS One | 10.1371/journal.pone.0189756 | 2017 | |
| Pathogenicity | Salmonella enterica Serovar Typhimurium Temporally Modulates the Enteric Microbiota and Host Responses To Overcome Colonization Resistance in Swine. | Bescucci DM, Moote PE, Ortega Polo R, Uwiera RRE, Inglis GD. | Appl Environ Microbiol | 10.1128/aem.01569-20 | 2020 | |
| Considerations for best practices in studies of fiber or other dietary components and the intestinal microbiome. | Klurfeld DM, Davis CD, Karp RW, Allen-Vercoe E, Chang EB, Chassaing B, Fahey GC, Hamaker BR, Holscher HD, Lampe JW, Marette A, Martens E, O'Keefe SJ, Rose DJ, Saarela M, Schneeman BO, Slavin JL, Sonnenburg JL, Swanson KS, Wu GD, Lynch CJ. | Am J Physiol Endocrinol Metab | 10.1152/ajpendo.00058.2018 | 2018 | ||
| Phylogeny | Host contributes to longitudinal diversity of fecal microbiota in swine selected for lean growth. | Lu D, Tiezzi F, Schillebeeckx C, McNulty NP, Schwab C, Shull C, Maltecca C. | Microbiome | 10.1186/s40168-017-0384-1 | 2018 | |
| Metabolism | Microbiota and body weight control: Weight watchers within? | Boscaini S, Leigh SJ, Lavelle A, Garcia-Cabrerizo R, Lipuma T, Clarke G, Schellekens H, Cryan JF. | Mol Metab | 10.1016/j.molmet.2021.101427 | 2022 | |
| Metabolism | Microbial and Genetic Resources for Cobalamin (Vitamin B12) Biosynthesis: From Ecosystems to Industrial Biotechnology. | Balabanova L, Averianova L, Marchenok M, Son O, Tekutyeva L. | Int J Mol Sci | 10.3390/ijms22094522 | 2021 | |
| Shotgun Metagenomics of 250 Adult Twins Reveals Genetic and Environmental Impacts on the Gut Microbiome. | Xie H, Guo R, Zhong H, Feng Q, Lan Z, Qin B, Ward KJ, Jackson MA, Xia Y, Chen X, Chen B, Xia H, Xu C, Li F, Xu X, Al-Aama JY, Yang H, Wang J, Kristiansen K, Wang J, Steves CJ, Bell JT, Li J, Spector TD, Jia H. | Cell Syst | 10.1016/j.cels.2016.10.004 | 2016 | ||
| Analytical performance of a PCR assay for the detection of KRAS mutations (codons 12/13 and 61) in formalin-fixed paraffin-embedded tissue samples of colorectal carcinoma. | Lee S, Brophy VH, Cao J, Velez M, Hoeppner C, Soviero S, Lawrence HJ. | Virchows Arch | 10.1007/s00428-011-1180-0 | 2012 | ||
| Genetics | The impact of sequence database choice on metaproteomic results in gut microbiota studies. | Tanca A, Palomba A, Fraumene C, Pagnozzi D, Manghina V, Deligios M, Muth T, Rapp E, Martens L, Addis MF, Uzzau S. | Microbiome | 10.1186/s40168-016-0196-8 | 2016 | |
| Pathogenicity | Comparative activities of eight quinolones against members of the Bacteroides fragilis group. | Borobio MV, Conejo M, Ramirez E, Suarez AI, Perea EJ. | Antimicrob Agents Chemother | 10.1128/aac.38.6.1442 | 1994 | |
| Genometa--a fast and accurate classifier for short metagenomic shotgun reads. | Davenport CF, Neugebauer J, Beckmann N, Friedrich B, Kameri B, Kokott S, Paetow M, Siekmann B, Wieding-Drewes M, Wienhofer M, Wolf S, Tummler B, Ahlers V, Sprengel F. | PLoS One | 10.1371/journal.pone.0041224 | 2012 | ||
| Genome-wide detection of conservative site-specific recombination in bacteria. | Sekulovic O, Mathias Garrett E, Bourgeois J, Tamayo R, Shen A, Camilli A. | PLoS Genet | 10.1371/journal.pgen.1007332 | 2018 | ||
| Molecular cloning of a Bacteroides caccae TonB-linked outer membrane protein identified by an inflammatory bowel disease marker antibody. | Wei B, Dalwadi H, Gordon LK, Landers C, Bruckner D, Targan SR, Braun J. | Infect Immun | 10.1128/iai.69.10.6044-6054.2001 | 2001 | ||
| Metabolism | Decreased microbial co-occurrence network stability and SCFA receptor level correlates with obesity in African-origin women. | Dugas LR, Bernabe BP, Priyadarshini M, Fei N, Park SJ, Brown L, Plange-Rhule J, Nelson D, Toh EC, Gao X, Dong Q, Sun J, Kliethermes S, Gottel N, Luke A, Gilbert JA, Layden BT. | Sci Rep | 10.1038/s41598-018-35230-9 | 2018 | |
| Pathogenicity | Gut Microbiota and Gestational Diabetes Mellitus: A Review of Host-Gut Microbiota Interactions and Their Therapeutic Potential. | Hasain Z, Mokhtar NM, Kamaruddin NA, Mohamed Ismail NA, Razalli NH, Gnanou JV, Raja Ali RA. | Front Cell Infect Microbiol | 10.3389/fcimb.2020.00188 | 2020 | |
| Intestinal Microbiota Is Influenced by Gender and Body Mass Index. | Haro C, Rangel-Zuniga OA, Alcala-Diaz JF, Gomez-Delgado F, Perez-Martinez P, Delgado-Lista J, Quintana-Navarro GM, Landa BB, Navas-Cortes JA, Tena-Sempere M, Clemente JC, Lopez-Miranda J, Perez-Jimenez F, Camargo A. | PLoS One | 10.1371/journal.pone.0154090 | 2016 | ||
| The role of the microbiome in cancer development and therapy. | Bhatt AP, Redinbo MR, Bultman SJ. | CA Cancer J Clin | 10.3322/caac.21398 | 2017 | ||
| Metabolism | The human gut Firmicute Roseburia intestinalis is a primary degrader of dietary beta-mannans. | La Rosa SL, Leth ML, Michalak L, Hansen ME, Pudlo NA, Glowacki R, Pereira G, Workman CT, Arntzen MO, Pope PB, Martens EC, Hachem MA, Westereng B. | Nat Commun | 10.1038/s41467-019-08812-y | 2019 | |
| Pathogenicity | In vitro activity of gemifloxacin (SB 265805) against anaerobes. | Goldstein EJ, Citron DM, Warren Y, Tyrrell K, Merriam CV. | Antimicrob Agents Chemother | 10.1128/aac.43.9.2231 | 1999 | |
| Pathogenicity | Dietary Factors: Major Regulators of the Gut's Microbiota. | Moschen AR, Wieser V, Tilg H. | Gut Liver | 10.5009/gnl.2012.6.4.411 | 2012 | |
| Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. | Chen W, Liu F, Ling Z, Tong X, Xiang C. | PLoS One | 10.1371/journal.pone.0039743 | 2012 | ||
| Pathogenicity | The Microbiome and the Gut-Liver-Brain Axis for Central Nervous System Clinical Pharmacology: Challenges in Specifying and Integrating In Vitro and In Silico Models. | Hawkins KG, Casolaro C, Brown JA, Edwards DA, Wikswo JP. | Clin Pharmacol Ther | 10.1002/cpt.1870 | 2020 | |
| Metabolism | Composition and metabolic activities of bacterial biofilms colonizing food residues in the human gut. | Macfarlane S, Macfarlane GT. | Appl Environ Microbiol | 10.1128/aem.00754-06 | 2006 | |
| Toward an understanding of changes in diversity associated with fecal microbiome transplantation based on 16S rRNA gene deep sequencing. | Shahinas D, Silverman M, Sittler T, Chiu C, Kim P, Allen-Vercoe E, Weese S, Wong A, Low DE, Pillai DR. | mBio | 10.1128/mbio.00338-12 | 2012 | ||
| Metabolism | Metabolic niche of a prominent sulfate-reducing human gut bacterium. | Rey FE, Gonzalez MD, Cheng J, Wu M, Ahern PP, Gordon JI. | Proc Natl Acad Sci U S A | 10.1073/pnas.1312524110 | 2013 | |
| Pathogenicity | Occurrence of enterotoxigenic and nonenterotoxigenic Bacteroides fragilis in calves and evaluation of their antimicrobial susceptibility. | Almeida FS, Nakano V, Avila-Campos MJ. | FEMS Microbiol Lett | 10.1111/j.1574-6968.2007.00732.x | 2007 | |
| Genetics | Microbial strain-level population structure and genetic diversity from metagenomes. | Truong DT, Tett A, Pasolli E, Huttenhower C, Segata N. | Genome Res | 10.1101/gr.216242.116 | 2017 | |
| Phylogeny | The treatment-naive microbiome in new-onset Crohn's disease. | Gevers D, Kugathasan S, Denson LA, Vazquez-Baeza Y, Van Treuren W, Ren B, Schwager E, Knights D, Song SJ, Yassour M, Morgan XC, Kostic AD, Luo C, Gonzalez A, McDonald D, Haberman Y, Walters T, Baker S, Rosh J, Stephens M, Heyman M, Markowitz J, Baldassano R, Griffiths A, Sylvester F, Mack D, Kim S, Crandall W, Hyams J, Huttenhower C, Knight R, Xavier RJ. | Cell Host Microbe | 10.1016/j.chom.2014.02.005 | 2014 | |
| Evaluation of pathogen detection from clinical samples by real-time polymerase chain reaction using a sepsis pathogen DNA detection kit. | Yanagihara K, Kitagawa Y, Tomonaga M, Tsukasaki K, Kohno S, Seki M, Sugimoto H, Shimazu T, Tasaki O, Matsushima A, Ikeda Y, Okamoto S, Aikawa N, Hori S, Obara H, Ishizaka A, Hasegawa N, Takeda J, Kamihira S, Sugahara K, Asari S, Murata M, Kobayashi Y, Ginba H, Sumiyama Y, Kitajima M. | Crit Care | 10.1186/cc9234 | 2010 | ||
| Genetics | Gnotobiotic mouse model of phage-bacterial host dynamics in the human gut. | Reyes A, Wu M, McNulty NP, Rohwer FL, Gordon JI. | Proc Natl Acad Sci U S A | 10.1073/pnas.1319470110 | 2013 | |
| Colonic bacteria express an ulcerative colitis pANCA-related protein epitope. | Cohavy O, Bruckner D, Gordon LK, Misra R, Wei B, Eggena ME, Targan SR, Braun J. | Infect Immun | 10.1128/iai.68.3.1542-1548.2000 | 2000 | ||
| Metabolism | Responsiveness of cardiometabolic-related microbiota to diet is influenced by host genetics. | O'Connor A, Quizon PM, Albright JE, Lin FT, Bennett BJ. | Mamm Genome | 10.1007/s00335-014-9540-0 | 2014 | |
| Pathogenicity | In vitro activity of Biapenem plus RPX7009, a carbapenem combined with a serine beta-lactamase inhibitor, against anaerobic bacteria. | Goldstein EJ, Citron DM, Tyrrell KL, Merriam CV. | Antimicrob Agents Chemother | 10.1128/aac.02418-12 | 2013 | |
| Gut microbiome diversity influenced more by the Westernized dietary regime than the body mass index as assessed using effect size statistic. | Davis SC, Yadav JS, Barrow SD, Robertson BK. | Microbiologyopen | 10.1002/mbo3.476 | 2017 | ||
| Enzymology | Temperature gradient gel electrophoresis of fecal 16S rRNA reveals active Escherichia coli in the microbiota of patients with ulcerative colitis. | Sokol H, Lepage P, Seksik P, Dore J, Marteau P. | J Clin Microbiol | 10.1128/jcm.02600-05 | 2006 | |
| Phylogeny-corrected identification of microbial gene families relevant to human gut colonization. | Bradley PH, Nayfach S, Pollard KS. | PLoS Comput Biol | 10.1371/journal.pcbi.1006242 | 2018 | ||
| Pathogenicity | Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. | Chang CJ, Lin CS, Lu CC, Martel J, Ko YF, Ojcius DM, Tseng SF, Wu TR, Chen YY, Young JD, Lai HC. | Nat Commun | 10.1038/ncomms8489 | 2015 | |
| Therapeutic Strategies to Modulate Gut Microbial Health: Approaches for Chronic Metabolic Disorder Management. | Rondanelli M, Borromeo S, Cavioni A, Gasparri C, Gattone I, Genovese E, Lazzarotti A, Minonne L, Moroni A, Patelli Z, Razza C, Sivieri C, Valentini EM, Barrile GC. | Metabolites | 10.3390/metabo15020127 | 2025 | ||
| Enzymology | Crystal structure and putative substrate identification for the Entamoeba histolytica low molecular weight tyrosine phosphatase. | Linford AS, Jiang NM, Edwards TE, Sherman NE, Van Voorhis WC, Stewart LJ, Myler PJ, Staker BL, Petri WA. | Mol Biochem Parasitol | 10.1016/j.molbiopara.2014.01.003 | 2014 | |
| Anti-microbial antibodies in celiac disease: trick or treat? | Papp M, Foldi I, Altorjay I, Palyu E, Udvardy M, Tumpek J, Sipka S, Korponay-Szabo IR, Nemes E, Veres G, Dinya T, Tordai A, Andrikovics H, Norman GL, Lakatos PL. | World J Gastroenterol | 10.3748/wjg.15.3891 | 2009 | ||
| Enzymology | Biochemical and structural analyses of a bacterial endo-beta-1,2-glucanase reveal a new glycoside hydrolase family. | Abe K, Nakajima M, Yamashita T, Matsunaga H, Kamisuki S, Nihira T, Takahashi Y, Sugimoto N, Miyanaga A, Nakai H, Arakawa T, Fushinobu S, Taguchi H. | J Biol Chem | 10.1074/jbc.m116.762724 | 2017 | |
| In vitro communities derived from oral and gut microbial floras inhibit the growth of bacteria of foreign origins. | He X, Tian Y, Guo L, Ano T, Lux R, Zusman DR, Shi W. | Microb Ecol | 10.1007/s00248-010-9711-9 | 2010 | ||
| Phylogeny | Stressor exposure disrupts commensal microbial populations in the intestines and leads to increased colonization by Citrobacter rodentium. | Bailey MT, Dowd SE, Parry NM, Galley JD, Schauer DB, Lyte M. | Infect Immun | 10.1128/iai.00862-09 | 2010 | |
| Enzymology | Metagenomic analysis of human diarrhea: viral detection and discovery. | Finkbeiner SR, Allred AF, Tarr PI, Klein EJ, Kirkwood CD, Wang D. | PLoS Pathog | 10.1371/journal.ppat.1000011 | 2008 | |
| Pathogenicity | Tobacco-induced alterations to Porphyromonas gingivalis-host interactions. | Bagaitkar J, Williams LR, Renaud DE, Bemakanakere MR, Martin M, Scott DA, Demuth DR. | Environ Microbiol | 10.1111/j.1462-2920.2008.01852.x | 2009 | |
| Phylogeny | Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. | Suau A, Bonnet R, Sutren M, Godon JJ, Gibson GR, Collins MD, Dore J. | Appl Environ Microbiol | 10.1128/aem.65.11.4799-4807.1999 | 1999 | |
| Metabolism | Transposons to toxins: the provenance, architecture and diversification of a widespread class of eukaryotic effectors. | Zhang D, Burroughs AM, Vidal ND, Iyer LM, Aravind L. | Nucleic Acids Res | 10.1093/nar/gkw221 | 2016 | |
| Phylogeny | PCR-restriction fragment length polymorphism analysis for identification of Bacteroides spp. and characterization of nitroimidazole resistance genes. | Stubbs SL, Brazier JS, Talbot PR, Duerden BI. | J Clin Microbiol | 10.1128/jcm.38.9.3209-3213.2000 | 2000 | |
| Mining the human gut microbiota for effector strains that shape the immune system. | Ahern PP, Faith JJ, Gordon JI. | Immunity | 10.1016/j.immuni.2014.05.012 | 2014 | ||
| Pathogenicity | Comparative In vitro activities of ertapenem (MK-0826) against 1,001 anaerobes isolated from human intra-abdominal infections. | Goldstein EJ, Citron DM, Vreni Merriam C, Warren Y, Tyrrell KL. | Antimicrob Agents Chemother | 10.1128/aac.44.9.2389-2394.2000 | 2000 | |
| Pathogenicity | The Crohn's disease polymorphism, ATG16L1 T300A, alters the gut microbiota and enhances the local Th1/Th17 response. | Lavoie S, Conway KL, Lassen KG, Jijon HB, Pan H, Chun E, Michaud M, Lang JK, Gallini Comeau CA, Dreyfuss JM, Glickman JN, Vlamakis H, Ananthakrishnan A, Kostic A, Garrett WS, Xavier RJ. | Elife | 10.7554/elife.39982 | 2019 | |
| Metabolism | Insights into the evolution of sialic acid catabolism among bacteria. | Almagro-Moreno S, Boyd EF. | BMC Evol Biol | 10.1186/1471-2148-9-118 | 2009 | |
| Pathogenicity | Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996. | Snydman DR, Jacobus NV, McDermott LA, Supran S, Cuchural GJ, Finegold S, Harrell L, Hecht DW, Iannini P, Jenkins S, Pierson C, Rihs J, Gorbach SL. | Antimicrob Agents Chemother | 10.1128/aac.43.10.2417 | 1999 | |
| Metabolism | Colonization of mucin by human intestinal bacteria and establishment of biofilm communities in a two-stage continuous culture system. | Macfarlane S, Woodmansey EJ, Macfarlane GT. | Appl Environ Microbiol | 10.1128/aem.71.11.7483-7492.2005 | 2005 | |
| Pathogenicity | High incidence of cefoxitin and clindamycin resistance among anaerobes in Taiwan. | Teng LJ, Hsueh PR, Tsai JC, Liaw SJ, Ho SW, Luh KT. | Antimicrob Agents Chemother | 10.1128/aac.46.9.2908-2913.2002 | 2002 | |
| Pathogenicity | Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species. | Aldridge KE, Ashcraft D, Cambre K, Pierson CL, Jenkins SG, Rosenblatt JE. | Antimicrob Agents Chemother | 10.1128/aac.45.4.1238-1243.2001 | 2001 | |
| Phylogeny | Genome-Based Taxonomic Classification of Bacteroidetes. | Hahnke RL, Meier-Kolthoff JP, Garcia-Lopez M, Mukherjee S, Huntemann M, Ivanova NN, Woyke T, Kyrpides NC, Klenk HP, Goker M. | Front Microbiol | 10.3389/fmicb.2016.02003 | 2016 | |
| Arabinogalactan Utilization by Bifidobacterium longum subsp. longum NCC 2705 and Bacteroides caccae ATCC 43185 in Monoculture and Coculture. | Wang Y, LaPointe G | Microorganisms | 10.3390/microorganisms8111703 | 2020 | ||
| Phylogeny | "Bacteroides goldsteinii sp. nov." isolated from clinical specimens of human intestinal origin. | Song Y, Liu C, Lee J, Bolanos M, Vaisanen ML, Finegold SM. | J Clin Microbiol | 10.1128/jcm.43.9.4522-4527.2005 | 2005 | |
| Phylogeny | Bacteroides stercorirosoris sp. nov. and Bacteroides faecichinchillae sp. nov., isolated from chinchilla (Chinchilla lanigera) faeces. | Kitahara M, Sakamoto M, Tsuchida S, Kawasumi K, Amao H, Benno Y, Ohkuma M | Int J Syst Evol Microbiol | 10.1099/ijs.0.032706-0 | 2011 |
| #7844 | Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH ; Curators of the DSMZ; DSM 19024 |
| #20215 | Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.: List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. IJSEM ( DOI 10.1099/ijsem.0.004332 ) |
| #20218 | Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P.: StrainInfo introduces electronic passports for microorganisms.. Syst Appl Microbiol. 37: 42 - 50 2014 ( DOI 10.1016/j.syapm.2013.11.002 , PubMed 24321274 ) |
| #34561 | ; Curators of the CIP; |
| #54426 | Culture Collection University of Gothenburg (CCUG) ; Curators of the CCUG; CCUG 38735 |
| #66792 | Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann: Automatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) . |
| #66794 | Antje Chang, Lisa Jeske, Sandra Ulbrich, Julia Hofmann, Julia Koblitz, Ida Schomburg, Meina Neumann-Schaal, Dieter Jahn, Dietmar Schomburg: BRENDA, the ELIXIR core data resource in 2021: new developments and updates. Nucleic Acids Res. 49: D498 - D508 2020 ( DOI 10.1093/nar/gkaa1025 , PubMed 33211880 ) |
| #67770 | Japan Collection of Microorganism (JCM) ; Curators of the JCM; |
| #68367 | Automatically annotated from API 20A . |
| #68380 | Automatically annotated from API rID32A . |
| #68382 | Automatically annotated from API zym . |
| #69479 | João F Matias Rodrigues, Janko Tackmann,Gregor Rot, Thomas SB Schmidt, Lukas Malfertheiner, Mihai Danaila,Marija Dmitrijeva, Daniela Gaio, Nicolas Näpflin and Christian von Mering. University of Zurich.: MicrobeAtlas 1.0 beta . |
| #117087 | Collection of Institut Pasteur ; Curators of the CIP; CIP 104201 |
| #124043 | Isabel Schober, Julia Koblitz: Data extracted from sequence databases, automatically matched based on designation and taxonomy . |
| #125439 | Philipp Münch, René Mreches, Martin Binder, Hüseyin Anil Gündüz, Xiao-Yin To, Alice McHardy: deepG: Deep Learning for Genome Sequence Data. R package version 0.3.1 . |
| #126262 | A. Lissin, I. Schober, J. F. Witte, H. Lüken, A. Podstawka, J. Koblitz, B. Bunk, P. Dawyndt, P. Vandamme, P. de Vos, J. Overmann, L. C. Reimer: StrainInfo—the central database for linked microbial strain identifiers. ( DOI 10.1093/database/baaf059 ) |
You found an error in BacDive? Please tell us about it!
Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.
Successfully sent
If you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive1617.20260601.11
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data